LIST OF SCIENTIFIC PRESENTATIONS

  MONDAY, MAY 17, 1999

OPENING CEREMONY
Chairperson: J.S. Borer, New York NY, USA

GREETINGS
Asher Kimchi, USA
Founder and Chairman, International Academy of Cardiology
1st International Congress on Heart Disease

Jeffrey S. Borer, USA
Chairman, Scientific Executive Committee
Chairman, Section of Diagnostic Methods
International Academy of Cardiology
1st International Congress on Heart Disease

Clive Rosendorff, USA
Member, Scientific Executive Committee
Chairman, Section of Molecular Cardiology, Basic Research
International Academy of Cardiology
1st International Congress on Heart Disease

Uri Elkayam, USA
Member, Scientific Executive Committee
Chairman, Section of Heart Failure
International Academy of Cardiology
1st International Congress on Heart Disease

John A. Elefteriades, USA
Member, Scientific Executive Committee
Chairman, Section of Cardiac Surgery
International Academy of Cardiology
1st International Congress on Heart Disease

OPENING LECTURE:
Chairperson: M. Gheorghiade, Chicago IL, USA

09:30 OPENING LECTURE

INTRODUCTION
M. Gheorghiade, Chicago IL, USA
Member, Scientific Executive Committee
Chairman, Section of Coronary Artery Disease
International Academy of Cardiology
1st International Congress on Heart Disease

09:35 OPENING LECTURE
NEW CONCEPTS CONCERNING THE CELL BIOLOGY OF VULNERABLE PLAQUES
J.S. Forrester, Los Angeles CA, USA

MONDAY, MAY 17, 1999

10:45 - 12:30 HALL A

PL01: Plenary Session
MOLECULAR CARDIOLOGY, GENE THERAPY
Chairpersons: J.L. Mehta, Gainesville FL, USA
                                R.J.A. Trent, Camperdown, Australia

10:45 MODIFYING GENETIC FACTORS IN FAMILIAL HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
B. Yu, R.W. Jeremy, D.R. Richmond, R.J. Trent, Camperdown, Australia

11:00 MOLECULAR GENETICS OF FAMILIAL HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
L. Fananapazir, Bethesda MD, USA

11:15 VASCULAR GENE THERAPY USING TISSUE INHIBITORS OF METALLOPROTEINASES (Invited Lecture)
A.C. Newby, A.H. Baker, S.J. George, C.T. Lloyd, G.D. Angelini, Bristol, UK

11:30 ENGINEERING SKELETAL MYOBLASTS TO CIRCUMVENT IMMUNE REJECTION
J.M. Meuchel, T.R. Jones, D.A. Taylor, Durham NC, USA

11:45 ADENOVIRAL-MEDIATED MYOCARDIAL EXPRESSION OF A b-ADRENERGIC RECEPTOR TRANSGENE IMPROVES IN VIVO CARDIAC FUNCTION: A COMPARISON OF IMMUNOSUPPRESSION STRATEGIES
J.A. Hata, D.C. White, A.S. Shah, D.D. Glower, W.J. Koch, Durham NC, USA

12:00 THE ROLE OF ANGIOTENSIN II RECEPTOR EXPRESSION IN ISCHEMIA-REPERFUSION INJURY AND THE ROLE OF GENE THERAPY THEREIN (Invited Lecture)
J. Mehta, M.I. Phillips, B.C. Yang, Gainesville FL, USA

12:15 A GENOME-BASED STRATEGY FOR IDENTIFYING GENES ASSOCIATED WITH CARDIAC HYPERTROPHY AND HEART FAILURE (Invited Lecture)
A.A. Dempsey, C-C. Liew, Toronto ONT, Canada

12:30 L u n c h B r e a k

PL02: Plenary Session
NEW DEVELOPMENTS IN ECHOCARDIOGRAPHY AND INTRA CORONARY DOPPLER
Chairpersons: D.J. Sahn, Portland OR, USA
                                J.D. Thomas, Cleveland, OH, USA

10:45 ADVANCES IN ECHO ARCHITECTURE: NEW HORIZONS FOR NONINVASIVE DIAGNOSIS (Invited Lecture)
D. Sahn, Portland OR, USA

11:00 NEW ECHO METHODS FOR ASSESSING DIASTOLIC FUNCTION (Invited Lecture)
J.D. Thomas, Cleveland OH, USA

11:15 THE ROLE OF TRANSESOPHAGEAL ECHOCARDIOGRAPHY IN PATIENTS WITH ATRIAL FIBRILLATION: ITS ROLE IN RISK STRATIFICATION FOR THROMBOEMBOLISM AND SUCCESSFUL CARDIOVERSION (Invited Lecture)
R. Grimm, Cleveland OH, USA

11:30 THE ROLE OF 3D ECHOCARDIOGRAPHY IN VALVULAR HEART DISEASE (Invited Lecture)
F.J. Pinto, Lisbon, Portugal

11:45 NOVEL THREE-DIMENSIONAL ECHOCARDIOGRAPHY FOR VOLUMETRIC ASSESSMENT IN ONE CARDIAC CYCLE
T.S.M. Tsang, N.M. Rajamannan, Y. Agmon, M.E. Hagen, A. Joseph Jr., B.K. Khandheria, I. Meissner, J.B. Seward, Rochester MN, USA

12:00 ANGIOGRAPHIC CORONARY SLOW FLOW PHENOMENON INDICATES MICROVASCULAR DYSFUNCTION: STUDY WITH INTRACORONARY DOPPLER (Invited Lecture)
J. Ge, D. Baumgart, J. Qian, G. Gorge, M. Haude, R. Erbel, Essen, Germany

12:15 GENDER DIFFERENCES IN CORONARY SIZE ASSESSED BY INTRAVASCULAR ULTRASOUND
S.E. Sheifer, M.R. Canos, K.P. Weinfurt, U.K. Arora, F.O. Mendelsohn, B.J. Gersh, N.J. Weissman, Washington DC, USA

12:30 L u n c h B r e a k

S67: NEW APPROACHES TO SURGICAL REVASCULARIZATION, MINIMAL INVASIVE SURGERY, ANGIOGENESIS
Chairpersons: S.D. Herman, Newark NJ, USA
                                N.M. Katz, Washington, DC, USA

10:45 THERAPEUTIC ANGIOGENESIS IN ISCHEMIC MYOCARDIUM BY FIBRIN MESHWORK AND GROWTH FACTORS IN PATIENTS WITH ADVANCED CORONARY ARTERY DISEASE IN COMBINATION WITH VINEBERG PROCEDURE
W.D. Johnson, N.N. Kipshidze, Milwaukee WI, USA

11:00 PREOPERATIVE AND INTRAOPERATIVE BRAIN SPECT IMAGING: PREDICTORS OF NEUROLOGIC INJURY DURING OPEN HEART SURGERY
R.A. Hall, J.H. Holmes, D. Fordyce, M. Lee, R.P. Anderson, W.G. Campbell, R. Lee, Seattle WA, USA

11:15 A DIFFERENTIATED CONCEPT FOR THE TREATMENT OF CORONARY ARTERY DISEASE USING A VARIETY OF MINIMALLY INVASIVE SURGICAL TECHNIQUES
R. Cichon, M. Knaut, V. Gulielmos, T. Ahmadzade, T. Jost, S. Schueler, Dresden, Germany

11:30 REPAIR OF LLIAC ANEURYSM BY ENDOVASCULAR ENDOPROSYSTEM I: THE FRENCH EXPERIENCE
J.M. Cardon, A. Cardon, N. Mangialardi, A. Joyeux, D. Noblet, V. Vidal, T. Nguyen, Nimes, France

11:45 A HIGH MID-TERM GRAFT PATENCY RATE OBTAINED WITH A NEW NO-TOUCH SAPHENOUS VEIN GRAFT FOR CABG
D. Souza, H. Skoglund, G. Johansson, D. Filbey, V. Bomfim, Orebro, Sweden

12:00 PSEUDOANEURYSM OF THE FEMORAL ARTERY: TREATMENT BY THROMBIN INJECTION
H. Sievert, W. Pfeil, A. Baser, A. Fach, H. Merle, H. Spies, R. Ensslen, R. Schrader, D. Scherer, Frankfurt, Germany

12:15 CLINICAL EXPERIENCE AND ANGIOGRAPHIC OUTCOME OF PATIENTS UNDERGOING MINIMALLY INVASIVE DIRECT CORONARY ARTERY BYPASS GRAFT BY INFERIOR MINISTERNOTOMY TECHNIQUE
F. Guerra, L. Menicanti, E. Mossutto, G. Sangiorgi, L. Inglese, A. Frigiola, Milan, Italy

12:30 OFF-PUMP SURGERY FOR SINGLE- AND MULTIVESSEL CORONARY ARTERY DISEASE
R. Cichon, V. Gulielmos, M. Knaut, T. Jost, S. Schueler, Dresden, Germany

12:45 MINIMALLY TRAUMATIC CARDIAC SURGERY AN APPROACH TO REDUCE MORBIDITY AND LENGTH OF STAY
S.D. Herman, R. Sahni, C. Delacruz, A. Shehadeh, T. Schwarz, M. Farzin Aliasghapour, J. Haft, D. Bregman, Newark NJ, USA

13:00 LONG-TERM FUNCTIONAL CONSEQUENCES OF RADIAL ARTERY REMOVAL: ECHO-DOPPLER AND TRANSCUTANEOUS OXIMETRY ASSESSMENT
P. Pola, M. Serricchio, P. Tondi, M. Gaudino, D. De Martini, A. Gasbarrini, L. Gerardino, R. Pola, A. Santoliquidido, G.F. Possati, Rome, Italy

13:15 L u n c h B r e a k

MONDAY, MAY 17, 1999

S57: SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION
Chairpersons: H.R. Superko, San Mateo CA, USA
                                H.J. Geschwind, Creteil, France

10:45 IS THE MINIMAL MYOCARDIAL DAMAGE A NEW DIFFERENT ENTITY IN ACUTE CORONARY SYNDROME?
E.R. Perna, S.M. Macin, V. Mayans, J.P. Cimbaro Canella, D. Tacchi, M. Chacon, M.M. Civetta, E.F. Farias, S.M. Ruveda, J.R. Badaracco, Corrientes, Argentina

11:00 SMOKING CESSATION, BUT NOT SMOKING REDUCTION, REDUCES PLASMA HOMOCYSTEINE LEVELS
M. Bushara, P.E. McBride, D.E. Jorenby, T.B. Baker, M.C. Fiore, J.H. Stein, Madison WI, USA

11:15 THE EFFECT OF OBESITY ON LDL-CHOLESTEROL LEVELS IN AMERICAN INDIANS: THE STRONG HEART STUDY
D. Hu, J. Hannah, K.A. Jablonski, B.V. Howard, Washington DC, USA

11:30 REDUCTION IN TIME DOMAIN INDICES OF HEART RATE VARIABILITY FOLLOWING CAROTID ENDARTERECTOMY OR CAROTID ANGIOPLASTY
R.P. Steeds, A. Sivaguru, K. English, K.S. Channer, Sheffield, UK

11:45 DOES HEALTH AFFECT DRINKING BEHAVIOR? PRELIMINARY FINDINGS IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY, 1987-95
M. Eigenbrodt, F. Fuchs, R. Hutchinson, C. Paton, D. Goff, D. Couper, Chapel Hill NC, USA

12:00 ST DEPRESSION AND NEW LBBB ARE PREDICTORS OF INCREASED IN-HOSPITAL MORTALITY IN ACUTE MYOCARDIAL INFRACTION
R.S. Wright, W.L. Miller, J.P. Grill, S.L. Kopecky, F. Sgura, S. Asirvathamm, Rochester MN, USA

12:15 GRAPHICAL PLOTTING OF FRAMINGHAM RISK SCORES FOR OFFICE USE
J.G. Keevil, P. McBride, Madison WI, USA

12:30 THE PROGNOSTIC ROLE OF BIPHASIC RESPONSE DURING DIPYRIDAMOLE - ECHOCARDIOGRAPHY TEST IN PATIENTS AFTER UNCOMPLICATED ACUTE MYOCARDIAL INFARCTION
M. Radosavljevic, Z. Vasiljevic, N. Radovanovic, A. Karadzic, J. Kostic, V. Vukcevic, P. Mitrovic, D. Babic, T. Jozic, M.M. Nesovic, Belgrade, Yugoslavia

12:45 L u n c h B r e a k

MONDAY, MAY 17, 1999

S62: CARDIOMYOPATHY AND HEART FAILURE, MECHANISMS AND MANAGEMENT
Chairpersons: N.J. Angomachalelis, Thessaloniki, Greece
                                D.R. Nul, Buenos Aires, Argentina

10:45 CARDIAC INVOLVEMENT IN THE ACQUIRED IMMUNODEFICIENCY SYNDROME: A MULTICENTER CLINICAL-PATHOLOGIC-STUDY
G. Barbaro, G. Di Lorenzo, B. Grisorio, G. Barbarini, Pavia, Italy

11:00 MODIFICATION OF POST-INFARCTION REMODELING USING ANGIOTENSIN II RECEPTOR BLOCKADE
B.I. Jugdutt, Edmonton, Alberta, Canada

11:15 IMMUNOADSORPTION IMPROVES CARDIAC PERFORMANCE IN PATIENTS WITH SEVERE DILATED CARDIOMYOPATHY
J. Mueller, G. Wallukat, M. Dandel, H. Bieda, M. Hummel, R. Hetzer, Berlin, Germany

11:30 THREE DECADES OF FOLLOW-UP OF 1.196 CHAGAS DISEASE PATIENTS WITH COMPLETE AV BLOCK HEART FAILURE AND PACING
O.T. Greco, A. Cardinalli Neto, R. Costa, J. Vitola, S.A.C. Garzon, A.M. Lorga, R.V. Ardito, Sao Paulo, Brazil

11:45 INCIDENCE OF CARDIOMYOPATHY AND DETECTION OF HIV IN MYOCARDIAL CELLS OF HIV-POSITIVE PATIENTS
G. Barbaro, G. Di Lorenzo, B. Grisorio, G. Barbarini, Pavia, Italy

12:00 DIFFERENT BASELINE SYMPATHO-VAGAL BALANCE AND IMPAIRED AUTONOMIC RESPONSIVENESS IN ISCHEMIC AND IDIOPATHIC CARDIOMYOPATHY
G. Malfatto, M. Facchini, L. Sala, G.B. Perego, G. Branzi, R. Bragato, G. Leonetti, Milano, Italy

12:30 L u n c h B r e a k

MONDAY, MAY 17, 1999

P111: Poster Session
THE PLAQUE AND ACUTE CORONARY SYNDROME

Board No.

1 PLAQUE INFLAMMATION OCCURS IN THE ENTIRE CORONARY TREE OF PATIENTS DIED BY ACUTE MYOCARDIAL INFARCTION
A. Mauriello, E. Bonanno, G. Sangiorgi, G. Palmieri, L. Anemona, L.G. Spagnoli, Rome, Italy

2 LINKS BETWEEN CAROTID AND CORONARY ATHEROSCLEROSIS
Z. Huang, L. Gong, Z. Shi, Guangzhou, China

3 VULNERABILITY OF A PLAQUE SEARCHED BY NONINVASIVE, NOVEL DOPPLER TECHNIQUE
Y. Koiwa, H. Kanai, H. Hasegawa, H-I. Kamada, H. Chikama, K. Shirato, N. Chubachi, E. Fusimi, M. Hayashi, Sendai, Japan

4 MELATONIN IN PATIENTS WITH CORONARY ARTERY DISEASE, HYPERTENSIVE HEART DISEASE AND DILATED CARDIOMYOPATHY
P. Lercher, K. Stoschitzky, A. Sakotnik, P. Liebmann, W. Klein, Graz, Austria

5 EVOLUTION OF ACUTE CORONARY SYNDROME: A COMPARISON BETWEEN UNSTABLE ANGINA, NON-Q WAVE INFARCTION AND Q WAVE INFARCTION
E.R. Perna, S.M. Macin, J.P. Cimbaro Canella, V. Mayans, D. Tacchi, M. Chacon, J. Parras, E.F. Farias, M. Caceres, J.R. Badaracco, Corrientes, Argentina

6 A PRELIMINARY STUDY ON THE PROGNOSTIC VALUE OF TRANSIENT ISCHEMIA FOUND IN 24-HOUR MONITORING IN PATIENTS WITH UNSTABLE ANGINA
O.A. Najos, F. Enrique, B. Posas, A.A. Miranda, M.A.S. Lao, W.G. Dee, M.A.M. Iboleon, R.D. Saavedra, H.B. Calleja, Manila, Philippines

7 DIFFERENCE IN THE IN-HOSPITAL CASE-FATALITY RATE OF UNSTABLE ANGINA BETWEEN MEN AND WOMEN
L.C.S. Passos, A.A. Lopes, U. Costa, L. Nascimento, N. Lobo, A. Rabelo Jr., Salvador, Brazil

8 ACUTE CORONARY SYNDROMES - DIFFERENCE BETWEEN PATIENTS WITH OBSTRUCTIVE AND NORMAL CORONARY ARTERIES
L.C.S. Passos, A.C. Lopes, A.L. Rosario, N.O. Filho, R.V. Boss, A. Neri, A.R. Junior, Salvador, Brazil

9 CHLAMYDIA PNEUMONIAE INFECTION AND ATHEROSCLEROTIC CORONARY DISEASE
M. Penco, A. Varveri, L. Sgorbini, A. Dagianti, E. Biffani, S. Romano, A. Dagianti, R. Sessa, M. Di Pietro, M. Del Piano, Rome, Italy

10 DOES THE CORONARY ARTERY SPASM LEAD TO ATHEROSCLEROTIC STENOSIS? LONG-TERM FOLLOW-UP OF PATIENTS WITH VASOSPASTIC ANGINA
M. Watarai, H. Horibe, F. Matsubara, K. Takemoto, S. Shimizu, Y. Shiga, F. Takatsu, Aichi, Japan

MONDAY, MAY 17, 1999

P115: Poster Session
INTERVENTIONAL CARDIOLOGY, ANGIOPLASTY, STENTS

Board No.

11 PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY FOR TOTAL CORONARY OCCLUSION: THE EFFECT OF RESTENOSIS ON LEFT VENTRICULAR FUNCTION
T. Tukek, V. Akkaya, A.B. Sozen, S. Demirel, Y. Nisanci, Instanbul, Turkey

12 DIRECT CORONARY STENTING WITHOUT PREVIOUS BALLOON ANGIOPLASTY
A. Albarran, F. Hernandez, R. Gascuena, J. Tascon, P. Hernandez, M. Lazaro, J. Andreu, M. Alonso, Madrid, Spain

13 ELECTIVE AND NON-ELECTIVE INTRACORONARY STENTING: PROSPECTIVE COMPARISON OF CLINICAL OUTCOME
F.R. Amin, M. Yousufuddin, R.H. Stable, D. Francis, W. Shamim, A.S. Kurban, J.S. Clague, U. Sigwart, London, UK

14 FEMORAL HAEMOSTASIS AFTER TRANSCATHETER THERAPEUTIC INTERVENTION: A PROSPECTIVE RANDOMISED STUDY OF ANGIO-SEAL VS FEMOSTOP
F.R. Amin, M. Yousufuddin, W. Shamim, R.H. Stables, J. Clague, A.S. Kurban, U. Sigwart, London, UK

15 EFFECTS OF DIFFERENT DILATATION-PRESSURES ON THE EXPANSION OF CORONARY STENTS - A COMPARATIVE POSTMORTAL HISTOMORPHOLOGICAL AND MORPHOMETRICAL STUDY
T. Deneke, K.-M. Mueller, J. Barmeyer, S. Holt, P.H. Grewe, Bochum, Germany

16 SURFACE-STRUCTURE OF 30 DIFFERENT CORONARY STENTS - A SEM AND MORPHOMETRICAL ANALYSIS
K.-M. Muller, T. Deneke, A. Machraoui, S. Holt, J. Barmeyer, P.H. Grewe, Bochum, Germany

17 CHARACTERISTICAL MORPHOLOGICAL FINDINGS AFTER CORONARY STENTING - A HISTOLOGICAL STUDY AFTER POSTMORTEM AND INTRAVITAL STENTING
P.H. Grewe, J. Barmeyer, T. Deneke, S. Holt, K.-M. Mueller, Bochum, Germany

18 EMERGENCY REVASCULARIZATION AND HYBRID APPROACHES IN CARDIOGENIC SHOCK
F. Hernandez, P. Hernandez, J.C. Tascon, A. Albarran, M. Alonso, J. Andreu, R. Gascuena, M. Lazaro, J.E. Rodriguez, J.J. Rufilanchas, Madrid, Spain

19 SEVEN YEARS' FOLLOW-UP OF 181 CASES OF PRIMARY PTCA
Z. Huang, Y. Hou, M. Jia, Y. Liu, P. Wu, D. Xu, Guangzhou, China

20 PERCUTANEOUS CORONARY INTERVENTION (PCI) IN ELDERLY PATIENTS WITH ACUTE MI
N.M. Keller, V. Lazo de la Vega, F. Feit, H. Winer, New York NY, USA

21 NEW NITINOL STENT FOR PERCUTANEOUS TREATMENT OF BIFURCATED LESIONS: RESULTS OF A PRELIMINARY STUDY
J.C. Laborde, J.R. Seguin, J. Fajadet, B. Cassagneau, J. Marco, Toulouse, France

MONDAY, MAY 17, 1999

P115: Poster Session
INTERVENTIONAL CARDIOLOGY, ANGIOPLASTY, STENTS (cont)

Board No.

22 NOR-I, A BIODEGRADABLE METAL FOR CARDIOVASCULAR IMPLANTS. IN VITRO BIOCOMPATIBILITY AND MECHANICAL PROPERTIES
M. Peuster, P. Wuebbolt, H. Brauer, A. Fischer, G. Hausdorf, Hannover, Germany

23 IMPLANTATION OF ePTFE COVERED STENTS IN PATIENTS WITH SAPHENOUS VEIN GRAFT DISEASE: ACUTE AND LONG-TERM FOLLOW-UP
G. Sangiorgi, P. Cioffi, M. Medda, S. Castelvecchio, L. Inglese, Milano, Italy

24 THE EFFECT OF CORONARY STENT IMPLANTATION ON PLASMA PLATELET - ACTIVATING FACTOR LEVELS
C. Sekuri, H. Kultursay, L. Can, M. Kayikcioglu, M. Zoghi, O. Yavuzgil, S. Payzin, Izmir, Turkey

25 THE EFFECT OF STENT IMPLANTATION PRESSURE ON STENT-INDUCED THROMBOEMBOLISM IN AN OVINE ARTERIO-ARTERIAL EX-VIVO SHUNT MODEL
S. Sukavaneshvar, Y. Zheng, J. Danforth, M. Williams, K.A. Solen, F. Mohammad, Provo UT, USA

26 OUTCOME OF URGENT CORONARY INTERVENTIONS IN PATIENTS PRESENTING WITH ACUTE NON-Q-WAVE MYOCARDIAL INFARCTION IN A COMMUNITY HOSPITAL SETTING
R. Wolyn, P. Chowdhury, G.C. Timmis, J.A. Goldstein, W.W. O'Neill, Royal Oak MI, USA

 

MONDAY, MAY 17, 1999

P116: Poster Session
BLOCKADE OF TISSUE PROLIFERATION AFTER CORONARY INTERVENTIONS

Board No.

27 LP STENT IN A PORCINE MODEL
A. Popov, S. Kaul, N. Sinaii, P.K. Shah, P. Barath, Los Angeles CA, USA

28 HPA-3 POLYMORPHISM OF THE PLATELET FIBRINOGEN RECEPTOR IS NOT ASSOCIATED WITH AN INCREASED RISK OF THROMBOSIS OR RESTENOSIS AFTER CORONARY STENT PLACEMENT
C. Bottiger, A. Kastrati, W. Koch, J. Mehilli, N.V. Beckerath, A. Schoemig, Munich, Germany

29 ANTIPLATELET AND ANTICOAGULANT THERAPY IN POST-STENTING PATIENTS
Y. Hou, Z. Huang, Y. Liu, M. Jia, Guangzhou, China

MONDAY, MAY 17, 1999

P116: Poster Session
BLOCKADE OF TISSUE PROLIFERATION AFTER CORONARY INTERVENTIONS (cont)

Board No.

30 ADMINISTRATION OF CILOSTAZOL THERAPY AFTER SUCCESSFUL CORONARY STENT IMPLANTATION WAS USEFUL FOR THE PREVENTION OF RESTENOSIS
T. Kunishima, H. Musha, T. Iwasaki, J. Nagahima, Y. Masui, T. So, T. Nakamura, M. Sakakibara, H. Tochiki, M. Murayama, Kawasaki, Japan

31 REOPRO DOSAGE REGIMENS: CONFUSION OVER THE INFUSION TO ENHANCE PERFUSION?
D.J. Price, H. Bunce, P.G. Campbell, E.D. Grech, M.J. Stewart, A. Davies, J.A. Hall, M.A. de Belder, Middlesbrough, UK

32 ABCIXIMAB IN CORONARY STENTING: ROUTINE USE CANNOT BE JUSTIFIED
D.J. Price, P.G. Campbell, E.D. Grech, M.J. Stewart, A. Davies, J.A. Hall, M.A. de Belder, Middlesbrough, UK

33 REALISTIC USE OF ABCIXIMAB IN PERCUTANEOUS CORONARY INTERVENTION
D.J. Price, P.G. Campbell, A.G. Sutton, E.D. Grech, M.J. Stewart, A. Davies, J.A. Hall, M.A. de Belder, Middlesbrough, UK

34 THE EFFECT OF ABCIXIMAB AND WEIGHT-ADJUSTED HEPARIN ON ACTIVATED CLOTTING TIME IN ASIAN PATIENTS
H.C. Tan, Y.T. Lim, T.C. Yeo, T.T. Lim, A. Cheng, B.L. Chia, Singapore, Singapore

 

MONDAY, MAY 17, 1999

P122: Poster Session
HYPERTENSION, BASIC AND CLINICAL

Board No.

35 EFFECT OF ANTIPLATELET DRUGS ON ULTRASOUND-INDUCED AGGREGATIONOF PLATELETS IN VITRO
I.E. Adzerikho, A.G. Mrochek, A.B. Samal, Minsk, Belarus

36 EFFECTS OF TIME INTAKE OF TRANDOLAPRIL ON HEART RATE VARIABILITY AND BLOOD PRESSURE VALUES IN MODERATE ESSENTAIL HYPERTENSION
A. Campeanu, V. Teodorescu, Bucharest, Romania

37 AMBULATORY BLOOD PRESSURE MONITORING AND TARGET-ORGAN DAMAGE IN ESSENTIAL HYPERTENSION
H. Chen, B. Yuru, Y. Liuqin, Fuzhou, China

MONDAY, MAY 17, 1999

P122: Poster Session
HYPERTENSION, BASIC AND CLINICAL (cont)

Board No.

38 MICROCIRCULATION REACTIVITY IN NORMOTENSIVE SUBJECTS WITH A FAMILIAL PREDISPOSITION TO HYPERTENSION
J. Maver, M. Strucl, Ljubljana, Slovenia

39 EXERCISE PERFORMANCE IN HYPERTENSIVES: FELODIPINE VS CILAZAPRIL CROSS-OVER STUDY
G. Parrinello, S. Paterna, A. Pinto, P. Amato, E. Capodieci, A. Tuttolomondo, T. Maniscalchi, A. Bova, V. Accardo Palumbo, G. Follone, A. Ortoleva, G. Licata, Palermo, Italy

MONDAY, MAY 17, 1999

P125: Poster Session
DIABETES MELLITUS, OBESITY AND ATHEROSCLEROSIS

Board No.

40 THE ELECTROCARDIOGRAM IN MORBID OBESITY
M.A. Alpert, B.E. Terry, Mobile AL, USA

41 THE EFFECT OF THE K ⁺ AGONIST NICORANDIL ON PERIPHERAL VASCULAR RESISTANCE
M. Brodmann, U. Haiden, L. Schwarzl, R. Gasser, G. Stark, E. Pilger, Graz, Austria

42 USE OF STRESS DUPLEX AND ANKLE BRACHIAL INDEX IN THE ASSESSMENT OF PERIPHERAL VASCULAR DISEASE IN PATIENTS WITH DIABETES MELLITUS
M.J.D. Garcia, R.V. Anastacio, D.R. Flores Jr., E.S. Caguioa, R.A. Naranjilla, E. del Fuerte, Manila, Philippines

43 INFLUENCE OF DIABETES MELLITUS ON EARLY OUTCOME AFTER PERCUTANEOUS CORONARY INTERVENTIONS
A. Neri-Souza, G. Godinho, N. Ramos, R. Santos-Jesus, A. Rabelo, Salvador, Brazil

44 CORONARY ARTERY DISEASE IN DIABETIC WOMEN: COMPARISON OF THE SEVERITY OF CORONARY ARTERY DISEASE IN INSULIN DEPENDENT AND NON-INSULIN DEPENDENT DIABETIC WOMEN BY CORONARY ANGIOGRAPHY
A.M. Radwan, H.A. Hajar, Doha, Qatar

45 SILENT MYOCARDIAL ISCHAEMIA IN DIABETIC PATIENTS
M. Negrusz-Kawecka, J. Moszczynska-Stulin, D. Zytkiewicz-Jaruga, P. Salomon, Wroclaw, Poland

46 EFFECT OF HIGH FIBRE, LOW FAT DIET IN THE PREVENTION OF CORONARY ARTERY DISEASE IN DIABETICS
R. Sharma, New Delhi, India

47 DURATION OF DIABETES AFFECTS CARDIAC FUNCTION IN ASYMPTOMATIC, NORMOTENSIVE TYPE 2 DIABETES
B.H. Sung, K. Shah, S. Kidambi, M.F. Wilson, Buffalo NY, USA

MONDAY, MAY 17, 1999

P127: Poster Session
PRIMARY PREVENTION OF CORONARY ARTERY DISEASE

Board No.

48 HIGH ADMISSION RATES FOR PREMATURE CORONARY ARTERY DISEASE: ARE CURRENT GUIDELINES ON PRIMARY PREVENTION ADEQUATE?
K.O. Akosah, B. Gower, La Crosse WI, USA

49 THE TIME DEPENDENT EFFECT OF WATER HARDNESS ON HEART MUSCLE IN THE RATS
V. Bada, J. Kucharska, A. Gvozdjakova, Z. Braunova, j. Gvozdjak, Bratislava, Slovak Republic

50 THE FLAVONOIDS IN PROVEX CV® SIGNIFICANTLY INHIBIT EXPERIMENTAL THROMBOSIS IN STENOSED AND DAMAGED CANINE CORONARY ARTERIES
J. Folts, H. Osman, J. Reed, Madison WI, USA

51 FLAVONOIDS IN PROVEX CV®, INHIBIT HUMAN EX VIVO PLATELET AGGREGATION AND IN VITRO LDL OXIDATION
J. Folts, D. Shanmuganayagam, D. Wiebe, Madison WI, USA

52 STUDY OF HEART RATE VARIABILITY IN THE CHARACTERIZATION OF ANAEROBIC THRESHOLD (AT) IN DISCONTINUOUS DYNAMIC EXERCISE TESTS (DDET)
V.R.F.S. Maraes, E. Silva, T.F. Ribeiro, J. Petto, M.S.A. Moura, A.M. Catai, L. Oliveira, L.C. Trevelin, L. Gallo Jr., Sao Carlos, Brazil

53 ASSOCIATION OF RISK FACTORS IN A TEN-YEAR SURVEY MONICA PROGRAMME
M. Marin-Tarlea, C. Carp, E. Apetrei, I. Serban, C. Ceck, M. Patrascoiu, N. Florica, D. Mihaescu, Bucharest, Romania

54 PHYSICIAN PERSONAL COMPLIANCE TO NCEP GUIDELINES AND PRESENCE OF ADDITIONAL CAD RISK FACTORS
H.R. Superko, R.M. Krauss, P.T. Williams, San Mateo CA, USA

55 ATT (AGGREGATION, THROMBOSIS, THROMBOLYSIS) MODEL FOR TESTING PATIENTS WITH ATHEROTHROMBOTIC DISEASES, ITS PREDICTIVE, DIAGNOSTIC ROLE IN MONITORING & ASSESSING DISEASE & THERAPY IN INDIVIDUAL SUBJECTS
M.H. Wiener, F. Wiener, M. Burke, I. Yust, A. Iana, Tel Aviv, Israel

MONDAY, MAY 17, 1999

P138: Poster Session
ACE INHIBITORS AND ANGIOTENSIN-II RECEPTOR BLOCKER

Board No.

56 LOSARTAN VS. DELAPRIL IN PATIENTS WITH HEART FAILURE
O. Biadi, N. Gigli, R. Della'Anna, G. Musumeci, L. Papi, R. Mariotti, M. Mariani, Pisa, Italy

57 COMBINED TREATMENT WITH EPROSARTAN AND AN ANGIOTENSIN-CONVERTING ENZYME INHIBITOR IN CHRONIC HEART FAILURE
A. Lazar, A. Salajan, V. Salajan, O. Burta, L. Lazar, M. Popescu, Oradea, Romania

58 LISINOPRIL VERSUS ENALAPRIL IN PATIENTS WITH CONGESTIVE HEART FAILURE
M. Otljanska, B. Sidovska, M. Nospal, E. Srbinovska, S. Jovanova, Skopje, Macedonia

 

MONDAY, MAY 17, 1999

P139: Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY - BASIC
AND CLINICAL

Board No.

59 PROARRHYTHMIC EFFECTS OF FLECAINIDE DEPENDS ON CORONARY PATENCY AFTER THROMBOLYSED Q WAVE MYOCARDIAL INFARCTION
K.G. Adamian, A.V. Astvatsatrian, a.L. Chilingarian, A.Z. Garibgeanian, Yerevan, Armenia

60 HIGH-DOSE IV AMIODARONE IN THE CONVERSION TO SINUS RHYTHM OF  PAROXISMAL ATRIAL FIBRILLATION. WHEN IS IT NECESSARY?
F. Bellandi, R.P. Dabizzi, R. Palchetti, Prato, Italy

61 GENDER AND BETA-BLOCKER USE PREDICT SINUS RHYTHM MAINTENANCE AFTER ELECTIVE CARDIOVERSION FOR ATRIAL FIBRILLATION
J. Chakrabarti, S.D. Piraino, J.R. Cook, Springfield MA, USA

62 QT-DISPERSION IN PATIENTS WITH BRAIN INJURY OR SUBARACHNOID HEMORRHAGE
V. Dimitroula, G.F. Grekas, V.G. Koulouras, C.G. Siogas, D.A. Sideris, G. Nakos, Ioannina, Greece

63 APPLICATION OF HEART RATE VARIABILITY IN CHAGAS' DISEASE
A.S. Menezes Jr., C.F.M. Queiroz, F.P. Cazorla, J.C. Dourado, W.L. Carvalho, Goiania, Brazil

64 REACTION OF CARDIOVASCULAR SYSTEM TO THE PHYSICAL LOAD IN PATIENTS WITH ISCHEMIC HEART DISEASE, COMPLICATED BY  ATRIAL FIBRILLATION
A. Mrochek, A. Bulgak, V. Duda, A. Prystrom, M. Zakherevsky, Minsk, Belarus

65 TRANSMURAL DISPERSION OF REPOLARISATION AS A PREDICTOR OF VENTRICULAR ARRHYTHMIAS INDUCTION IN POST-MYOCARDIAL PATIENTS
A.Z. Pietrucha, D. Mroczek-Czernecka, W. Piwowarska, Cracow, Poland

MONDAY, MAY 17, 1999

P139: Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY - BASIC
AND CLINICAL (cont)

Board No.

66 CARDIAC MANIFESTATIONS OF ACUTE CARBAMATE AND ORGANOPHOSPHATE POISONING
A.M. Saadeh, N.A. Farsakh, M.K. Al-Ali, Irbid, Jordan

67 CLINICAL CHARACTERISTICS AND LONG-TERM COURSES IN 5 PATIENTS WITH ATRIAL STANDSTILL
S. Tsuji, N. Kotooka, K. Yoshida, T. Morooka, K. Kidou, T. Ryu, K. Yoshida, T. Ogata, K. Ohmori, T. Utsunomiya, S. Matsuo, Saga, Japan

68 THE COMBINATION OF REDUCED DOSES OF PROPAFENONE WITH MEXILETINE IS MORE EFFICACIOUS THAN PROCAINAMIDE PLUS MEXILETINE IN SUPPRESSING VENTRICULAR ARRHYTHMIAS
E. Zaimi, V. Gjini, G. Ndrepepa, E. Maci, S. Qirko, P. Cina, Tirana, Albania

 

MONDAY, MAY 17, 1999

P143: Poster Session
ELECTROPHYSIOLOGIC TECHNIQUES OF MAPPING AND RADIOFREQUENCY ABLATION

Board No.

69 RADIOFREQUENCY CATHETER ABLATION OF ATRIAL FLUTTER IN HEART TRANSPLANTED PATIENTS
S. Boveda, P. Lagrange, M. Galinier, N. Prouteau, E. Espaliat, A. Lagrange, P. Massabuau, M. Delay, J-M. Fauvel, J.-P. Bounhoure, Toulouse, France

70 INCIDENCE OF ATRIAL FIBRILATION AFTER RADIOFREQUENCY CATHETER ABLATION FOR COMMON ATRIAL FLUTTER
S. Boveda, P. Lagrange, N. Prouteau, M. Galinier, E. Espaliat, A. Lagrange, M. Delay, P. Massabuau, J-M. Fauvel, J.-P. Bounhoure, Toulouse, France

71 RECURRENCE OF ATRIAL ARRHYTHMIAS AFTER SUCCESSFUL RADIOFREQUENCY CATHETER ABLATION OF COMMON ATRIAL FLUTTER: SOME POSSIBLE FACTORS
S. Boveda, P. Lagrange, A. Pathak, M. Galinier, E. Espaliat, A. Lagrange, M. Delay, P. Massabuau, J-M. Fauvel, Toulouse, France

72 LONG-TERM RESULTS OF THE SURGICAL ABLATION GUIDED BY SINUS RHYTHM INTRAOPERATIVE MAPPING IN PATIENTS WITH VENTRICULAR TACHYCARDIA AFTER MYOCARDIAL INFARCTION
J. Bytesnik, J. Pirk, V. Vancura, K. Lefflerova, Prague, Czech Republic

MONDAY, MAY 17, 1999

P143: Poster Session
ELECTROPHYSIOLOGIC TECHNIQUES OF MAPPING AND RADIOFREQUENCY ABLATION (cont)

Board No.

73 OBSERVATION TIME AFTER A SUCCESSFUL RADIOFREQUENCY ABLATION IN AV ACCESSORY PATHWAYS
J.A. Gomez Guindal, J.L. Merino, R. Peinado, J. Perea, A. Sanchez, N. Sobrino, J.A. Sobrino, Madrid, Spain

74 RADIOFREQUENCY CATHETER ABLATION OF VENTRICULAR TACHYCARDIA IN RIGHT VENTRICULAR CARDIOMYOPATHY. IDENTIFICATION OF THE TARGET SITES BY CONCEALED ENTRAINMENT
E.E. Lazaris, A.G. Katsivas, A.G. Manolis, C. Vassilopoulos, D. Karatza, N. Louvros, Athens, Greece

75 CORONARY SINUS ABNORMALITIES IN PATIENTS WITH PARASEPTAL PATHWAYS
K.K. Talwar, R. Juneja, A.K. Chopra, P. Kamath, New Delhi, India

 

MONDAY, MAY 17, 1999

P145: Poster Session
PEDIATRIC CARDIOLOGY AND CARDIAC SURGERY, CONGENITAL HEART DISEASE

Board No.

76 DEEP VEIN THROMBOSIS AND PULMONARY EMBOLISM IN A 12-YEAR-OLD PATIENT WITH LARGE CELL LYMPHOMA: INTERVENTIONAL RECANALIZATION WITH THE AMPLATZ THROMBECTOMY DEVICE
M. Peuster, T. Paul, H. Bertram, G. Hausdorf, Hannover, Germany

77 LUNG FUNCTION BEFORE AND AFTER SURGERY FOR ATRIAL SEPTAL DEFECT AND TETRALOGY OF FALLOT
J. Sulc, A. Zapletal, J. Hruda, B. Hucin, M. Samanek, Prague, Czech Republic

78 BRONCHIAL HYPERREACTIVITY IN PATIENTS WITH CORRECTED CHT. COULD THESE PATIENTS DEVELOP ASTHMA?
J. Sulc, J. Hruda, A. Zapletal, B. Hucin, M. Samanek, Prague, Czech Republic

79 INTERVENTRICULAR COMMUNICATION IN COMPLETE ATRIOVENTRICULAR SEPTAL DEFECT
K. Suzuki, S.Y. Ho, R.H. Anderson, A.E. Becker, W.H. Neches, Tokyo, Japan

MONDAY, MAY 17, 1999

PL03: Plenary Session
LEFT VENTRICULAR HYPERTROPHY, HYPERTROPHIC CARDIOMYOPATHY
Chairperson: B.J. Maron, Minneapolis MN, USA
                                D.E. Wigle, Toronto, Ontario, Canada

13:45 STRATEGIES FOR THE MANAGEMENT AND RISK STRATIFICATION OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY (Invited Lecture)
B.J. Maron, Minneapolis MN, USA

14:00 ASSESSMENT AND TREATMENT OF HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (Invited Lecture)
W.H. Spencer III, Houston TX, USA

14:15 HYPERTROPHIC REMODELING OF THE LEFT VENTRICLE AND THE IMPLICATIONS OF RELATIVE WALL THICKNESS (Invited Lecture)
W.H. Gaasch, Burlington MA, USA

14:30 LEFT VENTRICULAR HYPERTROPHY AND MYOCARDIAL DAMAGE (Invited Lecture)
M. Ballester, Barcelona, Spain

14:45 THE SCIENTIFIC BASIS FOR EXCESS CARDIOVASCULAR MORTALITY IN LEFT VENTRICULAR HYPERTROPHY (Invited Lecture)
G.A. Mensah, Augusta GA, USA

15:00 TREATMENT OF HYPERTENSIVE LEFT VENTRICULAR HYPERTROPHY (Invited Lecture)
P.R. Liebson, Chicago IL, USA

15:15 PATHOLOGIC FIBROSIS AND CONNECTIVE TISSUE MATRIX IN LEFT VENTRICULAR HYPERTROPHY DUE TO CHRONIC ARTERIAL HYPERTENSION IN MAN
M.A. Rossi, Sao Paulo, Brazil

15:30 C o f f e e B r e a k

MONDAY, MAY 17, 1999

PL04: Plenary Session
ARRHYTHMIAS MECHANISMS, ANTIARRYTHMIC DRUGS AND IMPLANTABLE ANTIARRYTHMIC DEVICES
Chairpersons: M.E. Cain, St. Louis MO, USA
                                B. Luderitz, Bonn, Germany

13:45 MECHANISMS OF ATYPICAL RIGHT ATRIAL FLUTTER (Invited Lecture)
J. Cheng, W. Cabeen, M.M. Scheinman, Syracuse NY, USA

14:00 RECENT ADVANCES AND FUTURE DIRECTIONS IN THE TREATMENT OF ATRIAL FIBRILLATION - PHARMACOLOGICAL AND NON-PHARMACOLOGICAL ALTERNATIVES (Invited Lecture)
G.K. Feld, San Diego, CA, USA

14:15 QUALITY OF LIFE IN ATRIAL FIBRILLATION (Invited Lecture)
B. Luderitz, W. Jung, Bonn, Germany

14:30 INCIDENCE OF SPONTANEOUS ATRIAL TACHYARRHYTHMIAS IN PATIENTS TREATED WITH A COMBINED ATRIOVENTRICULAR DEFIBRILLATOR (Invited Lecture)
W. Jung, C. Wolpert, B. Luderitz, Bonn, Germany

14:45 PARENTERAL ANTIARRHYTHMIC DRUGS FOR SUPRAVENTRICULAR OR VENTRICULAR ARRHYTHMIAS (Invited Lecture)
P. Kowey, R.A. Marinchak, S.J. Rials, D.B. Bharucha, Wynnewood PA, USA

15:00 SUDDEN DEATH AND ARRHYTHMIAS IN TRANSGENIC MOUSE MODELS OF HEART DISEASE (Invited Lecture)
J. Jalife, Syracuse NY, USA

15:15 NONINVASIVE DETECTION OF THE ELECTROPHYSIOLOGIC FINGERPRINT THAT INCREASES SUSCEPTIBILITY TO SUSTAINED VENTRICULAR ARRHYTHMIAS (Invited Lecture)
M.E. Cain, H.D. Ambos, R.M. Arthur, St. Louis MO, USA

15:30 AMIODARONE PLUS BETA BLOCKERS, FAR FROM BEWILDERMENT, IN HIGH RISK SUDDEN DEATH PATIENTS (Invited Lecture)
D.R. Nul, Buenos Aires, Argentina

15:45 NEW DETECTION ALGORITHMS IN DUAL-CHAMBER IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS (Invited Lecture)
C. Wolpert, W. Jung, B. Luederitz, Bonn, Germany

16:00 C o f f e e B r e a k

MONDAY, MAY 17, 1999

S56: INTERVENTIONAL CARDIOLOGY: STENTS
Chairpersons: P.C. Block, Portland OR, USA
                                J.W. Moses, New York, NY, USA

13:45 IN-VIVO ASSESSMENT OF AN ACTIVATED PROTEIN C-ELUTING STENT
R.S. Foo, K. Hogrefe, J.H. Baron, D.P. de Bono, A.H. Gershlick, Leicester, UK

14:00 PERCUTANEOUS DIRECT MYOCARDIAL REVASCULARIZATION GUIDED BY BIOSENSE™ LEFT VENTRICULAR MAPPING IN PATIENTS WITH REFRACTORY CORONARY ISCHEMIC SYNDROMES
R. Kornowski, J. Moses, D.S. Baim, M.K. Hong, A. Stine, R.E. Kuntz, M.B. Leon, Washington DC, USA

14:15 THE SAFETY AND FEASIBILITY OF STENTING SMALL CORONARY ARTERIES: THE ACUTE AND MID TERM RESULTS OF BESTENT SMALL AND NIR-7
R. Moer, Y. Myreng, P. Molstad, K. Ytre-Ame, P.A. Simes, S. Golf, Feiring, Norway

14:30 REDUCED 6 MONTH ANGIOGRAPHIC RESTENOSIS RATE AFTER TREATMENT OF SAPHENOUS VEIN GRAFT DISEASE WITH THE WIKTOR HEPARIN COATED STENT
G. Van Langenhove, P. Vermeersch, D. Stockman, C. Convens, F. Van den Branden, P. Van den Heuvel, Antwerp, Belgium

14:45 CATHETER-BASED CORONARY INTERVENTIONS IN ATHEROSCLEROTIC CORONARY ARTERY ANEURYSMS: SHORT AND LONG-TERM CLINICAL OUTCOMES
S. Fuchs, R. Kornowski, H. Faraj, L.F. Satler, A.D. Pichard, A. Negoita, K.M. Kent, M.B. Leon, Washington DC, USA

15:00 CAROTID-PTA: STENT IMPLANTATION BEFORE BALLOON DILATATION MAY PREVENT THROMBOEMBOLIC COMPLICATIONS
H. Sievert, W. Pfeil, H-J. Schultze, H. Spies, H. Merle, R. Ensslen, R. Theis, K-F. Beykirch, A. Fach, C. Rubel, J. Peters, Frankfurt, Germany

15:15 STENTING OF TRUE BIFURCATION LESIONS WITH WIKTOR STENT: IMMEDIATE AND LONG TERM RESULTS
F. Airoldi, A. Anzuini, S. Rosanio, V. Legrand, H. Bonnier, M. Tocchi, M. Carlino, I. Sheiban, C. Di Mario, A. Colombo, Milan, Italy

15:30 C o f f e e B r e a k

MONDAY, MAY 17, 1999

S66: PEDIATRIC CARDIOLOGY AND CARDIAC SURGERY / CONGENITAL HEART DISEASE
Chairpersons: M. Hauser, Munich, Germany
                                H. Sievert, Frankfurt, Germany

13:45 MORPHOMETRIC ANALYSIS OF COMPLETE ATRIOVENTRICULAR SEPTAL DEFECT
K. Suzuki, S.Y. Ho, R.H. Anderson, A.E. Becker, W.H. Neches, Tokyo, Japan

14:00 TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE (PFO) IN 90 PATIENTS WITH SIX DIFFERENT OCCLUSION SYSTEMS
H. Sievert, U. Krumsdorf, P. Keppeler, R. Schrader, S. Rux, J. Dirks, U.U. Babic, R. Ensslen, A. Fach, H. Merle, D. Scherer, H. Spies, Frankfurt, Germany

14:15 STRESS-TESTING IN CHILDREN WITH TRANSPOSITION OF THE GREAT ARTERIES AFTER ARTERIAL SWITCH OPERATION: EXERCISE CAPACITY, VENTRICULAR FUNCTION AND MYOCARDIAL PERFUSION
M. Hauser, A. Kuhn, S. Braun, M. Schwaiger, J. Hess, Munich, Germany

14:30 COMPARISON OF CAPTOPRIL AND PROPRANOLOL THERAPY IN INFANTS WITH SEVERE CONGESTIVE HEART FAILURE DUE TO CONGENITAL HEART DISEASE
R. Buchhorn, M. Hulpke Wette, D. Bartmus, R. Schulz, A. Wessel, J. Buersch, Goettingen, Germany

14:45 CONVERSION OF ATRIOPULMONARY OR LATERAL ATRIAL TUNNEL CAVOPULMONARY ANASTOMOSIS TO EXTRACARDIAC CONDUIT CAVOPULMONARY ANASTOMOSIS
J.A.M. van Son, H. Hess, J. Hambsch, P. Schneider, G.S. Haas, F.W. Mohr, Leipzig, Germany

15:00 PREDICTION OF PSYCHOPATHOLOGY IN CHILDREN AND ADOLESCENTS WITH OPERATED CONGENITAL HEART DISEASE: FOLLOW-UP RESULTS
E.M.W.J. Utens, F.C. Verhulst, H.J. Duivenvoorden, F.J. Meijboom, R.A.M. Erdman, J. Hess, Rotterdam, The Netherlands

15:15 POST REPAIR FOLLOW UP OF TETRALOGY OF FALLOT
O. Milanesi, R. Biffanti, S. Salvadori, G. Svaluto Moreolo, S. Secchieri, M. Rubino, G. Stellin, Padova, Italy

15:30 CHANGES IN SUPERIOR VENA CAVA VELOCITY PATTERNS IN NORMAL NEONATES
M. Tamura, K. Harada, G. Takada, Akita, Japan

15:45 C o f f e e B r e a k

MONDAY, MAY 17, 1999

S53: VASCULAR BIOLOGY, BASIC AND CLINICAL RESEARCH I
Chairpersons: J.M. Hare, Baltimore MD, USA
                                 H. Schroder, Halle (Saale), Germany

13:45 LASER MYOCARDIAL REVASCULARIZATION ENHANCES EXPRESSION OF ANGIOGENIC CYTOKINES IN A PORCINE MODEL OF CHRONIC MYOCARDIAL ISCHEMIA
S. Fuchs, Y. Vodovotz, M.B. Leon, R. Kornowski, Washington DC, USA

14:00 INHIBITION OF RESTENOSIS BY AN ORALLY AVAILABEL CELL CYCLE INHIBITOR
J. Ruef, K. Peter, C. Bode, C. Patterson, Heidelberg, Germany

14:15 ACE INHIBITOR ENALAPRIL AND PROPIONYL-I-CARNITINE INDUCE APOPTOSIS IN RAT AORTIC SMOOTH MUSCLE CELLS THROUGH DIFFERENT MECHANISMS
A. Orlandi, M. Marcellini, G. Di Biagio, L.G. Spagnoli, Rome, Italy

14:30 INCREASE RATE OF SPONTANEOUS CELL DEATH CHARACTERIZES THE VESSEL WALL STRUCTURAL CHANGES ASSOCIATED WITH EARLY CORONARY ATHEROSCLEROSIS IN PORCINE CORONARY ARTERIES
G. Sangiorgi, D. Hasdai, A. Mauriello, D.R. Holmes Jr., R.S. Schwartz, A. Lerman, L.G. Spagnoli, Rome, Italy

14:45 PERSISTENT ELEVATION OF sP-SELECTIN, TNF-a AND TNF-a RECEPTOR IN PATIENTS WITH ACUTE CARDIOGENIC PULMONARY EDEMA
P. Somasundaram, B.H. Sung, S.A. Mousa, M.F. Wilson, Buffalo NY, USA

15:00 STANDARDIZED B-MODE IMAGING OF CAROTID AND FEMORAL ARTERY WALLS PROVE INTIMA-MEDIA THICKNESS MEASUREMENTS AS VALID SURROGATE ENDPOINTS IN ATHEROSCLEROSIS STUDIES
E. de Groot, A. Wiegman, A.D.M. Swijndregt, A.F.W. van der Steen, R.J.G. Peters, R.G.A. Ackerstaff, J.J.P. Kastelein, A.V.G. Bruschke, Amsterdam, The Netherlands

15:15 MICROVASCULAR VASOCONSTRICTION DURING RESTING ISCHEMIA IN PATIENTS WITH UNSTABLE ANGINA
M. Marzilli, G. Sambuceti, S. Fedele, C. Marini, A. L'Abbate, Pisa, Italy

15:30 ANTIGEN-PRESENTING DENDRITIC CELLS ARE PRESENT IN AORTIC ATHEROSCLEROTIC LESIONS IN RATS WITH DIET-INDUCED HYPERCHOLESTEROLAEMIA
J. Ozmen, Y.V. Bobryshev, R.S.A. Lord, Sydney, Australia

15:45 C o f f e e B r e a k

MONDAY, MAY 17, 1999

PL05: Plenary Session
HYPERTENSION, BASIC AND CLINICAL
Chairpersons: W.H. Gaasch, Burlington MA, USA
                                I. Rubinstein, Chicago, IL, USA

16:00 HYPERTENSION - DISEASE OR SYMPTOM? A  NEW UNDERSTANDING FROM THE MOLECULAR VIEWPOINT (Invited Lecture)
R. Gasser, M. Brodmann, E. Kickenweiz, S. Barth, W. Klein, Graz, Austria

16:15 INTERRELATIONS BETWEEN STRUCTURE AND FUNCTION IN LARGE ARTERIES
(Invited Lecture)
C. Pitsavos, Athens, Greece

16:30 ULTRASONIC MYOCARDIAL TEXTURE AND HYPERINSULINEMIA IN ESSENTIAL HYPERTENSION
V. Di Bello, O. Giampietro, R. Pedrinelli, E. Matteucci, D. Giorgi, M.T. Caputo, A. Bertini, E. Boldrini, E. Talini, M. Paterni, C. Giusti, Pisa, Italy

16:45 RENOVASCULAR HYPERTENSION REDUCES b-ADRENERGIC MEDIATED CORONARY VASODILATION IN CONSCIOUS DOGSfs
G.P. Kline, M.A. Williams, P.A. Gwirtz, Fort Worth TX, USA

17:00 SYMPATHETIC ACTIVATION IN HYPERTENSION AND IN HEART FAILURE
(Invited Lecture)
G. Grassi, G. Mancia, Monza (Milan), Italy

17:15 THE HALLS HARBOUR SPONTANEOUSLY HYPERTENSIVE HAMSTER (4H): A NEW RODENT MODEL OF ESSENTIAL HYPERTENSION (Invited Lecture)
I. Rubinstein, Chicago IL, USA

17:30 SUBGROUP AND PER-PROTOCOL ANALYSIS OF THE RANDOMIZED EUROPEAN TRIAL ON ISOLATED SYSTOLIC HYPERTENSION IN THE ELDERLY
J.A. Staessen, R. Fagard, L. Thijs, H. Celis, W.H. Birkenhager, C.J. Bulpitt, P.W. DeLeeuw, Leuven, Belgium

17:45 STATE OF RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM AT SUDDEN CARDIAC DEATH IN ESSENTIAL HYPERTENSIVE SUBJECTS WITH ALCOHOL INTOXICATION
V. Volkov, R. Sokolova, A. Vikhert, V. Zhdanov, Moscow, Russia

MONDAY, MAY 17, 1999

PL06: Plenary Session
ANTITHROMBOTIC AND ANTIPLATELET THERAPY FOR CORONARY DISEASE AND POOR VENTRICULAR FUNCTION
Chairpersons: M.D. Ezekowitz, New Haven CT, USA
                                J.E. Tcheng, Durham, NC, USA

16:00 ANTITHROMBOTIC THERAPY FOR LEFT VENTRICULAR DYSFUNCTION (Invited Lecture)
M.D. Ezekowitz, New Haven CT, USA

16:15 THE PLATELET GP IIb/IIIa INHIBITORS: WHY, WHEN, AND WHICH? (Invited Lecture)
J.E. Tcheng, Durham NC, USA

16:30 GP IIb/IIIa INHIBITORS IN ACUTE CORONARY SYNDROMES; WHAT HAVE WE LEARNED? (Invited Lecture)
P.C. Block, Portland OR, USA

16:45 THE RATIONALE OF MAGNESIUM AS ANTITHROMBOTIC TREATMENT FOR PATIENTS WITH CORONARY ARTERY DISEASE (Invited Lecture)
M. Shechter, Tel Hashomer, Israel

17:00 LOCAL DRUG DELIVERY ENHANCES ReoPro™ BINDING TO THE VESSEL WALL IN NON-HUMAN PRIMATES
B. Sundell, S. Verheye, K. Robinson, J. Cui, S. Ishiwata, D. Forestner, T. Pertile, N.A.F. Chronos, L.A. Harker, S.R. Hanson, Atlanta GA, USA

17:15 SAFETY AND EFFICACY OF CLOPIDOGREL COMPARED TO TICLOPIDINE FOR INTRACORONARY STENTING
N.E. Lepor, S.B. Gross, S.P. Luko, N.A. Buchbinder, Los Angeles CA, USA

17:30 EFFECT OF HEPARIN, TICLOPIDINE, AND AGGRASTAT ON STENT-INDUCED THROMBOEMBOLISM IN AN OVINE EX-VIVO ARTERIO-ARTERIAL SHUNT MODEL
Y. Zheng, S. Sukavaneshvar, F. Mohammad, K. Solen, Provo UT, USA

17:45 INFARCT ANGIOPLASTY: ABCIXIMAB AFTER RECENT THROMBOLYTIC THERAPY IS SAFE
D.J. Price, P.G. Campbell, A.G. Sutton, E.D. Grech, M.J. Stewart, A. Davies, J.A. Hall, M.A. de Belder, Middlesbrough, UK

MONDAY, MAY 17, 1999

S76: NEW FRONTIERS IN THE MANAGEMENT OF HEART FAILURE
Chairpersons: B. Pieske, Gottingen, Germany
                                U. Thadani, Oklahoma City, OK, USA

16:00 SAFETY STUDY OF NESIRITIDE (HUMAN B-TYPE NATRIURETIC PEPTIDE) FOR THE TREATMENT OF HOSPITALIZED PATIENTS WITH ACUTELY DECOMPENSATED CHF
U. Elkayam, M. Neibaur, H. Haught, D.P. Horton, Los Angeles CA, USA

16:15 EFFECT OF NESIRITIDE VERSUS DOBUTAMINE FOR TREATMENT OF ACUTELY DECOMPENSATED HEART FAILURE ON CARDIOVASCULAR ADVERSE EVENTS
A.J. Burger, A. Johnson, D. Horton, Boston MA, USA

16:30 INTERACTION BETWEEN SOLUBLE AND PARTICULATE GUANYLATE CYCLASES ON PULMONARY RESISTANCE VESSELS IN VIVO: THE ROLE OF ANP
H. Lippton, A. Hyman, New Orleans LA, USA

16:45 COMBINED ANGIOTENSIN II AND ENDOTHELIN-1 RECEPTOR BLOCKADE IN HEART FAILURE: EFFECT ON EXERCISE PERFORMANCE
C-P. Cheng, Winston-Salem NC, USA

17:00 RELEVANCE OF VENTRICULAR REMODELING TO CHANGES IN EXERCISE CAPACITY IN PATIENTS WITH CHRONIC HEART FAILURE
V.G. Florea, M.Y. Henein, S.D. Anker, D.P. Francis, J.S. Chambers, D.G. Gibson, A.J.S. Coats, London, UK

17:15 INACTIVATION OF RENIN ANGIOTENSIN SYSTEM IN TISSUE PREVENTS EXCESS HYPERTROPHY CONTRIBUTING TO TRANSITION TO HEART FAILURE
Y. Sakata, T. Masuyama, K. Yamamoto, T. Kondo, H. Mano, R. Doi, K. Ono, T. Kuzuya, M. Hori, Suita, Japan

17:30 LOSARTAN PREVENTS CONTRACTILE DYSFUNCTION FOLLOWING MYOCARDIAL INFARCTION IN RATS
M.C.G. Daniels, R.S. Keller, P.P. de Tombe, Ben Bosch, The Netherlands

MONDAY, MAY 17, 1999

S54: VASCULAR BIOLOGY, BASIC AND CLINICAL RESEARCH II
Chairpersons: H.M. Hoffmeister, Tubingen, Germany
                                P.K. Singal, Winnipeg, Canada

16:00 LDL STIMULATES MKP-1 EXPRESSION INDEPENDENT OF LDL RECEPTORS IN VASCULAR SMOOTH MUSCLE CELLS
B. Metzler, C. Li, Y. Hu, Q. Xu, Innsbruck, Austria

16:15 INHIBITION OF RESTENOSIS BY ALDOSE REDUCTASE ANTAGONISM
J. Ruef, T.K. Nordt, C. Bode, C. Patterson, Heidelberg, Germany

16:30 ANGIOGRAPHICALLY NORMAL INTERNAL MAMMARY ARTERIES SHOW NEOINTIMA FORMATION IN LATE-STATE CHD
N. Al-Fakhri, B. Huang, M. Heidt, B. Hinrichs, F.W. Hehrlein, N. Katz, Giessen, Germany

16:45 LOCAL OR SYSTEMIC DELIVERY OF AN ANTISENCE INHIBITS C-MYC EXPRESSION FOLLOWING BALLOON ANGIOPLASTY
P. Iverson, V. Skrinska, E. Keane, D. Stein, D. Weller, P. Chawla, A. Tamarkin, N.N. Kipshidze, Milwaukee WI, USA

17:00 INHIBITION OF PLATELET FUNCTION BY PURPLE GRAPE JUICE IN VITRO AND IN VIVO
J. Freedman, L. Deak, R. Sauter, J.D. Folts, C. Parker, Washington DC, USA

17:15 EFFECT OF CORONARY ANGIOPLASTY ON CORONARY MICROVASCULAR RESPONSE TO TACHYCARDIA
G. Sambuceti, M. Marzilli, S. Fedele, C. Marini, A. L'Abbate, Pisa, Italy

17:30 CHARACTERIZATION OF THE CARDIOVASCULAR SYSTEM IN A NEW EXPERIMENTAL MODEL OF STRESS-SENSITIVE ARTERIAL HYPERTENSION (ISIAH RAT STRAIN)
N.A. Machanova, A.L. Markel, Novosibirsk, Russia

MONDAY, MAY 17, 1999

SAT: Satellite Symposium
ATHEROSCLEROSIS UPDATE: CAUSES, CONSEQUENCES AND CLINICAL MANAGEMENT OF CORONARY DISEASE
This Symposium is sponsored by the Long Island Jewish Medical Center, The Long Island Campus for the Albert Einstein College of Medicine
This Symposium is made possible in part by an unrestricted educational grant from Pfizer Inc.

Chairperson: M. Bodenheimer, New Hyde Park NY, USA

19:30 INTRODUCTION
M. Bodenheimer, New Hyde Park NY, USA

19:35 THE AGING HEART: CURRENT CONCEPTS AND CLINICAL COROLLARIES IN PATIENTS WITH CORONARY DISEASE
C.M. O'Connor, Durham NC, USA

20:00 TRADITIONAL AND NEWER IMAGING TECHNIQUES IN THE EVALUATION OF CORONARY DISEASE AND ITS TREATMENT
S. Nissen, Cleveland OH, USA

20:25 NEW DIRECTIONS IN THE MANAGEMENT OF ATHEROSCLEROSIS: CLINICAL TRIAL UPDATE
B. Pitt, Ann Arbor MI, USA

20:50 NEW MECHANISMS OF CYTOPROTECTION IN CARDIOVASCULAR DISEASE
R.P. Mason, Pittsburgh PA, USA

21:15 Discussion

21:25 CONCLUDING REMARKS
M. Bodenheimer, New Hyde Park NY, USA

MONDAY, MAY 17, 1999

P101: Poster Session
MOLECULAR CARDIOLOGY, BASIC RESEARCH

Board No.

1. DIFFERENTIAL EXPRESSION PATTERNS OF CARDIAC PROTEIN KINASE C ISOFORMS IN SEVERE DILATED CARDIOMYOPATHY AND IN AORTIC STENOSIS - A PIVOTAL ROLE FOR PKC-b?
S.K. Briem, S. Lichte, R. Lange, S. Hagl, W. Kuebler, R.H. Strasser, Heidelberg, Germany

2. ANTIISCHEMIA DRUG PREDUCTAL AS SELECTIVE, ACTIVATOR OF Cu,Zn-SUPEROXIDE DISMUTASE
E.V. Kalinina, I.A. Komissarova, R.M. Zaslavskaya, M.D. Novichkova, E.N. Kelimberdieva, Moscow, Russia

3. A NEW METHOD FOR SUCCESSFUL CULTURE OF HUMAN CARDIOMYOCYTES
K. Macfelda, T. Wild, S.C. Beutelspacher, A.M. Groeger, B. Kapella, U. Losert, E. Wolner, R. Seitelberger, Vienna, Austria

4. ENDOTHELIN INTERACTS WITH ADENYLATE CYCLES AND MODIFIES ELECTROPHYSIOLOGICAL EFFECTS OF ISOPROTERENOL ON ISOLATED CANINE VENTRICULAR MYOCYTES
A. Mohacsi, J. Magyar, T. Banyasz, P. Nanasi, Debrecen, Hungary

5. THE MORPHOLOGIC CHARACTERISTICS OF CARDIAC MYOCYTES AND COLLAGEN MATRIX IN PATIENTS WITH END-STAGE HEART FAILURE
J.J. Shyu, S.H. Chu, S.S. Wang, N.K. Chou, S.K. Liu, Taipei, Taiwan-R.O.C.

6. ANGIOTENSIN-CONVERTING ENZYME GENE INSERTION/DELETION POLYMORPHISM AND OBSTRUCTIVE SLEEP APNEA
J. Zhang, R. Hui, Gesangluobu, M. Xu, J. Ye, W. Pei, Y. Sun, B. Liu, L. Liu, Beijing, China

 

MONDAY, MAY 17, 1999

P109: Poster Session
NUCLEAR CARDIOLOGY

Board No.

7. NON INVASIVE ESTIMATION OF INVASIVE TREATMENT RESULTS OF PATIENTS WITH CORONARY ARTERY STENOSIS
B. Birkenfeld, E. Plonska, R. Gil, J. Goracy, E. Slovinska, M. Puchala, A. Wojtarowicz, Szczecin, Poland

8. DETECTION OF VIABLE MYOCARDIUM: A STUDY OF PERFUSION, BEFORE AND AFTER SURGICAL REVASCULARIZTION, IN SUBJECTS WITH PREVIOUS MYOCARDIAL INFARCT
W.A. Chalela, P.J. Moffa, J.F. Ramires, A.P. Moraes, J. Soares Jr., C. Meneghetti, Sao Paulo, Brazil

MONDAY, MAY 17, 1999

P109: Poster Session
NUCLEAR CARDIOLOGY (cont)

Board No.

9. DUAL ISOTOPES (TI-201 AND I-123-BMIPP) SPECT STUDIES IN DETECTING MYOCARDIAL SALVAGE EFFECTS OF ACUTE MYOCARDIAL INFARCTION WITH VARIOUS REPERFUSION THERAPIES
T. Furuta, T. Kondo, M. Sarai, A. Matsuba, S. Motoyama, M. Tokuda, H. Yokoi, Y. Abo, Y. Watanabe, Nagoya, Japan

10. PROGNOSTIC VALUE OF THE MYOCARDIUM PERFUSION STUDIES WITH 99Tcm-SESTAMIBI SPECT
F.G. Gallego, J. Pereira, J. Perea, P. Robles, D. Hernandez, Madrid, Spain

11. COMPARISON OF RADIONUCLIDE ANGIOGRAPHY AND TWO - DIMENSIONAL ECHOCARDIOGRAPHY WITH CONTRAST ANGIOGRAPHY IN DETECTION OF VENTRICULAR ANEURYSM
C.T. Ginghina, E. Apetrei, G. Jovin, B. Fotiade, I. Ene, I. Kulcsar, D. Qeshta, Bucharest, Romania

12. EFFECT OF CHAMBER SIZE ON ACCURACY OF DUAL ISOTOPE MYOCARDIAL PERFUSION SPECT
E.Y. Kimchi, X. Kang, H.C. Lewin, J.D. Friedman, G. Germano, R. Hachamovitch, D.S. Berman, Los Angeles CA, USA

13. VISUALIZATION OF SUBENDOCARDIAL ISCHEMIA / INFARCTION BY SERIAL ECG-GATED DUAL (TE-99m-TETROFOSMIN (Tf) MYOCARDIAL AND Tc-99mm-HSAD CARDIAC POOL) SPECT
T. Kondo, M. Sarai, J. Wang, M. Tokuda, S. Motoyama, A. Matsuba, H. Shinozaki, E. Ishikawa, K. Ohshima, Y. Nakamura, T. Furuta, J. Ishii, H. Kurokawa, H. Naruse, Y. Watanabe, S. Tachiki, Toyoake, Japan

14. COMPARISON OF THE CK-MB LEVEL AFTER CABG WITH Tc-99m-MIBI SPECT AND RADIONUCLIDE VENTRICULOGRAPHY IN PREDICTING THE EFFICACY OF REVASCULARISATION
P. Kwinecki, A. Baszko, M. Jemielity, P. Buczkowski, K. Blaszyk, M. Ruchala, A. Cieslinski, A. Ponizynski, J. Sowinski, Poznan, Poland

15. THE VALIDATION OF RISK AREA ASSESSMENT BY ECG AT HOSPITAL ARRIVAL OBTAINED BEFORE REPERFUSION THERAPY IN ACUTE MYOCARDIAL INFARCTION. -COMPARISON WITH SCINTIGRAPHICAL AREA AT RISK
K. Watanabe, H. Matsuo, K. Sano, K. Suzuki, Y. Hashimoto, I. Murata, K. Hayakawa, S. Tanihata, T. Matsubara, Y. Matsuno, S. Watanabe, Gifu, Japan

MONDAY, MAY 17, 1999

P117: Poster Session
LEFT VENTRICULAR REMODELING AFTER MYOCARDIAL INFARCTION

Board No.

16. EXERCISE INDUCED QRS PROLONGATION IS A PREDICTOR OF POSTINFARCTION REMODELING
K.G. Adamian, A.L. Chilingarian, A.V. Astvatsatrian, A.Z. Garibgeanian, Yerevan, Armenia

17. EFFECTS OF REVASCULARIZATIONOF TOTALLY OCCLUDED CORONARY ARTERIES ON LEFT VENTRICULAR PERFORMANCE IN PATIENTS AFTER MYOCARDIAL INFARCTION
S. Ozgul, Kahramanmaras, Turkey

18. DECREASED SENSITIVITY TO b-ADRENERGIC STIMULATION OF VENTRICULAR L-TYPE CALCIUM CURRENT IN INFARCT-INDUCED HYPERTROPHY IN RATS
R.M. Saraiva, M.O. Masuda, Rio de Janeiro, Brazil

19. CHRONIC HEART FAILURE IN REMODELING AFTER MYOCARDIAL INFARCTION: SELECTIVE REGULATION OF THE ISOZYMES OF PROTEIN KINASE C
G. Simonis, J. Honold, C. Weinbrenner, U. Oehl, R.H. Strasser, Heidelberg, Germany

 

MONDAY, MAY 17, 1999

P119: Poster Session
SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION, CARDIAC REHABILITATION

Board No.

20. EPIDEMIOLOGICAL STUDY OF HYPERTENSION IN FOUR MOSCOW SUBURBAN TOWNS. RESULTS OF DEMOGRAPHY, SOCIAL AND MEDICAL SCREENING OF 1998
A. Britov, A. Deev, S. Shalnova, N. Eliseeva, R. Oganov, Moscow, Russia

21. THE IMPACT OF SILENT ISCHEMIA ON CARDIAC ENZYMES AND WALL MOTION IN PATIENTS UNDERGOING AEROBIC EXERCISE
D. Dobies, K. Tobin, H. Friedman, P. Marcovitz, M. Pica, W. O'Neill, B. Franklin, Royal Oak MI, USA

22. DOES LOW FLUID INTAKE INCREASE THE RISK OF STROKE? FINDINGS FROM THE ADVENTIST HEALTH STUDY
S.F. Knutsen, J. Chan, Loma Linda CA, USA

23. DETERMINANTS OF THE AMOUNT OF AUTONOMIC RESPONSE TO REHABILITATION AFTER MYOCARDIAL INFARCTION
G. Malfatto, M. Facchini, L. Sala, G. Branzi, R. Bragato, G. Leonetti, Milano, Italy

24. QUALITY OF LIFE IMPROVEMENT AFTER MYOCARDIAL REVASCULARISATION
B. Mihajlovic, M. Potic, Z. Potic, M. Popov, Z. Konstantinovic, S. Popovic, D. Jakovljevic, N. Radovanovic, Novi Sad, Yugoslavia

MONDAY, MAY 17, 1999

P119: Poster Session
SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION, CARDIAC REHABILITATION (cont)

Board No.

25. PROGNOSTIC FACTORS OF RECURRENT MYOCARDIAL INFARCTION
R. Radisauskas, Kaunas, Lithuania

26. TIME TRENDS OF THE HEALTH PROFILE AND MORTALITY IN THE MALE POPULATION OF TALLINN, ESTONIA
O. Volozh, A. Deev, T. Kalyuste, R. Kaup, E. solodkaya, J. Abina, G. Goldsteine, A. Olferiev, Tallinn, Estonia

 

MONDAY, MAY 17, 1999

P121: Poster Session
MODIFICATION OF LIPOPROTEINS AND CORONARY DISEASE

Board No.

27. IS MILD HYPERCHOLESTEROLEMIA WITHOUT MULTIPLE RISK FACTORS BENIGN IN YOUNG ADULTS? THE GUNDERSEN PREMATURE CORONARY DISEASE REVIEW
K.O. Akosah, B. Gower, La Crosse WI, USA

28. LOWER INCIDENCE OF CORONARY DISEASE IN PUERTO RICO (USA ISLAND) THAN IN THE CONTINENTAL USA: A POSSIBLE PROTECTIVE EFFECT OF A LOWER LDL/HDL LIPOPROTEIN RATIO
P.I. Altieri, E. Rodriguez, N. Escobales, R. Gonzalez, H. Banch, M.J. Crespo, J. Rodriguez, San Juan, Puerto Rico

29. SHORT-TERM TREATMENT WITH HIGH-DOSE SIMVASTATIN IMPROVES WIDESPREAD VASCULAR PERMEABILITY IN SUBJECTS WITH OVERT ATHEROSCLEROTIC DISEASE
S. Bandinelli, G. dell'Omo, L. Pucci, M. Mariani, R. Navalesi, R. Pedrinelli, G. Penno, Pisa, Italy

30. SAFETY AND EFFICACY OF FIBRATES IN DIABETIC AND NON-DIABETIC PATIENTS WITH REFRACTORY COMBINED HYPERLIPIDEMIA
M. Kayikcioglu, F. Ozerkan, O. Yavuzgil, M. Zoghi, C. Gurgun, H. Kultursay, L. Can, C. Turkoglu, Izmir, Turkey

31. PURPLE GRAPE JUICE PROTECTS LDL FROM OXIDATION IN CORONARY ARTERY DISEASE PATIENTS TAKING VITAMIN E
J.G. Keevil, D. Wiebe, J.D. Folts, Madison WI, USA

32. CORRELATION OF LIPOPROTEIN(A), HOMOCYSTEINE AND MYOCARDIAL STRESS THALLIUM SCINTIGRAPHY IN CHD PATIENTS
G. Lupattelli, B. Palumbo, D. Siepi, C. Casciari, P.F. Anniboletti, A. Bianchi, L. Pasqualini, G. Schillaci, R. Palumbo, E. Mannarino, Perugia, Italy

MONDAY, MAY 17, 1999

P121: Poster Session
MODIFICATION OF LIPOPROTEINS AND CORONARY DISEASE (cont)

Board No.

33. ORALLY APPLIED ENTEROCOCCUS FAECIUM M-74 IN PREVENTIVE CARDIOLOGY
Z. Mikes, M. Ferencik, L. Ebringer, E. Jahnova, I. Ciznar, Bratislava, Slovak Republic

34. PREVALENCE OF DYSLIPIDEMIA DURING IN-HOSPITAL PHASE OF THE ACUTE CORONARY SYNDROMES
L.C.S. Passos, R. Santos-Jesus, D. Flores, U. Costa, N. Lobo, A. Rabelo Jr., Salvador, Brazil

 

MONDAY, MAY 17, 1999

P126: Poster Session
DIABETES MELLITUS, OBESITY AND ATHEROSCLEROSIS

Board No.

35. WEIGHT LOSS, WEIGHT MAINTENANCE AND IMPROVEMENT IN CARDIOVASCULAR RISK AFTER 2 YEARS OF ORLISTAT THERAPY
A.E. Meinders, Leiden, The Netherlands

36. BODY HABITUS IN ACUTE HEART FAILURE PATIENTS: OBESITY PREDICTS IMPROVED OUTCOMES
D. Milzman, R. Samaddar, K. Samaddar, J. Morissey, L. Moscowitz, Washington DC, USA

37. DIABETES MELLITUS - AN INCREASED RISK FACTOR FOR ISCHEMIC HEART DISEASE IN FEMALE?
M. Monteiro, A. Felix, V. Mendes, C. Barradas, A. Sousa, I. Joao, J. Sa Nogueira, A. Aleixo, A. Sales Luis, Lisbon, Portugal

38. RELATION OF HEART RATE VARIABILITY AND LEFT VENTRICLE DIASTOLIC FUNCTION TO SILENT ISCHEMIA DURING 24 HOUR AMBULATORY ECG IN PATIENT WITH NON-INSULIN DEPENDENT DIABETES MELLITUS
A. Mrochek, D. Goncharik, Minsk, Belarus

 

MONDAY, MAY 17, 1999

P129: Poster Session
HORMONE THERAPY IN POSTMENOPAUSAL WOMEN

Board No.

39. TIBOLONE EFFECT ON BLOOD PRESSURE AND PLASMA LIPIDS IN HYPERTENSIVE WOMEN
G. Lloyd, N. Patel, E. McGing, A. Cooper, A. Wierzbicki, G. Jackson, London, UK

40. CORONARY ARTERY LESIONS AND LEFT VENTRICULAR FUNCTION IN FEMALE PATIENTS WITH CORONARY ARTERY DISEASE
S. Ozgul, Kahramanmaras, Turkey

MONDAY, MAY 17, 1999

P130: Poster Session
CARDIAC INVOLVEMENT IN HIV INFECTION

Board No.

41. DIASTOLIC DYSFUNCTION IS AN EARLY MARKER OF CARDIAC INVOLVEMENT IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION
F. Hernandez, P. Escribano, M.T. Velazquez, F. Lombera, M. Pombo, R. Dalmau, C.S. de la Calzada, Madrid, Spain

42. ECHOCARDIOGRAPHY DETECTS IMMUNE-RELATED ASYMPTOMATIC CARDIAC INVOLVEMENT IN HUMAN IMMUNODEFICIENCY VIRUS INFECTION
F. Hernandez, P. Escribano, M.T. Velazquez, F. Lombera, P. Hernandez, R. Gascuena, M. Lazaro, C.S. de la Calzada, Madrid, Spain

 

MONDAY, MAY 17, 1999

P131: Poster Session
NITRIC OXIDE AND NITRIC OXIDE SYNTHASE IN HEART FAILURE

Board No.

43. NO DOES NOT MEDIATE CORONARY VASODILATION SECONDARY TO SIMULATED ISCHEMIA: A STUDY ON K_ATP -CHANNELS AND N^W -NITRO-1-ARGININ ON CORONARY PERFUSION PRESSURE IN ISOLATED LANGENDORFF-PERFUSED GUINEA PIG HEARTS
E. Kickenweiz, M. Brodmann, R. Gasser, H. Brussee, W. Klein, Graz, Austria

 

MONDAY, MAY 17, 1999

P148: Poster Session
ANGIOPLASTY OR SURGERY FOR MULTIVESSEL CORONARY ARTERY DISEASE

Board No.

44. SURGICAL REVASCULARIZATION OF POSTERIOR CORONARY ARTERIES WITHOUT CARDIOPULMONARY BYPASS
J.G. Lobo Filho, J.M.A.C. de Albuquerque, C. Bellini, G. Gomes, M.C. Letiao, E.B. Pinheiro, J.N. Paes Jr., R.P. de Siqueira, M.M. Landim, R.R.M. Oliveira, Fortaleza, Brazil

45. OUTCOMES IN A RANDOMIZED COMPARISON OF MINIMALLY INVASIVE CABG WITH CONVENTIONAL CABG AND PTCA STENT; THE OCTOPUS STUDY
E. Buskens, Utrecht, The Netherlands

46. LONG TERM SURVIVAL IN PATIENTS WITH CORONARY ARTERY BYPASS GRAFTING: IMPACT OF ARTERIAL REVASCULARIZATION
O. Garcia, J. Fourcade, D. Roux, Y. Glock, P. Berdague, G. Fournial, Toulouse, France

MONDAY, MAY 17, 1999

P148: Poster Session
ANGIOPLASTY OR SURGERY FOR MULTIVESSEL
CORONARY ARTERY DISEASE (cont)

Board No.

47. PREDICTORS OF LONG TERM SURVIVAL AFTER CORONARY ARTERY BYPASS GRAFTING IN PATIENTS UNDER 65 YEARS
O. Garcia, J. Fourcade, D. Roux, Y. Glock, P. Berdague, G. Fournial, Toulouse, France

48. HYBRID REVASCULARIZATION: MINIMALLY INVASIVE SURGERY PLUS ANGIOPLASTY, INITIAL RESULTS IN 16 PATIENTS
R. Gascuena, A. Albarran, F. Hernandez, E. Rodriquez, M.J. Lopez, J. Tascon, J. Andreu, M. Alonso, M. Lazaro, P. Hernandez, Madrid, Spain

49. CORONARY ARTERY SURGERY WITHOUT CARDIOPULMONARY BYPASS IN PATIENTS OVER 80 YEARS OF AGE
G. Lobo Filho, C.B.G. Gomes, J.M.A.C. de Albuquerque, A. Feitosa, M.C. Leitao, E.B. Pinheiro, J.N. Paes Junior, R.M. Landim, R.P. de Siqueira, R.M. Oliveira, Fortaleza, Brazil

50. SURGICAL TREATMENT OF DIFFUSE AND DISTAL CORONARY ARTERY DISEASE - EXPERIENCE IN OVER 3,000 OPERATED PATIENTS
N. Radovanovic, L. Petrovic, S. Nicin, J. Selestiansky, Z. Jonjev, J. Lavac, M. Fabri, P. Kovacevic, M. Mijatov, V. Scekic, S. Popovic, Z. Konstantinovic, M. Preradovic, Novi Sad, Yugoslavia

 

MONDAY, MAY 17, 1999

P151: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULT

Board No.

51. IMMEDIATE AND LONG TERM OUTCOME AFTER AORTIC VALVE REPLACEMENT AMONG PATIENTS WITH SEVERE AORTIC STENOSIS AND LEFT VENTRICULAR SYSTOLIC DYSFUNCTION PHILIPPINE HEART CENTER EXPERIENCE
A.M.L.A. Delos Reyes-Javier, P. Palmes, S.M. Lacson, R.D. Jara, R.J. Santos, A. Rico, Manila, Philippines

52. THE VALUE OF CARDIAC TROPONIN IN THE DIAGNOSIS OF RHEUMATIC FEVER
M.J.D. Garcia, R.V. Anastacio, D.R. Flores Jr., E.S. Caguioa, R.A. Naranjilla, E.S. del Fuerte, Manila, Philippines

53. AIRWAY FUNCTION DISTURBANCES AFTER SUCCESSFUL CORRECTION OF A MITRAL VALVE DISEASE. LONG TERM FOLLOW UP
T. Hryniewiecki, I. Rawczynska-Englert, R. Malinowski, P. Gutkowski, Warsaw, Poland

MONDAY, MAY 17, 1999

P151: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULT (cont0

Board No.

54. SURGICAL OUTCOME AND LONG-TERM RESULTS AFTER AORTIC VALVE REPLACEMENT IN OCTOGENARIANS
P. Kolh, L. Lahaye, P. Gerard, R. Limet, Liege, Belgium

55. EFFECTIVE MITRAL REGURGITANT ORIFICE AREA. COMPARISON OF THREE ECHOCARDIOGRAPHIC METHODS
C.S. Berensztein, D.J. Pineiro, M.M. Marcotegui, R.L. Brunoldi, G. Lanosa, J. Lerman, Buenos Aires, Argentina

56. EVOLUTION OF AORTIC REGURGITATION AFTER PERCUTANEOUS BALLOON MITRAL VALVULOTOMY
A. Popa, E. Apetrei, C. Ginghina, M. Iacob, I. Coman, C. Carp, Bucharest, Romania

57. LEFT ATRIAL KINETIC ENERGY IN NORMAL SUBJECTS AND IN PATIENTS WITH MITRAL STENOSIS
S. Qirko, T. Goda, A. Dibra, Tirana, Albania

 

MONDAY, MAY 17, 1999

P154: Poster Session
PRACTICE GUIDELINES, COST CONTAINMENT

Board No.

58. ANALYSIS AND COMPARISON OF CORONARY CARE UNIT COST PROCESS IN TWO CONSECUTIVE YEARS
J.A. Gomez, I. Roldan, I.G. Maqueda, J. Perea, A. Sanchez, E.R. Armada, H. Navarro, L.M. Jadraque, H. La Paz, Madrid, Spain

59. CARDIO-RESPIRATORY PATTERNS OF THE OBESE SUBJECT DURING EXERCISE IN THE PERSPECTIVE OF A TRAINING PROGRAM
A. Salvadori, P. Fanari, F. Nibbio, A. Saezza, E. Longhini, Verbania, Italy

60. FEASIBILITY AND SAFETY OF EARLY EXERCISE TESTING USING THE BRUCE PROTOCOL AFTER ACUTE MYOCARDIAL INFARCTION
M.P. Senaratne, G.A. Smith, Edmonton, Alberta, Canada

61. MANAGEMENT OF 1700 HYPERTENSIVE DIABETIC OUTPATIENTS AND GUIDELINES USE IN GENERAL PRACTICE
A. Zaninelli, A. Filippi, Florence, Italy

MONDAY, MAY 17, 1999

P156: Poster Session
MISCELLANEOUS

Board No.

62. GRAPE SEED PROCYANIDINS: ISOLATION, IDENTIFICATION, AND ENDOTHELIUM-DEPENDENT VASORELAXING ACTIVITY
D.F. Fitzpatrick, B. Bing, D. Maggi, D. Fries, R. O'Malley, Tampa FL, USA

63. ECHOCARDIOGRAPHY BEFORE AND AFTER PERICARDIECTOMY IN PATIENTS WITH CONSTRICTIVE PERICARDITIS - COULD BE ONLY ONE METHOD TO EXPLORE?
C.T. Ginghina, E. Apetrei, I. Stoian, I. Kulcsar, D. Qeshta, I. Ene, C. Matei, Bucharest, Romania

64. GRAVITATIONAL STRESS (GS) IN SYSTEMIC SCLEROSIS (SS)
E.S. Isasi, A. Cassinelli, R. Vignale, M.E. Isasi, Montevideo, Uruguay

65. CARDIAC INVOLVEMENT IN ANTIPHOSPHOLIPID SYNDROME
I. Moyssakis, M. Tektonidou, K. Boki, F. Triposkiadis, M. Gofa, M. Kyriakidis, Athens, Greece

66. CHANGES OF RIGHT VENTRICULAR DIASTOLIC FUNCTION IN PATIENTS WITH SYSTEMIC SCLEROSIS
I. Moyssakis, F. Triposkiadis, V. Vasiliou, M. Gofa, G. Anastasiadis, M. Kyriakidis, Athens, Greece

67. ABNORMAL SYSTOLIC BLOOD PRESSURE RESPONSE IN THE RECOVERY PHASE OF EXERCISE TESTING AS A PREDICTOR OF CORONARY ARTERY DISEASE
A. Zarife, E. Camara, F. Galvao, L. Viana, O. Marques, W. Freitas, C. Macedo, M. Santos, M. Guimaraes, A. Rabelo Jr., Salvador, Brazil

  TUESDAY, MAY 18, 1999

PL07: Plenary Session
NEW INSIGHTS INTO THE MECHANISMS OF HEART FAILURE
Chairpersons: W.C. Little, Winston-Salem NC, USA
                            H.N. Sabbah, Detroit MI, USA

08:30 DIASTOLIC DYSFUNCTION: CONTRIBUTION TO EXERCISE INTOLERANCE
(Invited Lecture)
W. Little, Winston-Salem NC, USA

08:45 INHIBITION OF DOPAMINE BETA-HYDROXYLASE AS A THERAPEUTIC TARGET IN THE TREATMENT OF HEART FAILURE (Invited Lecture)
H.N. Sabbah, S. Goldstein, Detroit MI, USA

09:00 ALTERED EXCITATION-CONTRACTION COUPLING IN HEART FAILURE (Invited Lecture)
G. Hasenfuss, B. Pieske, J. Prestle, Freiburg, Germany

09:15 APOPTOSIS AND CARDIAC DISEASES - NEW OPPORTUNITIES FOR NOVEL THERAPEUTICS (Invited Lecture)
G.Z. Feuerstein, Wilmington DE, USA

09:30 AGONIST STIMULATED NITRIC OXIDE PRODUCTION AND MYOCARDIAL CONTRACTILITY (Invited Lecture)
J.M. Hare, Baltimore MD, USA

09:45 CLINICAL USE OF INHALED NITRIC OXIDE IN ADULT CARDIAC SURGICAL PATIENTS (Invited Lecture)
K.J. Ramsay, M.A.E. Ramsay, K. Lynch, H.A.T. Hein, D.M. Meyer, Dallas TX, USA

10:00 OXIDATIVE STRESS AND HEART FAILURE: ROLE OF VITAMIN A (Invited Lecture)
V. Palace, M. Hill, I. Danelisen, P.K. Singal, Manitoba, Winnipeg, Canada

10:15 BASIC ASPECTS OF HEART FAILURE: HUMAN MYOCARDIUM (Invited Lecture)
C.J.F. Holubarsch, Freiburg, Germany

10:30 SARCOPLASMIC RETICULUM FUNCTION IN HEART FAILURE
P. Neary, A.M. Duncan, G.L. Smith, S.M. Cobbe, Glasgow, UK

10:45 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

PL08: Plenary Session
MODIFICATION OF LIPOPROTEINS AND CORONARY DISEASE
Chairpersons:       C. Rosendorff, New York NY, USA
                                Y. Stein, Jerusalem, Israel

08:30 REVERSE CHOLESTEROL TRANSPORT - A NEW METHOD FOR QUANTITATIVE ASSESSMENT OF CHOLESTEROL EFFLUX IN VIVO (Invited Lecture)
Y. Stein, O. Stein, Jerusalem, Israel

08:45 LDL CHOLESTEROL AND VASCULAR STRUCTURE AND FUNCTION (Invited Lecture)
C. Rosendorff, New York NY, USA

09:00 NON-HDLC DOES NOT REFLECT THE PRESENCE OF SMALL LDL PATTERN B
(Invited Lecture)
H.R. Superko, R.M. Krauss, San Mateo CA, USA

09:15 TISSUE O₂ AVAILABILITY IS A FUNCTION OF THE PLASMA CHOLESTEROL (Invited Lecture)
H. Buchwald, H.J. Menchaca, V.N. Michalek, B.A.T.D. Rohde, T.J. O'Dea, Minnesota MN, USA

09:30 THE INFLUENCE OF LIPIDS ON THE INCIDENCE OF THROMBOCYTOSIS FOLLOWING MYOCARDIAL REVASCULARIZATION
J.T. Christenson, Geneva, Switzerland

09:45 AN IN VITRO STUDY ON THE ANTIOXIDANT CAPACITY OF STATINS
F. Franzoni, F. Regoli, F. Galetta, Pisa, Italy

10:00 EFFECTS OF ATORVASTATIN ON PLASMA HOMOCYSTEINE LEVELS IN SUBJECTS WITH FAMILIAL HYPERCOLESTEROLEMIA
L. Pucci, S. Bandinelli, G. Penno, M. Pilo, R. Navalesi, A. Bertolotto, Pisa, Italy

10:15 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

S77: PEDIATRIC CARDIOLOGY AND CARDIAC SURGERY, CONGENITAL HEART DISEASE
Chairperson: M. Hauser, Munich, Germany

08:30 CORONARY FLOW RESERVE ASSESSED BY POSITRON EMISSION TOMOGRAPHY (PET) IN CHILDREN WITH TRANSPOSITION OF THE GREAT ARTERIES (TGA) AFTER ANATOMICAL CORRECTION
M. Hauser, A. Kuhn, M. Beckmann, F. Bengel, M. Schwaiger, J. Hess, Munich, Germany

08:45 CATHETER CLOSURE OF INTER-ATRIAL DEFECTS IN ADULTS WITH SELF-CENTERING DEVICES
H. Sievert, U. Krumsdorf, P. Keppeler, S. Rux, R. Schrader, A. Fach, D. Scherer, R. Ensslen, H. Merle, H. Spies, H. Zeplin, Frankfurt, Germany

09:00 PSYCHOPATHOLOGY IN YOUNG ADULTS WITH CONGENITAL HEART DISEASE: FOLLOW-UP RESULTS
E.M.W.J. Utens, H.J.M. Versluis, F.C. Verhulst, F.J. Meijboom, E. Bos, J.R.T.C. Roelandt, J. Hess, Rotterdam, The Netherlands

09:15 PULMONARY ARTERY SLING: REIMPLANTATION VERSUS ANTETRACHEAL TRANSLOCATION
J.A.M. van Son, G.S. Haas, H. Hess, J. Hambsch, P. Schneider, F.W. Mohr, Tampa, USA

09:30 STENT IMPLANTATION FOR THE TREATMENT OF EARLY POSTOPERATIVE THROMBOSIS OF MODIFIED BLALOCK-TAUSSIG-SHUNTS
M. Peuster, T. Paul, H. Bertram, G. Hausdorf, Hannover, Germany

09:45 PREDISPOSING FACTORS OF VALVE REGURGITATION IN COMPLETE ATRIOVENTRICULAR SEPTAL DEFECT
K. Suzuki, S. Mimori, T. Kikuchi, Y. Takahashi, Y. Murakami, Tokyo, Japan

10:00 THE RESULTS OF THE REPAIR OF ATRIAL SEPTAL DEFECT WITH OR WITHOUT PARTIAL ANOMALOUS PULMONARY VENOUS CONNECTION IN PATIENTS OVER 40 YEARS OLD. ECHOCARDIOGRAPHIC AND CLINICAL STUDY
L. Paluszkiewicz, M. Jemielity, B. Perek, P. Buczkowski, A. Szyszka, W. Dyszkiewicz, A. Ponizynski, Poznan, Poland

10:15 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

S78: ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY- BASIC AND CLINICAL
Chairpersons:        J. Jalife, Syracuse NY, USA
                                S. Schaefer, Davis CA, USA

08:30 QUANTITATIVE COMPARISON OF ATRIAL FIBRILLATION AND VENTRICULAR FIBRILLATION IN THE SAME ANIMALS
G.L. Pierpont, C.C. Gornick, J.A. Hauck, B.D. Pederson, J.J. Alwin, J.M. Weigenant, Minneapolis MN, USA

08:45 CHANGES OF AUTONOMIC NERVOUS SYSTEM ACTIVITY IN UREMIC PATIENTS ON HEMODIALYSIS
F. Franzoni, A. Cupisti, A. Caprioli, C. Giusti, G. Barsotti, F. Galetta, Pisa, Italy

09:00 OUABAIN PROMOTES DELAYED AFTERDEPOLARIZATION DEPENDENT TRIGGERED ACTIVITY IN THE HYPETROPHIED BUT NOT IN THE NON-HYPERTROPHIED CANINE HEART
M. De Groot, M. Vos, J. Leunissen, M. Schoenmakers, H.J.J. Wellens, Maastricht, The Netherlands

09:15 RADIOFREQUENCY CATHETER ABLATION OF CENTRAL SUPERHIGH WAY OF ATRIAL CONDUCTION IS EFFECTIVE IN TERMINATING SUSTAINED ATRIAL FIBRILLATION IN DOGS
D. Hu, T. Liu, X. Yang, C. Guo, Beijing, China

09:30 IMPLANTATION OF PERMANENT PACEMAKERS GUIDED BY TRANSTHORACIC ECHOCARDIOGRAPHY
G. Diaz, P. Pacheco, H. Acuna, A. Diaz, Chiclayo, Peru

09:45 INTRACARDIAC ECHOCARDIOGRAPHIC EVALUATION OF RADIOFREQUENCY LESION EFFECTS IN ATRIAL AND VENTRICULAR MYOCARDIUM
J.-F. Ren, D.J. Callans, D. Schwartzman, J.J. Michele, K.S. Li, F.E. Marchlinski, Pittsburgh PA, USA

10:00 NEW-ONSET ATRIAL FIBRILLATION IN Q WAVE ANTERIOR MYOCARDIAL INFARCTION; PROGNOSTIC SIGNIFICANCE OF RECURRENCES OF ATRIAL FIBRILLATION
M. Asanin, J. Perunicic, V. Vukcevic, A. Arandjelovic, D. Orlic, P. Mitrovic, B. Sreckovic, M. Nesovic, M. Matic, Z. Vasiljevic, D. Boskovic, Belgrade, Yugoslavia

10:15 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

S73: ECHOCARDIOGRAPHY, PHARMACOLOGIC STRESS TESTING
Chairpersons:        J. Ge, Essen, Germany
                                 F.J. Pinto, Lisboa, Portugal

08:30 MULTICENTER VIDEODENSITOMETRIC ASSESSMENT OF EFFECTS OF BIOLOGICAL FACTORS ON EFFICACY OF OPTISON™ AND ALBUNEX® IN DIFFICULT-TO-IMAGE PATIENTS
E. Hausnerova, J.S. Gottdiener, D.E. Bruns, H. Dittrich, J.L. Cohen, J.C. Pezzullo, Washington DC, USA

08:45 DETERIORATION OF MYOCARDIAL FUNCTION DURING DOBUTAMINE ECHOCARDIOGRAPHY DOES NOT EXCLUDE IMPROVEMENT AFTER SURGICAL REVASCULARIZATION
L. Paluszkiewicz, M. Jemielity, A. Szyszka, A. Baszko, A. Cieslinski, Poznan, Poland

09:00 EXERCISE ECHOCARDIOGRAPHY: ITS ACCURACY AND VALUE IN THE PROGNOSIS OF PATIENTS WITH KNOWN OR SUSPECTED CORONARY ARTERY DISEASE (CAD)
J.T. Baltasar, O.P. Saniel, E.B. Baello, Jr., Quezon city, Philippines

09:15 LOW-DOSE DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN CHILDREN AND YOUNG ADULTS
D. De Wolf, B. Suys, L. Foubert, H. Verhaaren, Y. Taeymans, D. Matthys, Gent, Belgium

09:30 STRESS TESTING OF PATIENTS WITH LEFT BUNDLE BRANCH BLOCK EVALUATED IN A CHEST PAIN CENTER FOR ACUTE CARDIAC ISCHEMIA
M.G. Mikhail, S. Frederiksen, Ann Arbor MI, USA

09:45 STRESS ECHOCARDIOGRAPHY IN PATIENTS WITH POOR ACOUSTIC WINDOWS: IS MULTIPLANE TRANSESOPHAGEAL ECHOCARDIOGRAPHY ESSENTIAL?
J. Gude, E. Horstmann, H.J. Trappe, Herne, Germany

10:00 IS A PACEMAKER INDICATED FOR VASOVAGAL PATIENTS WITH SEVERE CARDIO-INHIBITORY REFLEX AS IDENTIFIED BY THE ATP TEST? A PRELIMINARY RANDOMIZED TRIAL
D. Flammang, M. Antiel, T. Church, D. Hamani, E. Donal, Angouleme, France

10:15 PREDICTIVE VALUE OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY FOR CARDIAC EVENTS IN PATIENTS PRESENTING WITH CHEST PAIN
A.J. McNeill, P. Seydak, M. McBurney, S.H. Barr, H.M. Dunn, J.A. Purvis, Londonderry N. Ireland, UK

10:30 CONTRIBUTION OF HEAD-UP TILT TEST AND ATP TEST IN ASSESSING THE MECHANISMS OF VASOVAGAL SYNDROME. INFERENCES TO THE THERAPEUTIC STRATEGY
D. Flammang, D. Hamani, E. Donal, M. Erickson, T. Church, Angouleme, France

10:45 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

PL09: Plenary Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY
Chairpersons:        M.D.J. Antunes, Coimbra, Portugal
                                J.S. Borer, New York NY, USA

10:45 THE BIOLOGY OF REGURGITANT VALVULAR DISEASES (Invited Lecture)
J. Borer, New York NY, USA

11:00 THE DIRECTIONS OF MITRAL REGURGITATION: THE "INS" AND "OUTS" OF THE MITRAL VALVE (Invited Lecture)
E.D. Wigle, Toronto ONT, Canada

11:15 OPEN MITRAL COMMISSUROTOMY (Invited Lecture)
M.D. Antunes, M.J. Antunes, Coimbra, Portugal

11:30 AORTIC VALVE SURGERY: A PROSPECTIVE AND RANDOMIZED STUDY OF MINISTERNOTOMY VERSUS CONVENTIONAL SURGERY
R.R. Dias, N.A.G. Stoff, Sao Paulo, Brazil

11:45 LEFT VENTRICULAR REMODELLING AFTER AORTIC VALVE REPLACEMENT WITH A FREESTYLE STENTLESS BIOPROSTHESIS
L.H.B. Baur, Y. Houdas, C.H. Peels, A. Prat, A.P. Kappetein, J. Braun, E.E. van der Wall, H.A. Huysmans, Leiden, The Netherlands

12:00 POISEUILLE'S MODEL (POIS-M) IS LESS FLOW-DEPENDENT AND MORE USEFUL IN DESCRIBING CIRCULATORY IMPAIRMENT IN AORTIC STENOSIS (AS) THAN TORRICELLI'S MODEL (TORR-M)
A. Malavasi, A. Tucconi, G. Di Girolamo, L. Cassisa, M. Pala, C. Poddighe, P. Masala, C. Denurra, A. Muretto, E. Solinas, Sassari, Italy

12:15 BALLOON MITRAL VALVULOPLASTY USING MODIFIED TECHNIQUE - OUR EXPERIENCE
C.N. Manjunath, K.H. Srinivas, C.B. Patil, H.V. Venkatesh, T.S. Bhoopal, C. Dhanalakshmi, S. Jayadeva, Bangalore, India

12:30 LONG-TERM OUTCOME OF OPERATED PATIENTS WITH CHRONIC AORTIC REGURGITATION AND EXTREME LEFT VENTRICULAR DILATATION
B. Ivanovic, D. Kalimanovska, D. Simic, D. Matic, B. Vujisic, D. Nikcevic, P. Djukic, Belgrade, Yugoslavia

12:45 L u n c h B r e a k

TUESDAY, MAY 18, 1999

PL10: Plenary Session
CLINICAL ASPECTS OF CORONARY ARTERY DISEASE
Chairpersons:        R.O. Cannon, III, Bethesda MD, USA
                                J.S. Forrester, Los Angeles CA, USA

10:45 Na-H EXCHANGE INHIBITION IN LIMITING ISCHEMIC INJURY - CLINICAL IMPLICATIONS (Invited Lecture)
S. Schaefer, Davis CA, USA

11:00 HEMOSTASIS AND INFLAMMATION IN ACUTE CORONARY SYNDROMES (Invited Lecture)
H.M. Hoffmeister, Tubingen, Germany

11:15 ASPIRIN INCREASES FERRITIN SYNTHESIS IN ENDOTHELIAL CELLS: A NOVEL ANTIOXIDANT PATHWAY (Invited Lecture)
H. Schroder, Halle (Saale), Germany

11:30 ARE NEW PHARMACOLOGICAL AGENTS SUPERIOR TO OLD DRUGS FOR TREATING PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE? EFFECTS ON SURVIVAL AND FUNCTIONAL STATUS (Invited Lecture)
U. Thadani, Oklahoma City OK, USA

11:45 IMPACT OF A HOSPITAL DISCHARGE PROTOCOL ON CORONARY ARTERY DISEASE TREATMENT UTILIZATION AND CLINICAL OUTCOMES (Invited Lecture)
G. Fonarow, Los Angeles CA, USA

12:00 VASCULAR EFFECTS OF ESTROGEN IN POSTMENOPAUSAL WOMEN AT RISK FOR CORONARY ARTERY DISEASE (Invited Lecture)
R.O. Cannon III, Bethesda MD, USA

12:15 ESTROGENS FOR THE PREVENTION OF CORONARY HEART DISEASE (Invited Lecture)
J.E. Rossouw, Bethesda MD, USA

12:30 CONTINUOUS COMBINED HORMONE REPLACEMENT DOES NOT INFLUENCE POSTPRANDIAL TRIGLYCERIDES IN WOMEN WITH CORONARY ATHEROSCLEROSIS
G. Lloyd, N. Patel, E. McGing, A. Cooper, A. Weizbicki, G. Jackson, London, UK

12:45 L u n c h B r e a k

TUESDAY, MAY 18, 1999

S70: SURGERY FOR LV DYSFUNCTION
Chairpersons:       V.S. Chekanov, Milwaukee WI, USA
                                W. Piccione Jr., Chicago IL, USA

10:45 LEFT VENTRICULAR DILATATION IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY SHOULD NOT EXCLUDE SURGICAL REVASCULARIZATION
R.W. Kim, B.S. Ugurlu, D.A. Tereb, G. Tellides, J.A. Elefteriades, New Haven CT, USA

11:00 QUALITY OF LIFE ASSESSMENT AFTER PARTIAL LEFT VENTRICULECTOMY
G. Bhat, M.A. Laureano, R.D. Dowling, P. Cerrito, Louisville KY, USA

11:15 DIASTOLIC FUNCTION IMPROVES PRIOR TO SYSTOLIC FUNCTION IN CRYOINJURED RABBIT HEARTS AFTER CELLULAR CARDIOMYOPLASTY
B.Z. Atkins, J.M. Meuchel, M.J. Cottman, K.A. Hutcheson, D.D. Glower, D.A. Taylor, Durham NC, USA

11:30 TRANSPLANTED SKELETAL MYOBLASTS, BUT NOT FIBROBLASTS, EXPRESS CARDIAC AND SKELETAL CHARACTERISTICS AND IMPROVE PERFORMANCE OF INJURED MYOCARDIUM
K.A. Hutcheson, B.Z. Atkins, M.C. Reedy, D.D. Glower, D.A. Taylor, Durham NC, USA

11:45 LONG-TERM SURVIVAL AFTER REDUCTIVE ANNULOPLASTY OF DOUBLE MITRAL AND TRICUSPID ORIFICE FOR END-STAGE PRIMARY DILATED CARDIOMYOPATHY
N. Radovanovic, L. Petrovic, M. Kovac, B. Mihajlovic, S. Nicin, V. Torbica, M. Popov, D.D. Zecevic, A. Milosavljevic, S. Susak, B. Kozic, M. Golubovic, A. Redzek, Novi Sad, Yugoslavia

12:00 HEMODYNAMIC AND CLINICAL IMPROVEMENT AFTER REDUCTIVE ANNULOPLASTY OF DOUBLE MITRAL AND TRICUSPID ORIFICES IN END-STAGE HEART FAILURE IN PRIMARY DILATED CARDIOMYOPATHY
N. Radovanovic, L. Petrovic, M. Kovac, S. Nicin, B. Mihajlovic, M. Mijatov, S. Popovic, M. Popov, Z. Konstantinovic, D.D. Zecevic, S. Susak, A. Redzek, Novi Sad, Yugoslavia

12:15 DIFFERENTIAL EFFECTS OF MYOCARDIAL CRYOINJURY ON GLOBAL AND REGIONAL VENTRICULAR INDICES OF PERFORMANCE IN THE RABBIT HEART
B.Z. Atkins, J.M. Meuchel, M.J. Cottman, K.A. Hutcheson, D.D. Glower, D.A. Taylor, Durham NC, USA

12:30 PREDICTION OF REGIONAL LEFT VENTRICULAR IMPROVEMENT AFTER CABG SURGERY: COMPARISON OF LOW DOSE DOBUTAMINE ECHOCARDIOGRAPHY (LDE) AND LOW DOSE DOBUTAMINE VENTRICULOGRAPHY (LDV)
L. Dalla Vecchia, T. Storti, P. Danna, C. Cogliati, S. Guzzetti, P. Di Biasi, R. Scrofani, A. Malliani, Milano, Italy

12:45 L u n c h B r e a k

TUESDAY, MAY 18, 1999

S55: BASIC RESEARCH, MOLECULAR CARDIOLOGY
Chairpersons:        L. Fananapazir, Bethesda MD, USA
                                A.C. Newby, Bristol, UK

10:45 IDENTIFICATION OF DENDRITIC CELLS IN AORTOCORONARY SAPHENOUS VEIN BYPASS GRAFTS: A POTENTIAL CAUSE OF GRAFT FAILURE
S.M. Cherian, Y.V. Bobryshev, S.J. Inder, R.S.A. Lord, H. Liang, A.E. Farnsworth, Sydney NSW, Australia

11:00 INDUCTION OF INTRACELLULAR ANTIOXIDANT ENZYMES SYSTEM BY GLUTIN - METABOLIC DRUG WITH ANTIISCHEMIC ACTION
E.V. Kalinina, I.A. Komissarova, R.M. Zaslavskaya, M.D. Novichkova, E.N. Kelimberdieva, Moscow, Russia

11:15 THE INSERTION/DELETION POLYMORPHISM WITHIN THE ANGIOTENSIN CONVERTING ENZYME AND REACTIVITY OF  ISOLATED RESISTANCE ARTERIES
R.P. Steeds, L. O'Toole, K. English, K.S. Channer, Sheffield, UK

11:30 LOCAL OVEREXPRESSION OF PROSTACYCLIN INHIBITS NEOINTIMAL FORMATION AFTER ARTERIAL INJURY: PROSTACYCLIN SYNTHASE GENE TRANSFER VS EXOGENOUS BERAPROST SODIUM
M. Harada, Y. Toki, Y. Numaguchi, T. Ito, K. Okumura, Nagoya, Japan

11:45 INTRACORONARY PROUROKINASE GENE TRANSFER WITH PROTEIN-COATED STENT PREVENTS CORONARY RESTENOSIS IN MINI-SWINE
R. Gao, J. Yuan, R. Shi, Beijing, China

12:00 OXIDATIVE AGENTS INDUCE APOPTOSIS IN VASCULAR SMOOTH MUSCLE CELLS FROM SPONTANEOUSLY HYPERTENSIVE RATS BUT NOT FROM WISTAR-KYOTO RATS
E. Bonanno, L. Ghibelli, A. Mauriello, L. Anemona, L.G. Spagnoli, Rome, Italy

12:15 IMMUNOHISTOCHEMISTRY IN THE IDENTIFICATION OF FIBRONECTIN DEPOSITS AND ICAM-I EXPRESSION IN INFLAMED MYOCARDIUM
V. Maravic-Stojkovic, M. Bojic, Belgrade, Yugoslavia

12:30 QUINAPRIL, A NON-SH-CONTAINING ANGIOTENSIN CONVERTING ENZYME INHIBITOR PREVENTS LIPID PEROXIDES GENERATION IN CHOLESTEROL-FED RABBITS
M. Stajszczyk, J. Gminski, W. Wojakowski, K. Siemianowicz, M. Goss, M. Machalski, Katowice, Poland

12:45 THE IMPORTANCE OF ENDOCARDIAL ENDOTHELIUM ON THE EFFECTS OF db-cAMP ON THE POTASSIUM CONTENT IN THE ISOLATED RIGHT VENTRICLE OF RAT HEART
M.T. Nesic, M.R. Pavlovic, V.S. Jankovic, Belgrade, Yugoslavia

13:00 I/D POLYMORPHISM OF THE ACE GENE PREDICTS LEFT VENTRICULAR FUNCTION IN PATIENTS WITH CORONARY HEART DISEASE BUT NOT C/A POLYMORPHISM OF THE ANGIOTENSIN II TYPE 1 RECEPTOR GENE
L. Mierzejewski, W. Dubaniewicz, R. Targonski, M. Gruchala, W. Sobiczewski, D. Ciecwierz, K. Ochman, P. Romanowski, Gdansk, Poland

13:15 L u n c h B r e a k

TUESDAY, MAY 18, 1999

S64: RECENT ADVANCES AND FUTURE DIRECTIONS IN THE TREATMENT OF ARRHYTHMIAS
Chairpersons:        A. Caspi, Rehovot, Israel
                                M. Shechter, Tel Hashomer, Israel

 

10:45 ATRIAL STIMULATION USING FLOATING ELECTRODE AND A COUNTER ELECTRODE IN THE VENA CAVA SUPERIOR
A.S. Menezes Jr., C.F.M. Queiroz, F.P. Cazorla, J.C. Dourado, W.L. Carvalho, U. Bernardes, M. Schaldach, M. Taskiran, Goiana, Brazil, Erlangen, Germany

11:00 DOES THE DEFIBRILLATION THRESHOLD PREDICTS DEFIBRILLATION SUCCESS?
B. van Veen, B. Gerritse, Maastricht, The Netherlands

11:15 EFFECTIVE ATRIAL CONTRIBUTION IN SEQUENTIALLY PACED PATIENTS WITH IMPAIRED VENTRICULAR FUNCTION
J. Kvasnicka, M. Mest'an, V. Rozsival, M. Tauchman, J. Jandik, I. Gajdosova, P. Rejchrt, P. Stransky, Kralove, Czech Republic

11:30 TWO DIFFERENT SINGLE LEAD DDD PACING SYSTEMS COMPARATIVE STUDY
A.S. Menezes, C.F.M. Queiroz, F.P. Cazorla, J.C. Dourado, W.L. Carvalho, U. Bernardes, M. Schaldach, M. Taskiran, Goiania, Brazil, Erlangen, Germany

11:45 TREATMENT OF CARDIAC FAILURE IN PATIENTS WHO RECEIVE DUAL-CHAMBER ICDs WITH RARE-ADAPTIVE PACING FUNCTIONS
M. Achtelik, P. Pfitzner, B. Voigt, L. Obergassel, H.J. Trappe, Herne, Germany

12:00 OCCURRENCE PROBABILITY OF FATAL VENTRICULAR ARRHYTHMIA - CHAGAS DISEASE X NON-CHAGAS DISEASE
M.F. Martinelli, H.B. Moreira, S. Siqueira, A.A.A. Pedrosa, S.A.D. Nishioka, R. Costa, M. Scanavacca, A. d'Avila, E.A. Sosa, Sao Paulo, Brazil

12:15 SYNCHRONIZATION OF ATRIAL DEPOLARIZATION BY ATRIAL SEPTAL PACING IN PATIENTS WITH DELAYED INTERATRIAL CONDUCTION
A. Katsivas, E. Lazaris, A.G. Manolis, G. Kazamias, D. Karatza, C. Vassilopoulos, N. Louvros, Athens, Greece

12:30 L u n c h B r e a k

TUESDAY, MAY 18, 1999

P102: Poster Session
VASCULAR BIOLOGY, BASIC RESEARCH

Board No.

1. THROMBOSIS EFFECT ON VASCULAR REMODELING AT OCCLUDED ANGIOPLASTY ARTERY IN RABBIT MODEL
Z.-Q. Chen, H.V. Anderson, R. Pakala, C.R. Benedict, Houston TX, USA

2. GRAVITATIONAL STRESS: A STIMULATOR OF ENDOGENOUS PGI2 SYNTHESIS AND ENDOTHELIAL CELL DESQUAMATION
M.E. Isasi, E.S. Isasi, D. Mancioni, Montevideo, Uruguay

3. STUDY ON CHANGES OF PLASMA ADRENOMEDULLIN AND ENDOTHELIN IN ESSENTIAL HYPERTENSIVE PATIENTS
L.-X. Jiang, N.-L. Sun, C.-S. Tang, Y.-Z. Pang, Beijing, China

4. EXPRESSION OF EXTRACELLULAR SUPEROXIDE DISMUTASE AND INDUCIBLE NITRIC OXIDE SYNTHASE IN HUMAN AND RABBIT ATHEROSCLEROTIC LESIONS
J.S. Luoma, S. Yla-Herttuala, A.I. Virtanen, Kuopio, Finland

P103: Poster Session
PHARMACOLOGIC MODULATION OF VASCULAR - ENDOTHELIAL FUNCTION

Board No.

5. CHRONIC FEEDING OF PURPLE GRAPE JUICE REDUCES CHOLESTEROL ENHANCE PLATELET ACTIVITY AND DEVELOPMENT OF ATHEROSCLEROSIS IN RABBITS
D. Shanmuganayagam, T. Warner, J. Folts, Madison WI, USA

 

TUESDAY, MAY 18, 1999

P104: Poster Session
GENETIC DETERMINANTS OF CORONARY ARTERY DISEASE / CARDIOMYOPATHIES, GENE THERAPY

Board No.

6. IS PL^A POLYMORPHISM OF PLATELET GLYCOPROTEIN IIIA ASSOCIATED WITH CORONARY ARTERY DISEASE OR ACUTE MYOCARDIAL INFARCTION
C. Bottiger, A. Kastrati, W. Koch, J. Mehilli, N. v. Beckerath, A. Schoemig, Munich, Germany

TUESDAY, MAY 18, 1999

P104: Poster Session
GENETIC DETERMINANTS OF CORONARY ARTERY DISEASE / CARDIOMYOPATHIES, GENE THERAPY (cont)

Board No.

7. ASSOCIATION OF APOLIPOPROTEIN (a) PHENOTYPES WITH HISTORY OF MYOCARDIAL INFARCTION IN YOUNG MEN
M.V. Ezhov, A.A. Lyakishev, O.I. Afanasieva, G.F. Benevolenskaya, S.N. Pokrovsky, Moscow, Russia

8. ANGIOTENSIN-CONVERTING ENZYME GENOTYPE IN HYPERTROPHIC CARDIOMYOPATHY AND HYPERTROPHY IN HYPERTENSION
M. Gao, J. Lu, D. Hu, B. Xiao, Z. Xu, Beijing, China

9. MUTATION DETECTION IN THE MITOCHONDRIAL DNA OF PATIENTS WITH DCM: COMPARISON OF DIDEOXY-FINGERPRINTING AND DIRECTED TERMINATION PCR
V. Ruppert, B. Maisch, Marburg, Germany

10. INCREASED TIME DOMAIN PARAMETERS OF HEART RATE VARIABILITY IN ASSOCIATION WITH THE D ALLELE OF THE ANGIOTENSIN CONVERTING ENZYME GENE POLYMORPHISM
R.P. Steeds, A. Sivaguru, A. English, K.S. Channer, Sheffield, UK

11. THE 4G/5G INSERTION/DELETION POLYMORPHISM IN THE PROMOTER REGION OF THE PAI-1 (TYPE-1 PLASMINOGEN ACTIVATOR INHIBITOR) GENE IS RELATED TO MYOCARDIAL INFARCTION AND OTHER ARTERIAL THROMBOSIS IN THE ANTIPHOSPHOLIPID SYNDROME
D. Tassies, G. Espinosa, F.J. Munoz-Rodriguez, J.C. Reverter, J. Font, C. Freire, G. Escolar, M. Ingelmo, A. Ordinas, Barcelona, Spain

12. LIPOSOME-MEDIATED GENE TRANSFER WITH BCL-2, VEGF-165, bFGF AND cT-1 FOR TREATMENT OF ISCHEMIC AND DILATIVE CARDIOMYOPATHY: FIRST RESULTS
T. Wild, S.C. Beutelspacher, W. Barusch, K. Macfelda, B. Kappella, A.M. Groeger, E. Wolner, U. Losert, R. Seitelberger, Vienna, Austria

13. INTRAVASCULAR LOCAL GENE TRANSFER MEDIATED BY PROTEIN-COATED METALLIC STENT
J. Yuan, R. Gao, R. Shi, Beijing, China

TUESDAY, MAY 18, 1999

P108: Poster Session
PHARMACOLOGIC STRESS TESTING - ECHOCARDIOGRAPHY

Board No.

14. CLINICAL APPLICATION OF EXERCISE STRESS ECHOCARDIOGRAPHY: SUPINE BICYCLE OR POST TREADMILL?
A. Dagianti, M. Penco, L. Sgorbini, F. Fedele, Rome, Italy

15. MULTIPLANE TRANSESOPHAGEAL STRESS ECHOCARDIOGRAPHY: IS ENDOCARDIAL VISUALISATION DIFFERENT IN THE VARIOUS STANDARD PROJECTIONS?
J. Gude, E. Horstmann, H.J. Trappe, Herne, Germany

16. STRESS ECHOCARDIOGRAPHY IN PATIENTS WITH POOR ACOUSTIC WINDOWS: IS MULTIPLANE TRANSESOPHAGEAL ECHOCARDIOGRAPHY APPLICABLE?
J. Gude, H.J. Mueller, E. Horstmann, H.K. Beyer, H.J. Trappe, Herne, Germany

17. INCREASED DIASTOLIC LEFT VENTRICULAR WALL THICKNESS AND HETEROGENEITY OF REGIONAL WALL THICKENING DURING DOBUTAMINE STRESS ECHOCARDIOGRAPHY
E. Hausnerova, J.S. Gottdiener, G.M. Hecht, P.F. Hausner, R. Chavko, Washington DC, USA

18. PROGNOSTIC IMPACT OF DOBUTAMINE ECHOCARDIOGRAPHY AND EXERCISE-REDISTRIBUTION-REINJECTION THALLIUM SPECT IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY AND SEVERE LEFT VENTRICULAR DYSFUNCTION
A.G. Economou, S. Feggos, G. Kazianis, A. Gournizakis, P. Economopoulos, G. Avgeropoulos, Athens, Greece

19. CAN DOBUTAMINE ECHOCARDIOGRAPHY INDUCE MYOCARDIAL DAMAGE IN PATIENTS WITH DYSFUNCTIONAL BUT VIABLE MYOCARDIUM SUPPLIED BY A SEVERELY STENOTIC CORONARY ARTERY?
J. Meluzin, J. Toman, L. Groch, I. Hornacek, J. Sitar, B. Fischerova, Brno, Czech Republic

20. DOBUTAMINE ECHOCARDIOGRAPHY STUDY OF AUTO AND HOMOGRAFTS AND ROSS PROCEDURE
H.H. Filho, R. Pinton, W. Lemke, F.D.A. Costa, Santa Casa de Curitiba, PR, Brazil

21. SYNERGISTIC EFFECTS OF PROPRANOLOL IN THE INDUCTION OF MYOCARDIAL ISCHAEMIA DURING DOBUTAMINE-STRESS-ECHOCARDIOGRAPHY
P. Piovesana, F. De Conti, N. Lafisca, A. Pantaleoni, Padova, Italy

22. BALLOON MITRAL COMMISSUROTOMY: LONG-TERM RESULTS
I. Riecansky, V. Fridrich, P. Chnupa, I. Simkova, M. Grozajova, S. Mizera, Bratislava, Slovak Republic

TUESDAY, MAY 18, 1999

P112: Poster Session
MYOCARDIAL STUNNING, HIBERNATION AND PRECONDITIONING

Board No.

23. DELAYED MYOCARDIAL PROTECTION FOLLOWING EXERCISE-INDUCED ISCHEMIA IN HUMANS
M. Bilinska, S. Rudnicki, A. Beresewicz, Warsaw, Poland

24. APPEARANCE OF SHOCK AFTER DECOMPRESSION IN CARDIAC TAMPONADE CAN BE EXPRESSION OF MYOCARDIAL STUNNING AFTER THE CHRONIC HIBERNATING IN SUBENDOCARDIAL ZONE
C. Carp, V. Candea, C. Ginghina, A. Popa, C. Macarie, A. Carp, M. Tarlea, D. Gherghiceanu, R. Vasile, V. Iliescu, B. Rotareasa, Bucharest, Romania

25. EXERCISE ECHOCARDIOGRAPHY FOR MYOCARDIAL VIABILITY ASSESSMENT
A. Dagianti Jr., L. Sgorbini, A. Varveri, Rome, Italy

26. IS THERE ANY DIFFERENCE IN THE DOPPLER MYOCARDIAL IMAGING CHARACTERISTICS IN ACUTE AND CHRONIC ISCHAEMIC MYOCARDIAL WALL SEGMENTS?
I. Hegedus, L. Voith, Z. Koszegi, Debrecen, Hungary

27. PROGNOSTIC VALUE OF THE AMOUNT OF DYSFUNCTIONAL BUT VIABLE MYOCARDIUM IN REVASCULARIZED PATIENTS WITH CORONARY ARTERY DISEASE AND LEFT VENTRICULAR DYSFUNCTION
J. Meluzin, J. Cerny, M. Frelich, F. Stetka, J. Popelova, R. Stipal, Brno, Czech Republic

 

TUESDAY, MAY 18, 1999

P118: Poster Session
SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION, CARDIAC REHABILITATION

Board No.

28. COAGULATION SCREENING IN PATIENTS WITH CHEST PAIN
O. Biadi, L. Papi, M. Cecchini, N. Gigli, G. Musumeci, L. Ruocco, M. Tassi, A. Lofaro, R. Mariotti, M. Mariani, Pisa, Italy

29. RE-ATTACK OF MYOCARDIAL INFARCTION AND RISK FACTORS IN YOUNG PATIENTS
S. Eguchi, N. Ohtake, T. Ryu, T. Ogata, S. Tsuji, K. Ohmori, T. Utsunomiya, S. Matsuo, Saga, Japan

30. HEART RATE VARIABILITY, BAROREFLEX SENSITIVITY, CATECHOLAMINE OF THE PATIENTS WITH MYOCARDIAL INFARCTION
Z. Fan, N. Wu, Beijing, China

31. SPURIOUS ELEVATION OF PLASMA HOMOCYSTEINE LEVELS ASSOCIATED WITH ACUTE MYOCARDIAL INFARCTION
J.M. Griffiths, J. Nagendran, M.P. Senaratne, Edmonton, Alberta, Canada

TUESDAY, MAY 18, 1999

P118: Poster Session
SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION, CARDIAC REHABILITATION (cont)

Board No.

32. NEW APPROACHES ON HEMODYNAMICS OF CORONARY ARTERY DISEASE DURING WARM WATER BATH
J. Lukac, L. Adamovic, J. Celko, A. Makis, Teplice, Slovak Republic

33. COMPLIANCE TO THE PRESCRIBED LIFESTYLE CHANGES MAINTAINS THE FAVORABLE AUTONOMIC BALANCE INDUCED BY REHABILITATION AFTER MYOCARDIAL INFARCTION
G. Malfatto, M. Facchini, L. Sala, G. Branzi, R. Bragato, G. Leonetti, Milano, Italy

34. CHOLESTEROL METABOLISM IN POSTMENOPAUSAL WOMEN WITH CORONARY ARTERY DISEASE
R.A. Rajaratnam, H. Gylling, T.A. Miettinen, Helsinki, Finland

35. RATE OF GASTROINTESTINAL IRRITATION AND OCCULT BLOOD LOSS WITH D,L,-LYSINE-MONO-ACETYLSALICYLATE AND ASPIRIN
A.A. Schoneberger, E. Lipinski, C. Raschka, Koenigstein, Germany

36. PLASMA HOMOCYST(E)INE: A RISK FACTOR FOR ACUTE CORONARY SYNDROME
S. Soifer, F. Basilico, H.A. Cercos, H.G. Torres, O. Fridman, J.L. D'Eramo, A. Bronstein, A.E. Finkelstein, Buenos Aires, Argentina

37. TEMPORAL TRENDS INFLUENCE HOSPITAL LENGTH OF STAY IN ACUTE MYOCARDIAL INFARCTION INDEPENDENT OF CLINICAL AND TREATMENT STRATEGIES IN A DEFINED GEOGRAPHIC POPULATION
R.S. Wright, F.A. Sgura, J.P. Grill, G.S. Reeder, S.L. Kopecky, Rochester MN, USA

TUESDAY, MAY 18, 1999

P123: Poster Session
HYPERTENSION, BASIC AND CLINICAL

Board No.

38. 24 HRS. AMBULATORY BLOOD PRESSURE MONITORING: MEANING OF THE LOSS OF CIRCADIAN RHYTHM
O. Biadi, N. Gigli, G. Musumeci, L. Papi, M. Cecchini, G. Valente, R. Mariotti, M. Marini, Pisa, Italy

39. A-II RECEPTOR BLOCKADE WITH VALSARTAN AND CORRELATIONS BETWEEN METABOLIC AND HAEMODYNAMIC PARAMETERS IN ESSENTIAL HYPERTENSIVE PATIENTS
I. Notaristefano, R. Costa, M. Crippa, E. Chiari, R. Fariello, Brescia, Italy

40. RELATION OF LEFT ATRIAL EJECTION FORCE TO LEFT VENTRICULAR FUNCTION IN ARTERIAL HYPERTENSION
S. Qirko, T. Goda, L. Rroku, Tirana, Albania

41. THE SHORT-TERM AND CIRCADIAN BLOOD PRESSURE VARIABILITY IN THE PATIENTS WITH OBSTRUCTIVE SLEEP APNEA AND HYPERTENSION
J. Zhang, R. Hui, Y. Sun, X. Ni, M. Xu, B. Zhao, X. Wang, L. Liu, Beijing, China

 

TUESDAY, MAY 18, 1999

P134: Poster Session
PULMONARY CIRCULATION ASPECTS, PULMONARY HYPERTENSION

Board No.

42. IS CARDIOPULMONARY TEST USEFUL IN EVALUATION OF PATIENTS AFFECTED BY CORONARY HEART DISEASE?
O. Biadi, M. Cecchini, G. Musumeci, N. Gigli, L. Papi, R. Mariotti, M. Mariani, Pisa, Italy

43. CHEST COLOR DOPPLER SONOGRAPHY WITH ECHO CONTRAST AGENTS OF UNCLEAR PERIPHERAL LUNG LESIONS IN PATIENTS WITH SUSPECTED PULMONARY EMBOLISM
R. Bitschnau, G. Mathis, O. Gehmacher, A. Kopf, M. Scheier, Hohenems, Austria

44. PREVALENCE AND SHORT TERM PROGNOSIS OF LATENT HEMODYNAMIC COMPROMISE IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
S. Grifoni, I. Olivotto, F. Pieralli, P. Cecchini, A. Camaiti, G. Cagliarelli, A. Conti, G. Berni, Florence, Italy

45. CLINICAL OUTCOME OF CATHETER FRAGMENTATION AND SPIRATION THERAPY IN PATIENTS WITH ACUTE PULMONARY EMBOLISM
S. Hiramatsu, A. Ogihara, T. Sasaki, T. Ishikawa, K. Hayashi, M. Fuse, J. Muramatsu, T. Izumi, Namazu Shizuoka, Japan

TUESDAY, MAY 18, 1999

P134: Poster Session
PULMONARY CIRCULATION ASPECTS, PULMONARY HYPERTENSION (cont)

Board No.

46. VALUE OF CLINICAL ASSESSMENT IN THE DIAGNOSIS OF PULMONARY EMBOLISM
M. Miniati, B. Formichi, R. Prediletto, C. Marini, G. Di Ricco, L. Tonelli, G. Allescia, M. Pistolesi, Pisa, Italy

47. BRONCHIAL HYPERREACTIVITY IN HEALTHY LUNGS LONG TERM AFTER CONVENTIONAL MECHANICAL VENTILATION. IMPLICATION FOR PATIENTS AFTER REPAIR OF CHD?
J. Sulc, K. Dlask, J. Hruda, J. Stuj, A. Zapletal, B. Petrak, K. Chamoutova, Prague, Czech Republic

48. ADRENOMEDULLIN REDUCES THE RISK FOR PULMONARY HYPERTENSION IN RATS
P. Vijay, J.W. Brown, T.G. Sharp, Indianapolis IN, USA

 

TUESDAY, MAY 18, 1999

P136: Poster Session
EXERCISE PHYSIOLOGY IN HEART FAILURE

Board No.

49. CARDIOPULMONARY STRESS TEST IN PATIENTS WITH HEART FAILURE
O. Biadi, M. Cecchini, L. Papi, N. Gigli, R. Dell'Anna, G. Musumeci, R. Mariotti, M. Mariani, Pisa, Italy

50. PLASMA CATECHOLAMINES, POTASSIUM AND CARDIAC FUNCTION IN OBESE SUBJECTS DURING EXERCISE
P. Fanari, A. Salvadori, E. Giacomotti, M. Fontana, E. Longhini, Verbania, Italy

51. MODULATION OF NEURAL AND METABOLIC HEART RATE RESPONSE TO EXERCISE BY A BAROREFLEX MECHANISM
K. Oikawa, N. Fukuma, T. Tsuchida, N. Aisu, M. Tomimura, Y. Fukuma, J. Sano, T. Saitoh, Y. Kusama, K. Munakata, H. Kishida, Tokyo, Japan

52. ENDOTHELIUM-DEPENDENT AND INDEPENDENT VASCULAR RESPONSES AND BLOOD FLOW IN THE BRACHIAL ARTERY OF HEART FAILURE PATIENTS: RELATIONSHIP TO PEAK OXYGEN CONSUMPTION AND LEFT VENTRICULAR EJECTION FRACTION
M. Yousufuddin, W. Shamim, J.S. Chamber, S.D. Anker, A.J.C. Coats, London, UK

53. NON-INVASIVE ASSESSMENT OF EXERCISE INDUCED ALTERATIONS OF COUNDUIT ARTERY VASOMOTOR TONE IN HEALTHY SUBJECTS AND PATIENTS WITH CHRONIC HEART FAILURE: RELATIONSHIP WITH ENDOTHELIN-1 AND NOR-EPINEPHRINE
M. Yousufuddin, W. Shamim, J.S. Chamber, F.R. Amin, S.D. Anker, M. Kemp, A.J.C. Coats, London, UK

TUESDAY, MAY 18, 1999

P140: Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY - BASIC AND CLINICAL

Board No.

54. LONG-TERM SURVIVAL OF PATIENTS TREATED WITH INTRAVENOUS AMIODARONE FOR LIFE-THREATENING VENTRICULAR ARRHYTHMIAS IS INDEPENDENT OF DRUG DOSE OR DEFIBRILLATOR IMPLANTATION
C. Baessler, M. Schuster, S.E. Hessen, S.P. Kutalek, Philadelphia PA, USA

55. THE TREATMENT BY LOW-DOSE AMIODARONE AND DIGOXIN IN PATIENTS OF ATRIAL FIBRILLATION WITH CONGESTIVE HEART FAILURE
G.-P. Jong, S.L. Lin, Taichung, Taiwan-R.O.C.

56. EFFECTS OF INTRAVENOUS DOFETILIDE AND AMIODARONE ON SYMPATHETIC ACTIVATION AND CORONARY BLOOD IN HEART FAILURE PATIENTS
M.F. Rousseau, P.E. Massart, L. Galanti, S.A. Ahn, J. Etienne, H.G. Pouleur, Brussels, Belgium

57. THE DISTURBANCE OF AUTONOMIC BALANCE, DETECTED BY THE ANALYSIS OF HEART RATE VARIABILITY, IS A VERY COMMON TRIGGER OF PAROXISMAL ATRIAL FIBRILLATION IN PATIENTS WITHOUT STRUCTURAL HEART DISEASE
A. Sinani, V. Gjini, V. Paparisto, G. Ndrepepa, P. Cina, S. Qirko, Tirana, Albania

58. PREDICTORS OF ATRIAL FIBRILLATION AFTER CORONARY ARTERY BYPASS SURGERY
M. Sniezek-Maciejewska, A. Dziatkowiak, J. Kopacz, Cracow, Poland

59. RADIOFREQUENCY CATHETER ABLATION OF THE ATRIA TO TERMINATE SUSTAINED ATRIAL FIBRILLATION INDUCED WITH METHACHOLINE IN DOGS
X. Yang, T. Liu, C. Guo, D. Hu, Beijing, China

60. EFFECT OF RISPERIDONE ON QT INTERVAL AND QT DISPERSION IN THE ELDERLY
M. Yerrabolu, E. Delgado, I. Hussain, M. Tawam, K. Krishna, S. Prabhudesai, L. Costello, M. Kamalesh, L. Winter, Danville IL, USA

 

TUESDAY, MAY 18, 1999

P142: Poster Session
SUDDEN DEATH, SYNCOPE

Board No.

61. EXERCISE INDUCED QRS WIDENING CORRELATES WITH SCORE INDEX CONTRACTILITY AND LEFT VENTRICULAR MASS BUT NOT WITH NUMBER AND SEVERITY OF DISEASED VESSELS
K.G. Adamian, A.L. Chilingarian, A.V. Astvatsatrian, A.Z. Garibgeanian, Yerevan, Armenia

62. CARDIOPULMONARY RESUSCITATION WITH INTERPOSED ABDOMINAL COMPRESSION IN PROLONGED CARDIAC ARREST
G. Falsini, D. Rossini, M. Romel, S. Amidei, M. Forzoni, M. Grazzini, W. Vergoni, Arezzo, Italy

TUESDAY, MAY 18, 1999

P142: Poster Session
SUDDEN DEATH, SYNCOPE (cont)

Board No.

63. LESIONS OF AORTICOPULMONARY PARAGANGLIA RELATED TO SUDDEN DEATH: HISTOPATHOLOGIC CONSIDERATIONS
S.G. Ramos, L. Matturri, G. Ottaviani, L. Rossi, M.A. Rossi, Sao Paulo, Brazil

64. LONG TERM EFFICACY OF ETILEPHRINE VERSUS ATENOLOL IN PATIENTS WITH NEURALLY MEDIATED SYNCOPE
B. Xhaxho, G. Ndrepepa, A. Kastrati, G. Bajraktari, P. Cina, A. Dibra, Tirana, Albania

65. DIAGNOSTIC ACCURACY OF A LOW-DOSE NITROGLYCERINE SUBLINGUAL HEAD-UP TILT TESTING PROTOCOL
B. Xhaxho, G. Ndreppa, A. Kastrati, P. Cina, G. Bajraktari, L. Bica, A. Dibra, Tirana, Albania

66. HEAD-UP TILT TEST IN EVALUATING SYNCOPE IN PATIENTS WITH MITRAL VALVE PROLAPSE
B. Xhaxho, G. Ndrepepa, A. Kastrati, G. Bajraktari, P. Cina, L. Muka, L. Bica, Tirana, Albania

 

TUESDAY, MAY 18, 1999

P155: Poster Session
COMPUTERS IN CARDIOLOGY

Board No.

67. MACHINE LEARNING IMPROVES THE ACCURACY OF CORONARY ARTERY DISEASE DIAGNOSTIC METHODS
C. Groseli, J.J. Fettich, I. Kononenko, Ljubljana, Slovenia

68. A MODEL FOR INDIVIDUALIZED EDUCATION OF DIFFERENT USER GROUPS IN CARDIAC SURGERY USING ONLINE DATABASE SUPPORT
R. Friedl, M. Preisack, M. Schefer, J. Albers, W. Klas, T. Rose, A. Hannekum, Ulm, Germany

69. AN EXPERT SYSTEM FOR DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION WITH ECG ANALYSIS
A. Rabelo Jr., A.R. Rocha, A. Souza, A.C. Freitas, B. Pessoa, C. Andrade, I. Olivaes, K. Oliveira, L.C. Carvalho, N. Lobo, P. Cox, S. Sampaio, Salvador, Brazil

TUESDAY, MAY 18, 1999

P157: Poster Session
MISCELLANEOUS

Board No.

70. IMPROVEMENT IN HRV IS SEEN WITHIN 24 HOURS OF TREATMENT OF CONGESTIVE HEART FAILURE
H.B. Sherman, A.J. Burger, Boston MA, USA

71. ACTIONS OF PROSTACYCLIN AND b-ENDORPHINE ON THE DISTURBANCES OF CARDIOVASCULAR SYSTEM DURING ANAPHYLACTIC SHOCK
P. Cibas, B. Ruta, J. Ivaskeviciene, R. Obeleniene, Kaunas, Lithuania

72. INVESTIGATION OF CARDIOVASCULAR DEATH IN CONNECTION WITH WEATHER
S. Gall, B. Szekacs, E. Dinya, Budapest, Hungary

73. ZCLINICAL PREDICTION OF LEFT VENTRICULAR EJECTION FRACTION USING CHEST X-RAY VOLUMETRY AND ECG LV MASS ANALYSIS
M.J.D. Garcia, R.A. Naranjilla, R.V. Anastacio, D.R. Flores Jr., C. Mendoza, A.C. DeLara, Manila, Philippines

74. AORTIC DISTENSIBILITY IN SYSTEMIC SCLEROSIS
I. Moyssakis, F. Triposkiadis, M. Gofa, G. Anastasiadis, V. Vasiliou, M. Kyriakidis, Athens, Greece

75. RIGHT AND LEFT VENTRICULAR FILLING IN CARDIAC ASYMPTOMATIC SYSTEMIC LUPUS ERYTHEMATOSUS. THE INFLUENCE OF ANTIPHOSPHOLIPID ANTIBODIES
I. Moyssakis, F. Triposkiadis, K. Boki, P. Vlahoyannopoulos, M. Kyriakidis, H. Moutsopoulos, Athens, Greece

76. ELECTROCARDIOGRAPHIC DIAGNOSIS OF PREVIOUS MYOCARDIAL INFARCTION (MI) IN PATIENTS WITH LEFT BUNDLE BRANCH BLOCK (LBBB)
F.S. Silveira, A.J. Zago, L. Nucci, R.T.F. Ludwig, M. Both, M.C. Bozzetti, J.P. Ribeiro, Porto Alegre, Brazil

 

TUESDAY, MAY 18, 1999

P161: Poster Session
DIGOXIN AND OTHER INOTROPIC AGENTS IN HEART FAILURE

Board No.

77. ASSESSMENT OF RIGHT VENTRICULAR INOTROPIC RESERVE DURING DOBUTAMINE INFUSION IN PATIENTS WITH SECONDARY PULMONARY HYPERTENSION
C.D. Vizza, A. Di Roma, C. Lacobini, G. Benedetti, S. Sciomer, B. Pezza, D. Ricci, G. Della Rocca, F. Pugliese, F. Venuta, E.A. Redina, T. Di Giacomo, S. Quattrucci, F. Fedele, Rome, Italy

78. RESPONSE OF THE INTRACARDIAC IMPEDANCE TO INOTROPIC EFFECTIVE DRUGS (BETABLOCKER AND DIGITALIS) DURING VVIR PACING
O.T. Greco, R.V. Ardito, A. Cardinalli Neto, J.P. Stroebel, M. Schaldach, Sao Paulo, Brazil

TUESDAY, MAY 18, 1999

P161: Poster Session
DIGOXIN AND OTHER INOTROPIC AGENTS IN HEART FAILURE (cont)

Board No.

79. POSITIVE EFFECT OF DOBUTAMINE ON LEFT VENTRICULO-ARTERIAL COUPLING DURING ACUTE MYOCARDIAL ISCHEMIA
P. Kolh, B. Lambermont, C. Gomes, P. Gerard, R. Limet, V. D'Orio, Liege, Belgium

80. ACTION OF A SYNTHETIC DIGITALIS DERIVATIVE 14b, 17b CYCLOCETOESTER-3b-OH-ANDROSTANE (INCICH-D7) ON Na+,K+ -ATPase
O.M. Ramirez, M.L. Del Valle, H.G. Pastelin, Mexico, Mexico

 

TUESDAY, MAY 18, 1999

P162: Poster Session
BETA-BLOCKERS AND BETA-ADRENERGIC RECEPTORS IN HEART FAILURE

Board No.

81. CARVEDILOL ELIMINATES MORTALITY AND CARDIO-RENAL HISTOPATHOLOGY AND IMPROVES CARDIAC FUNCTION ASCERTAINED BY ULTRASOUND AND MRI AND RENAL FUNCTION IN SEVERE HYPERTENSION
R.W. Coatney, A.H. Nelson, W.G. Campbell, E.H. Ohlstein, S. Chandra, D.P. Brooks, G.Z. Feuerstein, F.C. Barone, King of Prussia PA, USA

82. COMBINATION THERAPY WITH METOPROLOL AND FELODIPINE LEADS TO IMPAIRED EXERCISE HEMODYNAMICS AS COMPARED WITH METOPROLOL ALONE IN PATIENTS WITH SEVERE CHRONIC HEART FAILURE
F. Edelmann, M. Knapp, G. Simonis, C. Weinbrenner, M.U. Braun, C. Schwencke, F.J. Meyer, R. Wipplinger, R.H. Strasser, Heidelberg, Germany

83. STUDY ON THE MECHANISM FOR THE POSITIVE INOTROPIC EFFECTS OF HIGENAMINE
Q. Ke, H. Terada, S. Sugiyama, H. Satoh, H. Hayashi, Hamamatsu, Japan

84. CARVEDILOL INFLUENCE ON BAROREFLEX SENSITIVITY IN SUBJECTS WITH CHRONIC HEART FAILURE
G. Piccirillo, P. Raganato, A. Mariano, M. Lionetti, A. Moise, R. Leonetti Luparini, V. Celli, V. Marigliano, Rome, Italy

PL11: Plenary Session
DILATED CARDIOMYOPATHY: VARIOUS ETIOLOGIES
Chairpersons:       M. Gheorghiade, Chicago IL, USA
                                H.P. Schultheiss, Berlin, Germany

13:45 1999 UPDATE: CHRONIC HEART FAILURE AS A MANIFESTATION OF CORONARY ARTERY DISEASE (Invited Lecture)
M. Gheorghiade, R.O. Bonow, Chicago IL, USA

14:00 MULTIPLE INDICES OF LEFT ATRIAL PERFORMANCE IN CARDIOMYOPATHY AND VALVULAR HEART DISEASE (Invited Lecture)
H. Boudoulas, Columbus OH, USA

14:15 NEW STRATEGIES IN THE DIAGNOSIS AND THERAPY OF INFLAMMATORY CARDIOMYOPATHY (Invited Lecture)
H.-P. Schultheiss, Berlin, Germany

14:30 IS APOPTOSIS A MECHANISM OF CELL DEATH OF CARDIOMYOCYTES IN CHRONIC CHAGASIC MYOCARDITIS? (Invited Lecture)
M.A. Rossi, Sao Paulo, Brazil

14:45 ENDEMIC INFESTATIONS AS A CAUSE OF HEART FAILURE (Invited Lecture)
O. Abdel-Aziz, Cairo, Egypt

15:00 ACROMEGALY AND CARDIOMYOPATHY. A RADIONUCLIDE DIAGNOSTIC CONSIDERATION (Invited Lecture)
N.J. Angomachalelis, G. Foroglou, N. Salem, A. Hourzamanis, E. Serasli, Thessaloniki, Greece

15:15 DILATED CARDIOMYOPATHY AS A RESULT OF VIRAL MYOCARDITIS (Invited Lecture)
N.N. Kipshidze, Tbilisi, Georgia

15:30 GENETIC CAUSES OF CARDIOMYOPATHIES (Invited Lecture)
K. Schwartz, Paris, France

15:45 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

PL12: Plenary Session
INTERVENTIONAL CARDIOLOGY: STENTS, PREVENTION OF RESTENOSIS
Chairpersons:     D.C. Cumberland, Sheffield, UK
                              J.W. Moses, New York NY, USA

13:45 HOW TO INFORM HEART DISEASED PATIENTS ON THE POTENTIAL USE OF NEW DIAGNOSTIC AND THERAPEUTIC TECHNIQUES? (Invited Lecture)
H.J. Geschwind, Creteil, France

14:00 ANGIOGRAPHIC AND CLINICAL OUTCOME OF PATIENTS UNDERGOING "STENTING AFTER OPTIMAL LESION DEBULKING" THE "SOLD" REGISTRY (Invited Lecture)
J.W. Moses, I. Moussa, C. Di Mario, A. Colombo, New York NY, USA

14:15 PERMANENT IMPLANTS IN CARDIOLOGY - NEED FOR FURTHER IMPROVEMENT (Invited Lecture)
B. Heublein, Hannover, Germany

14:30 POLYMER COATED STENTS - CLINICAL POTENTIAL (Invited Lecture)
D.C. Cumberland, J. Gunn, N. Malik, C. Holt, J. Armstrong, Sheffield, UK

14:45 DRUG ELUTING STENTS (Invited Lecture)
I. De Scheerder, Leuven, Belgium

15:00 CORONARY STENTING FOR LONG LESIONS (LESION LENGTH > 20mm) IN NATIVE CORONARY ARTERIES: COMPARISON OF THREE DIFFERENT TYPES OF STENT
(Invited Lecture)
M. Nobuyoshi, H. Yokoi, Y. Nakagawa, Kitakyushu, Japan

15:15 PREVENTION OF RESTENOSIS: AN IVUS LOOK (Invited Lecture)
R. Bonan, D. Meerkin, Montreal PQ, Canada

15:30 LOCAL DELIVERY OF ANTISENCE PHOSPHORODIAMIDATE COMPOUND - RESTIN NG INHIBITS MYOINTIMAL HYPERPLASIA FOLLOWING BALLOON ANGIOPLASTY
P. Iverson, V. Skrinska, E. Keane, D. Stein, D. Weller, P. Chawla, A. Tamarkin, N.N. Kipshidze, Milwaukee WI, USA

15:45 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

S71: CARDIAC TRANSPLANTATION
Chairperson: M. Ballester, Barcelona, Spain

13:45 DISAPPEARANCE OF PERSISTENT CARDIAC REJECTION LATE (>1 YEAR) AFTER TRANSPLANTATION AFTER CHANGING FROM AZATHIOPRINE TO MYCOPHENOLATE MOFETIL (MMF): SERIAL ASSESSMENT BY MYOCARDIAL UPTAKE OF 111ln-LABELED MONOCLONAL ANTIMYOSIN ANTIBODIES
M. Ballester, V. Brossa, L. Tuneu, M. Camprecios, M. Puig, M.R. Aymat, J.M. Padro, I. Carrio, Barcelona, Spain

14:00 SERUM CONCENTRATION OF SOLUBLE INTERCELLULAR ADHESION MOLECULE-1 AND RISKS OF SUBSEQUENT CORONARY ARTERY DISEASE OR GRAFT FAILURE IN HEART TRANSPLANT RECIPIENTS
C.A. Labarrere, D.R. Nelson, J.M. Nieto, J. Conner, S.J. Miller, D. Pitts, P. Kirlin, H. Halbrook, Indianapolis IN, USA

14:15 RENAL HEMODYNAMIC EFFECTS OF L-ARGININE AND SODIUM-NITROPRUSSIDE IN HEART TRANSPLANT RECIPIENTS
J. Koller-Strametz, M. Wolzt, C. Koppel, D. Putz, W. Wisser, C. Mensik, H.G. Eichler, G. Laufer, L. Schmetterer, Vienna, Austria

14:30 STANDARD VERSUS BICAVA TECHNIQUE IN HEART TRANSPLANTATION. IS THERE ANY BENEFICIAL EFFECT ON FUNCTIONAL CAPACITY?
R. Fabregas, M.G. Crespo, J.A. Rodriguez, M.A. Regueiro, J.M. Vazquez-Rodriguez, J.J. Cuenca, J. Muniz, J. Peteiro, N. Alvarez, A. Juffe, A. Castro-Beiras, La Coruna, Spain

14:45 PLASMA LEVELS OF OXIDIZED LDL PREDICT DEVELOPMENT OF CORONARY ARTERY DISEASE IN HEART TRANSPLANT PATIENTS
P. Holvoet, J. Van Cleemput, D. Collen, J. Vanhaecke, Leuven, Belgium

15:00 HIGH TOTAL PLASMA HOMOCYSTEINE IN HEART TRANSPLANT RECIPIENTS IS ASSOCIATED WITH TIME OF FOLLOW UP, RENAL FUNCTION AND GRAFT VASCULAR DISEASE
L. Potena, S. Sassi, G. Magnani, L. Marinucci, F. Semprini, N. Galie, A.M. Bargossi, C. Magelli, S. Coccheri, A. Branzi, Bologna, Italy

15:15 PEDIATRIC HEART TRANSPLANTATION: IMPROVING RESULTS IN HIGH-RISK PATIENTS
J.G. Coles, Toronto ONT, Canada

15:30 HEART PRESERVATION OF NON-HEART-BEATING DONORS BY IN-SITU-PERFUSION: COMPARISON OF THE ARTIFICIAL OXYGEN CARRIER PERFLUOROCARBONES WITH UW-SOLUTION IN A BIG ANIMAL MODEL
A.M. Scheule, J. Pappas, C. Strotmann, U. Vogel, S. Miller, S. Reuter, H.P. Wendel, G. Ziemer, Ulm, Germany

15:45 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

S74: DIAGNOSTIC METHODS: NUCLEAR CARDIOLOGY, EBCT, ECHOCARDIOGRAPHY
Chairpersons:     E. Hausnerova, Washington DC, USA
                              G. Sambuceti, Pisa, Italy

13:45 HEART INVOLVEMENT IN SYSTEMIC SCLEROSIS: AN ULTRASONIC TISSUE CHARACTERIZATION STUDY
V. Di Bello, C. Ferri, D. Giorgio, A. Martini, F.A.A. Storino, M.T. Caputo, A. Bertini, M. Paterni, E. Talini, G. Pasero, C. Giusti, Pisa, Italy

14:00 DIRECT COMPARISON OF SHADED SURFACE DISPLAY AND CURVED MULTIPLANAR RECONSTRUCTIONS FOR THE EVALUATION OF CONTRAST-ENHANCED ELECTRON BEAM COMPUTED TOMOGRAPHY OF THE CORONARY ARTERIES
S. Achenbach, D. Ropers, J. Nossen, W. Moshage, G. Muschiol, W.G. Daniel, Erlangen, Germany

14:15 USEFULNESS OF ELECTRON BEAM COMPUTED TOMOGRAPHY IN CHILDREN WITH HETEROTAXY SYNDROME
S-J. Chen, Y-W. Li, J-K. Wang, M-H. Wu, I-S. Chiu, C-I. Chang, S-C. Hsieh, C-T. Su, J.C-Y. Hsu, H-C. Lue, Taipei, Taiwan-R.O.C.

14:30 FUZZY CLUSTER ANALYSIS OF POSITIVE STRESS TESTS: COMPARISON WITH OTHER MODALITIES IN PATIENTS WITH TRIPLE VESSEL AND LEFT MAIN CORONARY DISEASE
R.M. Peters, Long Island NY, USA

14:45 ROLE OF FLUMAZENIL IN OUTPATIENTS TRANSESOPHAGEAL ECHOCARDIOGRAPHY
T.S.M. Tsang, M. Martin, K.R. Bailey, J.B. Seward, Rochester MN, USA

15:00 MYOCARDIAL VIABILITY ASSESSED BY ^99MTc-MIBI-SPECT AND LOW-DOSE DOBUTAMINE ECHOCARDIOGRAPHY (LDDE) IN PATIENTS WITH OR WITHOUT IMPROVEMENT OF REGIONAL CONTRACTILITY AFTER SURGICAL REVASCULARIZATION
E.N. Khodareva, M.A. Saidova, Y.N. Belenkov, V.B. Sergienko, A.A. Shiryaev, Moscow, Russia

15:15 PHASE-CONTROLLED SMALL-AMPLITUDE VIBRATION AT DIASTOLE AUGMENTS HUMAN CORONARY BLOOD FLOW
T. Naya, Y. Koiwa, H. Honda, H-I. Kamada, K. Shirato, S. Kibira, M. Miura, Sendai, Japan

15:30 THE CORRECTION OF HYPOKALEMIA IMPROVES DIASTOLIC FUNCTION OF LEFT VENTRICLE. AN ECHOCARDIOGRAPHIC STUDY
E. Maci, V. Fjini, T. Goda, L. Muka, S. Qirko, Tirana, Albania

15:45 TIME COURSE OF LEFT ATRIAL AND LEFT ATRIAL APPENDAGE MECHANICAL RECOVERY AFTER TEMPORARY INTERNAL CARDIOVERSION IN PATIENTS WITH CHRONIC ATRIAL FIBRILLATION: ECHOCARDIOGRAPHIC STUDY
G. Montanari, V. Mariotti, A. Mariani, P. Volpe, A. Dormi, M. Brun, M. Giunti, A. Andraghetti, N. Ciampani, Senigallia, Milano, Italy

16:00 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

S52: MOLECULAR BIOLOGY, BASIC RESEARCH
Chairpersons: R.N.A. Gasser, Graz, Austria
                          C.E. Pitsavos, Athens, Greece

13:45 RISK FACTORS AND ATHEROSCLEROSIS IN YOUTH
A.W. Zieske, J.P. Strong, New Orleans LA, USA

14:00 REGIONAL AND TEMPORAL COMPARISON OF ATRIAL AND BRAIN NATRIURETIC PEPTIDE GENE EXPRESSION IN AN OVINE MODEL OF MYOCARDIAL INFARCTION
V.A. Cameron, M.T. Rademaker, E.A. Espiner, M.G. Nicholls, A.M. Richards, Christchurch, New Zealand

14:15 CARDIAC GENE EXPRESSION OF ANGIOTENSIN II RECEPTORS SUBTYPES AT1 AND AT2 FOLLOWING ACUTE MYOCARDIAL INFARCTION UNDER PRETREATMENT WITH LOSARTAN
Y.Z. Zhu, Y.C. Zhu, J. Li, T. Yao, H.S. Lee, T. Unger, Singapore, Singapore

14:30 INDIRECT LECTIN-HISTOCHEMICAL STAINING OF THE INFILTRATED LYMPHOID CELLS IN THE MYOCARDIUM
V. Maravic-Stojkovic, L. Verner, Hannover, Germany

14:45 EXPRESSION OF PERFORIN AND FAS LIGAND IN INFILTRATING CELLS OF MURINE MYOCARDIUM INFECTED WITH COXSACKIEVIRUS B3
Y. Yang, D. Xiong, Y. Su, H. Chen, Shanghai, China

15:00 APOPTOSIS IN THE LEFT VENTRICLES OF CHRONIC ISCHEMIC HEART FAILURE SHEEP IS ASSOCIATED WITH AN ELEVATED EXPRESSION OF CASPASES
L. Jiang, Y. Huang, T. Yuasa, S. Hunyor, C.G. dos Remedios, Sydney NSW, Australia

15:15 IDENTIFICATION OF A VASOACTIVE AND GROWTH STIMULATING SUBSTANCE FROM PORCINE CARDIAC TISSUE
J. Luo, J. Jankowski, M. Tepel, W. Zidek, H. Schluter, Herne, Germany

15:30 ULTRASONIC MYOCARDIAL TEXTURAL ANALYSIS OF HYPERTENSIVE HEART: COMPARISON WITH PULSED DOPPLER ANALYSIS OF TRANSMITRAL FLOW
V. Di Bello, R. Pedrinelli, D. Giorgi, A. Bertini, M.T. Caputo, E. Talini, G. Valenti, M.F. Romano, G. Dell'Omo, C. Giusti, Pisa, Italy

15:45 FIBRONECTIN DEPOSITS IN THE EXTRACELLULAR MATRIX AND CD68 ⁺ MONOCYTE/MACROPHAGES IN PATIENTS WITH ACTIVE MYOCARDITIS
V. Maravic-Stojkovic, M. Miric, B. Radevic, Belgrade, Yugoslavia

16:00 C o f f e e B r e a k

TUESDAY, MAY 18, 1999

PL13: Plenary Session
NEW DIAGNOSTIC METHODS FOR ASSESSMENT OF CARDIAC AND CIRCULATORY FUNCTION
Chairpersons:        P.R. Liebson, Chicago IL, USA
                                E.E.van der Wall, Leiden, The Netherlands

16:00 CARDIAC MRI IN CONGENITAL HEART DISEASE (Invited Lecture)
T. Geva, Boston MA, USA

16:15 CONSTRICTIVE PERICARDITIS VS RESTRICTIVE CARDIOMYOPATHY: DIFFICULT DIFFERENTIAL DIAGNOSIS (Invited Lecture)
D.H. Spodick, Worcester MA, USA

16:30 IMAGING OF ATHEROSCLEROSIS: IS THERE A CLINICAL NEED? (Invited Lecture)
E.E. van der Wall, Leiden, The Netherlands

16:45 THE CLINICAL IMPACT OF MYOCARDIAL VIABILITY ON LONG TERM OUTCOME OF PATIENTS WITH ADVANCED ISCHEMIC LEFT VENTRICULAR DYSFUNCTION
(Invited Lecture)
P. Marzullo, Presented by: G. Sambuceti, Pisa, Italy

17:00 PREDICTORS OF HARD EVENTS IN PATIENTS SCREENED WITH ELECTRON BEAM COMPUTED TOMOGRAPHY
P. Raggi, T.Q. Callister, D.J. Russo, N.J. Lippolis, Nashville TN, USA

17:15 NON-INVASIVE ASSESSMENT OF THE CULPRIT VESSEL BY CONTRAST-ENHANCED ELECTRON-BEAM CT IN PATIENTS AFTER ACUTE MYOCARDIAL INFARCTION
S. Achenbach, D. Ropers, J. Nossen, W. Moshage, G. Muschiol, W.G. Daniel, Erlangen, Germany

17:30 INFARCT-AVID AGENT ENHANCED MRI: AN IN VIVO GOLD STANDARD FOR DETERMINATION OF ACUTE MYOCARDIAL INFARCTION
Y. Ni, H. Bosmans, Y. Miao, S. Dymarkowski, J. Bogaert, W. Semmler, G. Marchal, Leuven, Belgium

TUESDAY, MAY 18, 1999

S75: INTERVENTIONAL CARDIOLOGY, PREVENTION OF RESTENOSIS AFTER ACUTE INTERVENTION
Chairpersons:     I.K. De Scheerder, Leuven, Belgium
                              B. Heubelin, Hannover, Germany

16:00 PRESENT AND FUTURE ROLE OF "HYBRID PROCEDURES" COMBINING MINIMALLY INVASIVE BYPASS-SURGERY AND TRANSLUMINAL INTERVENTIONS IN THE TREATMENT OF CORONARY ARTERY DISEASE (Invited Lecture)
W. Voelker, R. Hauerwass, J. Strotmann, F.U. Sack, C. Roll, S. Hagl, G. Ertl, Wurzburg, Germany

16:15 ANGIOPLASTY AND PRIMARY STENTING OF THE SUBCLAVIAN, INNOMINATE, AND COMMON CAROTID ARTERIES IN 83 PATIENTS
T.M. Sullivan, B.H. Gray, J.M. Bacharach, J. Perl III, M.B. Childs, L. Modzelewski, E.G. Beven, Cleveland OH, USA

16:30 NEOINTIMAL PROLIFERATION FOLLOWING BALLOON ANGIOPLASTY IS REDUCED BY HIGH DIETARY POTASSIUM INTAKE IN THE PIG
N.T. Srivastava, D.B. Young, P.G. Anderson, G. Ma, T.N. Skelton, Jackson MS, USA

16:45 IVUS BASED DOSIMETRIC ANALYSIS OF INTRACORONARY RADIATION THERAPY (ICRT)
D. Meerkin, I.R. Crocker, A. Arsenault, T. Fox, J.-C. Tardif, R. Bonan, Montreal PQ, Canada

17:00 VERAPAMIL TREATMENT OF PROGRESSIVE PERIPHERAL OCCLUSIVE ARTERIAL DISEASE AFTER ANGIOPLASTY
J. Schweizer, W. Kirch, R. Koch, A. Muller, K. Uhlmann, Chemnitz, Germany

17:15 UPTAKE AND RETENTION DYNAMICS AND ABSORBED DOSES OF 99MTC-HEXAMETHYL PROPYLENAMINE OXIME (HM-PAO, CERETEC) AFTER INTRAMURAL DELIVERY WITH THE IRRADIATO/INFILTRATOR ANGIOPLASTY BALLOON CATHETER (IABC) DEVICE
P. Barath, A. Popov, J. Gerlach, E. Corday, P.K. Shah, D. Berman, Los Angeles CA, USA

17:30 TRAPIDIL FOR PREVENTION OF IN-STENT RESTENOSIS - THE TRAPIST TRIAL
M.J. Pieper, A.A. v.d. Bos, P.W. Serruys, C. Macaya, F. Kiemeney, Kreuzlingen, Switzerland

17:45 ANGIOGRAPHIC AND CLINICAL FOLLOW UP AFTER INTRAVASCULAR RED LASER LIGHT THERAPY AND STENTING
H. Sahota, I. De Scheerder, U. Kaul, B. Singh, S. Lee, J.M. Mao, M.H. Keelan, N. Kipshidze, Bellflower CA, USA

TUESDAY, MAY 18, 1999

S69: MECHANICAL SUPPORT, LEFT VENTRICULAR ASSIST DEVICES
Chairpersons: J.A. Elefteriades, New Haven CT, USA
                          R.E. Hobbs, Cleveland OH, USA

16:00 EXPANDING APPLICATIONS FOR A VERSATILE VENTRICULAR ASSIST SYSTEM: EXPERIENCE IN 1000 THORATEC VAD PATIENTS
D.J. Farrar, J.D. Hill, Pleasanton CA, USA

16:15 EFFECT OF ENHANCED EXTERNAL COUNTERPULSATION ON LIPID PEROXIDATION IN CORONARY DISEASE
X.-X. Qian, W.-K. Wu, Z.-S. Zheng, B.-Y. Yu, H.-C. Lou, W.E. Lawson, J.C.K. Hui, Stony Brook NY, USA

16:30 PRE-CLINICAL EVALUATION OF A TOTALLY IMPLANTABLE INTRATHORACIC VENTRICULAR ASSIST DEVICE
T. Mussivand, P.J. Hendry, R.G. Masters, W.J. Keon, Ottawa ONT, Canada

16:45 INR SELF-DETERMINATION ENABLES LONG TERM OUT-OF-HOSPITAL EXPERIENCE FOR PATIENTS WITH LEFT VENTRICULAR ASSIST DEVICES
H. Mair, A. Schuetz, G. Gillrath, C. Schmitz, C. Detter, B. Reichart, Munich, Germany

17:00 MECHANICAL CIRCULATORY SUPPORT IN CHILDREN WITH CARDIAC DISEASE
B.W. Duncan, V. Hraska, R.A. Jonas, D.L. Wessel, P.J. Del Nido, P.C. Laussen, J.E. Mayer, R.A. Lapierre, J.M. Wilson, Boston MA, USA

17:15 TESTS WITH A PERCUTANEOUS CARDIAC ASSIST DEVICE IN A LEFT VENTRICULAR FAILURE MODEL
O. Reitan, H. Ohlin, S. Steen, Lund, Sweden

TUESDAY, MAY 18, 1999

S58: THE PLAQUE AND ACUTE CORONARY SYNDROMES, BIOCHEMICAL MARKERS, PRECONDITIONING

Chairpersons:   A. Caspi, Rehovot, Israel
                    S. Fuchs, Washington DC, USA

16:15 PROGNOSTIC VALUE OF CARDIAC TROPONIN I LEVELS FOLLOWING CATHETER-BASED CORONARY INTERVENTIONS
S. Fuchs, R. Kornowski, R. Mehran, A.J. Lansky, L.F. Satler, A.D. Pichard, K.M. Kent, C.E. Clark, G.W. Stone, M.B. Leon, Washington DC, USA

16:30 CLINICAL USEFULNESS OF BEDSIDE TEST AND QUANTITATIVE DETERMINATION OF t-TROPONINA FOR RISK STRATIFICATION IN UNSTABLE ANGINA
S.M. Macin, E.R. Perna, E.F. Farias, J.P. Cimbaro Canella, M.M. Civetta, J. Garcia, J.R. Badaracco, M. Brizuela, F. Medina, E. Jantus, Corrientes, Argentina

16:45 ISCHEMIC PRECONDITIONING PROVIDES CARDIOPROTECTION THROUGH PKC-DEPENDENT AS WELL AS PKC-INDEPENDENT PATHWAYS
D.K. Das, N. Maulik, R.M. Engelman, M. Sato, P.S. Ray, Farmington CT, USA

TUESDAY, MAY 18, 1999

P105: Poster Session
BIOCHEMICAL MARKERS OF ACUTE ISCHEMIA

Board No.

1. SINGLE MEASUREMENT OF CARDIAC TROPONIN I FOR ASSESSMENT OF INFARCT SIZE IN ACUTE MYOCARDIAL INFARCTION
G. Belotti, M. Biffi, C. Gatti, A. Locatelli, E.F. Vigano, G. Tommasini, Treviglio, Italy

2. ULTRAFAST DIAGNOSIS OF AMI BY ANALYSIS OF MYOGLOBIN KINETICS
G. Belotti, M. Biffi, C. Poluzzi, G. Penati, E.F. Vigano, G. Tommasini, Treviglio, Italy

3. EARLY ASSESSMENT OF INFARCT SIZE BY CK, CK-MB AND TnT AFTER REPERFUSION IN ACUTE MYOCARDIAL INFARCTION
M. Zhao, D. Hu, L. Cui, Z. Xu, H. Wang, Beijing, China

4. INTRAOPERATIVE RELEASE OF TROPONIN T AND LEFT VENTRICULAR RECOVERY AND OXIDATIVE METABOLISM FOLLOWING CORONARY ARTERY SURGERY
J. Hooper, M. Kemp, T.W. Koh, F.D. Ferdinand, D.G. Gibson, J.R. Pepper, London, UK

5. MACROPHAGE CHEMOATTRACTANT PROTEIN-1 LEVEL IN PERICARDIAL FLUID IN PATIENTS WITH CORONARY HEART DISEASE
M. Hyogo, A. Azuma, M. Tsukamoto, H. Yaku, H. Sugihara, M. Nakagawa, Kyoto, Japan

6. BIOCHEMICAL MARKERS IN THE EARLY DIAGNOSIS OF ACUTE MYOCARDIAL INFARCTION. A PROPOSAL STRATEGY
M. Zaninotto, S. Altinier, M. Lachin, M. Plebani, Padova, Italy

7. ROLE OF CARDIAC MARKERS FOR EVALUATING CORONARY ARTERY DISEASE (CAD) IN RENAL TRANSPLANT PATIENTS
G.A. Porter, J.S. Stevens, T.L. Norton, J. Lindsey, W.B. Bennett, Portland OR, USA

8. CARDIAC TROPONIN I RELEVANCE IN ACUTE MYOCARDIAL INFARCTION DIAGNOSIS
I.A. Rivis, C. Dogaru, D. Burghina, D. Vasiluta, M. Mihalas, R. Popa, G. Ciobotaru, C. Domide, O. Tunea, Timisoara, Romania

9. PLASMA CONCENTRATION OF NEUROPEPTIDE Y IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AFTER THROMBOLYTIC THERAPY
B. Halawa, P. Salomon, Wroclaw, Poland

10. LIPID PEROXIDATION AND VITAMIN E IN ISCHEMIC HEART DISEASE
M. Sharma, N. Nand, N. Budhiraja, G.P. Singh, H.K. Aggarwal, P.B. Sharma, Rohtak, India

11. FIBRINOGEN, C-REACTIVE PROTEIN AND THE ALBUMIN-GLOBULIN RATIO AS RISK FACTORS IN STROKE
G.N. Ziakas, A.J. Hatzitolios, A.D. Kounanis, Ch.G. Savopoulos, N.H. Markoglou, D.J. Prokopidis, A.G. Ziakas, Thessaloniki, Greece

TUESDAY, MAY 18, 1999

P106: Poster Session
CONTRAST ECHOCARDIOGRAPHY

Board No.

12. ULTRASONIC MYOCARDIAL TEXTURE IN SUBCLINICAL HYPOTHYROIDISM
V. Di Bello, F. Monzani, A. Bertini, D. Giorgi, N. Caraccio, A. Cioppi, F. Cinotti, E. Talini, A. Casolaro, M.T. Caputo, C. Giusti, Pisa, Italy

13. LEFT VENTRICULAR FUNCTION IN SUBCLINICAL HYPOTHYROIDISM: COMPARISON BETWEEN ECHO-DOPPLER AND ULTRASONIC VIDEODENSITOMETRY
V. Di Bello, F. Monzani, A. Bertini, D. Giorgi, N. Caraccio, E. Talini, A. Casolaro, M.T. Caputo, A. Cioppi, C. Giusti, Pisa, Italy

14. THE DIFFERENCE BETWEEN PRE AND POST OPERATIVE REGIONAL WALL MOTION FOR LITA GRAFT PATIENTS AND THEIR RELATION TO POST OPERATIVE MYOCARDIAL CONTRAST OPACIFICATION
H. Kihara, Y. Kihara, T. Kihara, H. Takahashi, A. Ono, M. Fukunishi, M. Tanigushi, K. Nakayama, N. Kajiwara, Tokyo, Japan

 

TUESDAY, MAY 18, 1999

P107: Poster Session
PHARMACOLOGIC STRESS TESTING - ECHOCARDIOGRAPHY

Board No.

15. THE EXAMINATION OF THE LEFT VENTRICULAR CONTRACTILE RESERVE WITH DOPPLER MYOCARDIAL IMAGING TECHNIQUE
T. Fulop, I. Hegedus, Debrecen, Hungary

16. DETECTION OF ISCHEMIA: IS CORRECTNESS OF MULTIPLANE TRANSESOPHAGEAL STRESS ECHOCARDIOGRAPHY DEPENDING ON THE LOCATION OF THE STENOSIS?
J. Gude, E. Horstmann, H.J. Trappe, Herne, Germany

17. AUTOMATIC BACKSCATTER ANALYSIS OF REGIONAL RIGHT VENTRICULAR SYSTOLIC FUNCTION AFTER ANTERIOR ACUTE MYOCARDIAL INFARCTION USING COLOR KINESIS
T. Kurum, C. Korucu, F. Ozcelik, H. Eker, E. Oztekin, G. Ozbay, Edime, Turkey

18. SAFETY OF DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN THE ROUTINE CLINICAL PRACTICE
E. Plonska, H. Szwed, B. Birkenfeld, L. Batalia, A. Raczynska, M. Demczuk, J. Kadlowski, J. Ptasinski, A. Spring, J. Kasprzak, Szczecin, Poland

19. DOBUTAMINE STRESS ECHOCARDIOGRAPHY IN PATIENTS WITH LEFT BUNDLE BRANCH BLOCK WITHOUT CORONARY ARTERY DISEASE
E.G. Zakynthinos, P. Skiathitis, C. Evdoridis, M. Calachanis, P. Nihoyannopoulos, London, UK

TUESDAY, MAY 18, 1999

P110: Poster Session
DIAGNOSTIC METHODS

Board No.

20. PERICARDIAL EFFUSION AFTER ACUTE MYOCARDIAL INFARCTION
M. Alam, M. Gunda, F. Khaja, S. Borzak, G. Devine, H. Sabbah, L. Graham, S. Goldstein, Detroit MI, USA

21. SAFETY OF CORONARY ARTERIOGRAPHY IN CLINICALLY STABLE PATIENTS FOLLOWING CORONARY BYPASS SURGERY
F.L. Gobel, W.J. Stewart, L. Campeau, A. Hickey, J.A. Herd, S. Forman, C.W. White, Y. Rosenberg, Minneapolis MN, USA

22. THORACIC IMPEDANCE EVALUATES ADMISSION CHEST X-RAY CHANGES IN ACUTE HEART FAILURE PATIENTS
D.P. Milzman, A. Zlindenny, A. Battiata, T. Janchar, R. Samaddar, Washington DC, USA

23. ACOUSTICAL DETECTION OF DIASTOLIC STENOSIS SOUND IN PATIENTS WITH CORONARY ARTERY STENOSIS
T. Nogimura, K. Chinn, Y. Honda, Y. Gotou, O. Tateishi, S. Mochizuki, Tokyo, Japan

24. MYOCARDIAL FRACTIONAL FLOW RESERVE CALCULATED FROM CORONARY PRESSURE MEASUREMENTS CORRELATES OF MYOCARDIAL ISCHEMIA AND EVALUATION OF THE EFFECTIVENESS OF PTCA IN CHILDREN WITH KAWASAKI DISEASE
S. Ogawa, Y. Katsube, T. Ohkubo, Y. Kuramochi, D. Fukumi, Y. Uchikoba, Y. Hino, Tokyo, Japan

25. ASSESSMENT OF LEFT ANTERIOR DESCENDING CORONARY FLOW RESERVE WITH ADENOSINE TRIPHOSPHATE TEST BY TRANSESOPHAGEAL DOPPLER ECHOCARDIOGRAPHY: CORRELATION WITH QUANTITATIVE CORONARY ANGIOGRAPHY
G. Ugliengo, F. Margaria, F. Casasso, G. Leonardi, A. Dellavalle, E. Menardi, A. Vado, E. Uslenghi, Cuneo, Italy

26. USEFULNESS OF CORONARY ANGIOGRAPHY FOR ASSESSING LEFT VENTRICULAR FUNCTION
B. Wandt, A. Kahari, J. Zizala, L. Bojo, B. Wranne, Orebro, Sweden

TUESDAY, MAY 18, 1999

P114: Poster Session
ACUTE MYOCARDIAL INFARCTION, THROMBOLYSIS AND REPERFUSION

Board No.

27. PREHOSPITAL TREATMENT OF NON-Q-WAVE MYOCARDIAL INFARCTION WITH INITIAL ST SEGMENT DEPRESSION
T.B. Baltabaev, M.T. Beishenculov, N.T. Kudaibergenova, Bishkek, Kyrgyzstan

28. RANDOMIZED CLINICAL TRIAL OF MEGADOSE HEPARIN IN THE MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION
M.J.D. Garcia, D.R. Flores, R.V. Anastacio, E.S. Caguioa, C.M. Mendoza, Manila, Philippines

29. CAN ELECTROCARDIOGRAPHIC Q-WAVES BE USED AS AN INDICATOR OF PAST MYOCARDIAL INFARCTION?
L.L. Sandler, E.E. Pinnow, J. Lindsay Jr., Washington DC, USA

30. PLASMINOGEN-ACTIVATOR-INHIBITOR TYPE 1 (PAI-1) AND THE OUTCOME OF FIBRINOLYSIS WITH STREPTOKINASE OF PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
A. Sinkovic, V. Urlep-Salinovic, Maribor, Slovenia

31. ACCELERATED STREPTOKINASE IN ACUTE MYOCARDIAL INFARCTION - OUR THREE YEARS CORONARY CARE UNIT'S EXPERIENCE
G. Tatu-Chitoiu, C. Teodorescu, P. Capraru, A. Tatu-Chitoiu, M. Guran, V. Chioncel, A. Bumbu, Bucharest, Romania

32. DOUBLE BOLUS OF 750000 I.U. STREPTOKINASE IS A MORE EFFICIENT REGIMEN THAN THE STANDARD 1 500 000 I.U. OVER 60 MINUTES REGIMEN IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
G. Tatu-Chitoiu, P. Capraru, M. Guran, M. Dan, C. Teodorescu, A. Tatu-Chitoiu, A. Bumbu, V. Chioncel, Bucharest, Romania

33. BOLUS ADMINISTRATION OF 750000 I.U. STREPTOKINASE IN ASSOCIATION WITH ENOXAPARIN IN THE PREHOSPITAL MANAGEMENT OF ACUTE MYOCARDIAL INFARCTION
G. Tatu-Chitoiu, M. Oprisan, O. Cismara, T. Sfiriac, A. Marinescu, R. Marinescu, R. Turcu, Bucharest, Romania

34. SAFETY AND EFFICACY OF COMBINATION BETWEEN ACCELERATED STREPTOKINASE AND ENOXAPARIN IN ACUTE MYOCARDIAL INFARCTION
G. Tatu-Chitoiu, M. Guran, A. Tatu-Chitoiu, P. Capraru, M. Dan, A. Bumbu, V. Chioncel, Bucharest, Romania

35. FEMALE DEATHS FROM ISCHEMIC HEART DISEASE IN AND OUTSIDE HOSPITAL - A STUDY OF INTRA-URBAN VARIATIONS IN THE CITY OF MALMO, SWEDEN
P. Tyden, G. Engstrom, O. Hansen, B. Hedblad, L. Janzon, Malmo, Sweden

TUESDAY, MAY 18, 1999

P120: Poster Session
SECONDARY PREVENTION, PROGNOSIS, RISK STRATIFICATION, CARDIAC REHABILITATION

Board No.

36. INFLAMMATORY RESPONSE AND BASELINE CHOLESTEROL IN ACUTE MYOCARDIAL INFARCTION
S. Arvanitakis, E. Siniorakis, P. Hatziandreou, G. Voyatzopoulos, G. Plataris, P. Bonoris, Athens, Greece

37. EFFECT OF ATENOLOL AND ENALAPRIL ON PATIENTS WITH MYOCARDIAL INFARCTION
N. Wu, Z. Fan, Beijing, China

38. EFFECTIVENESS OF A PLANNED STRATEGY FOR THE MANAGEMENT OF DYSLIPIDEMIA IN PATIENTS WITH CORONARY ARTERY DISEASE
J.M. Griffiths, A. Fernando, D.E. Mooney, S. Hare, M.P. Senaratne, Edmonton, Alberta, Canada

39. CRACOVIAN PROGRAM FOR SECONDARY PREVENTION OF ISCHAEMIC HEART DISEASE; MANAGEMENT FOLLOWING DISCHARGE
K. Kawecka-Jaszcz, A. Pajak, P. Jankowski, D. Czarnecka, J. Dubiel, J. Maciejewicz, W. Piotrowski, W. Smielak-Korombel, W. Tracz, K. Zmudka, Cracow, Poland

40. ASSOCIATION OF SERUM ANTIBODIES TO HEART-SHOCK PROTEIN 65 WITH CAROTID ATHEROSCLEROSIS: CLINICAL SIGNIFICANCE DETERMINED IN A FOLLOW-UP STUDY
Q. Xu, S. Kiechl, M. Mayr, B. Metzler, G. Egger, F. Oberhollenzer, J. Willeit, G. Wick, Innsbruck, Austria

41. QUALITY ASSESSMENT IN OPEN HEART SURGERY BASED ON PARSONNET'S RISK STRATIFICATION MODEL
N. Radovanovic, D. Jakovljevic, B. Mihajlovic, Z. Potic, M. Popov, M. Potic, Novi Sad, Yugoslavia

42. DIFFERENCE IN PLASMA HOMOCYSTEINE LEVELS IN SOUTH ASIAN VERSUS EAST ASIAN PATIENTS WITH CORONARY ARTERY DISEASE
M.P. Senaratne, D. deSilva, K. MacDonald, Edmonton, Alberta, Canada

43. DOCTORS' REGISTRATION AND MANAGEMENT OF SMOKING BEHAVIOR OF PATIENTS WITH CORONARY ARTERY DISEASE: THE EUROASPIRE SURVEY
D.F.M. van Berkel, D. De Bacquer, D.A. Wood, Rotterdam, The Netherlands

44. MOTIVATION TO CHANGE SMOKING BEHAVIOR IN PATIENTS WITH CORONARY ARTERY DSIEASE IN EUROPE: THE EUROASPIRE SURVEY
D.F.M. van Berkel, D. De Bacquer, D.A. Wood, Rotterdam, The Netherlands

45. EPIDEMIOLOGICAL SIGNS OF CORONARY HEART DISEASE AS PREDICTOR OF DEATH
O. Volozh, A. Deev, T. Kalyuste, R. Kaup, E. Solodkaya, J. Abina, Tallinn, Estonia

TUESDAY, MAY 18, 1999

P124: Poster Session
HYPERTENSION, BASIC AND CLINICAL

Board No.

46. HYPOTENSIVE EFFECTS OF STATINS: PRELIMINARY DATA WITH ATORVASTATIN
S. Bandinelli, A. Bertolotto, L. Pucci, R. Navalesi, G. Penno, Pisa, Italy

47. ECG CHANGES AFTER RAPID REDUCTION OF BLOOD PRESSURE IN HYPERTENSIVE EMERGENCIES
P. Bara, A. Dibra, G. Ndrepepa, T. Sinjari, L. Bica, Tirana, Albania

48. ARTERIAL HYPERTENSION, HYPERCHOLESTEROLAEMIA AND ENDOTHELIAL DYSFUNCTION
D. Czarnecka, M. Malczewska-Malec, K. Kawecka-Jaszcz, A. Dembinska-Kiec, Krakow, Poland

49. BLOOD PRESSURE PROFILE AND VARIABILITY IN HYPERTENSIVES TREATED WITH L-ARGININE INFUSION
D. Czarnecka, K. Kawecka-Jaszcz, M. Malczewska-Malec, A. Dembinska-Kiec, Krakow, Poland

50. GENETIC MODE IN HEREDITARY HYPERTENSION
Z. Fan, L. Rui, C. Ma, Yichang City, China

51. EFFECT OF TRANDOLAPRIL-VERAPAMIL COMBINATION ON FIBRINOLYTIC FUNCTION IN OVERWEIGHT HYPERTENSIVE PATIENTS
R. Fogari, L. Corradi, L. Poletti, A. Zoppi, A. Mugellini, G.D. Malamani, Pavia, Italy

52. LEFT VENTRICULAR DIASTOLIC FUNCTION IN DIFFERENT PATTERNS OF LEFT VENTRICULAR HYPERTROPHY AND GEOMETRY IN HYPERTENSION
J. Jaroch, K. Loboz-Grudzien, A. Kowalska, A. Kostecka-Pokryszko, A. Wojszwillo, K. Poczatek, Wroclaw, Poland

53. HIGH PREVALENCE OF LEFT VENTRICULAR HYPERTROPHY IN PATIENTS WITH ABDOMINAL ANEURYSM
S.E. Kranendonk, M. Wullink, M. den Heyer, S.J. Graafsma, Tilburg, The Netherlands

54. COMPARISON OF BLOOD PRESSURE DYNAMICS FOR TREATMENT BY CAPTOPRIL AND LOSARTAN AND DURING ITS ABRUPT WITHDRAWAL IN MILD-TO-MODERATE ESSENTIAL HYPERTENSION PATIENTS
V.I. Metelitsa, I.V. Savina, A.D. Deev, Moscow, Russia

55. ANTIHYPERTENSIVE COMBINATION TREATMENT WITH VERAPAMIL SR 180 mg/ TRANSOLAPRIL 2 mg PRESERVES LEFT VENTRICULAR FUNCTION IN NYHA CLASS I AND II HEART FAILURE PATIENTS
V. Mitrovic, M. Parzeller, T. Notter, P. Zilles, S. Eberle, Ludwigshafen, Germany

56. EFFECTS OF LOSARTAN ON CARDIAC PERFORMANCE DURING TREADMILL EXERCISE IN HYPERTENSIVE SUBJECTS
S. Paterna, G. Parrinello, A. Pinto, G. Follone, A. Cardinale, P. Bologna, A. D'Angelo, G. Licata, Palermo, Italy

TUESDAY, MAY 18, 1999

P124: Poster Session
HYPERTENSION, BASIC AND CLINICAL (cont)

Board No.

57. IMPAIRMENT OF LONG AXIS FUNCTION IN ARTERIAL HYPERTENSION WITH APPARENTLY NORMAL SYSTOLIC FUNCTION
S. Qirko, T. Goda, L. Rroku, Tirana, Albania

58. IS IT POSSIBLE TO REVERSE CARDIAC HYPERTENSIVE REMODELING?
A.M. Szyszka, A. Cieslinski, S. Paradowski, A.H. Szyszka, Poznan, Poland

59. WHY DOES LEFT VENTRICULAR MASS INCREASE IN HYPERTENSION DESPITE OF BLOOD PRESSURE FALL?
A.M. Szyszka, A. Cieslinski, S. Paradowski, A.H. Szyszka, Poznan, Poland

60. ANTIHYPERTENSIVE EFFICACY AND INFLUENCE ON OBSTRUCTIVE SLEEP BREATHING OF AROTINOLOL
J. Zhang, R. Hui, X. Ni, Y. Sun, B. Zhao, X. Wang, L. Liu, Beijing, China

61. INTERRELATIONSHIP BETWEEN ENDOTHELIAL DYSFUNCTION AND INSULIN RESISTANCE IN HYPERTENSIVE PATIENTS AND IN NORMOTENSIVE OFFSPRING OF SUBJECTS WITH ESSENTIAL HYPERTENSION
B. Zizek, P. Poredos, L. Zaletel-Kragelj, V. Videcnik, Ljubljana, Slovenia

 

TUESDAY, MAY 18, 1999

P133: Poster Session
LEFT VENTRICULAR HYPERTROPHY, HYPERTROPHIC CARDIOMYOPATHY

Board No.

62. QT DISPERSION AND VENTRICULAR ARRHYTHMIAS REDUCTION AFTER LEFT VENTRICULAR HYPERTROPHY REGRESSION IN ESSENTIAL HYPERTENSION
F. Bellandi, R.P. Dabizzi, R. Palchetti, Prato, Italy

63. EFFECTS OF ANABOLIC-ANDROGENIC STEROIDS ON WEIGHT-LIFTER'S MYOCARDIUM: AN ULTRASONIC VIDEODENSITOMETRIC STUDY
V. Di Bello, D. Giorgi, A. Bertini, M.T. Caputo, G. Valenti, E. Talini, A. Lorenzi, M. Paterni, C. Giusti, Pisa, Italy

64. ULTRASONIC MYOCARDIAL TEXTURE PARAMETERS IN HEMODIALYTIC PATIENTS COMPARED WITH ESSENTIAL HYPERTENSIVE PATIENTS
V. Di Bello, V. Panichi, R. Pedrinelli, D. Giorgi, M. Bianchi, A. Bertini, G. Valenti, D. Taccola, M.T. Caputo, E. Talini, M. Paterni, C. Giusti, Pisa, Italy

65. THE DISPERSION OF QT INTERVAL HAS A GOOD CORRELATION WITH LEFT VENTRICULAR MASS
A. Dibra, V. Gjini, E. Pavli, E. Maci, A. Sinani, P. Cina, S. Qirko, Tirana, Albania

TUESDAY, MAY 18, 1999

P133: Poster Session
LEFT VENTRICULAR HYPERTROPHY, HYPERTROPHIC CARDIOMYOPATHY (cont)

Board No.

66. THE INCREASE OF QT DISPERSION OCCURS BEFORE THE DEVELOPMENT OF LEFT VENTRICULAR HYPERTROPHY IN HYPERTENSIVE PATIENTS
A. Dibra, V. Gjini, E. Pavli, E. Maci, A. Sinani, P. Cina, S. Qirko, Tirana, Albania

67. HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY (HOCM) AND DDD PACING WITH SHORT AV DELAY
O.T. Greco, A. Cardinalli Neto, S.A.C. Garzon, A. Parro Jr., J. Vitola, N.C.S. Machado, R. Costa, R.V. Ardito, Sao Paulo, Brazil

68. ENDSTAGE HEART FAILURE IN CATS WITH HYPERTROPHIC CARDIOMYOPATHY
S.K. Liu, P. Fox, Y.C. Chiu, J.J. Shyu, New York NY, USA, Taiwan-R.O.C.

69. IS TILT-TABLE TEST OF ANY VALUE IN IDENTIFYING HYPERTROPHIC CARDIOMYOPATHY PATIENTS AT RISK FOR SYNCOPE?
S. Mohiddin, D. Bedley, D. McAreavey, L. Fananapazir, Bethesda MD, USA

70. A COMPARISON OF BLOOD PRESSURE CHANGES TO TREADMILL AND BICYCLE EXERCISE TESTS IN PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
S. Mohiddin, G. Rowe, J. Arevalo, D. Tripodi, S. Biddle, L. Fananapazir, Bethesda MD, USA

71. EFFECT OF VERAPAMIL ON SYSTOLIC AND DIASTOLIC CORONARY BLOOD FLOW VELOCITY IN ASYMPTOMATIC AND MILDLY SYMPTOMATIC PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY
P. Petkow-Dimitrow, M. Krzanowski, R. Nizankowski, A. Szczeklik, J.S. Dubiel, Krakow, Poland

 

TUESDAY, MAY 18, 1999

P141: Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG THERAPY - BASIC AND CLINICAL

Board No.

72. PROVOCATIVE TESTING WITH SL NTG IN TILT TABLE STUDIES: ROLE IN PATIENTS WITH CAD
L.S. Adams, J. Reynolds, S. Hessen, C. Movsowitz, S.P. Kutalek, Philadelphia PA, USA

73. AMLODIPINA CAN PREVENT THE "REVERSE-USE DEPENDENCE" EFFECT OF SOTALOL
F. Bellandi, R.P. Dabizzi, R. Palchetti, Prato, Italy

74. COMBINATION OF SOTALOL AND DILTIAZEM REDUCES QT SEGMENT DISPERSION IN PATIENTS WITHOUT STRUCTURAL HEART DISEASE
A. Dibra, V. Gjini, G. Ndrepepa, E. Pavli, E. Maci, P. Cina, Tirana, Albania

TUESDAY, MAY 18, 1999

P141: Poster Session
ARRHYTHMIAS AND ANTIARRHYTHMIC DRUG
THERAPY - BASIC AND CLINICAL (cont)

Board No.

75. CLINICAL FEATURES ARE PREDICTORS OF NEW CONDUCTION DISTURBANCES DURING THE POSTOPERATIVE PERIOD OF CARDIOVASCULAR SURGERY
R. Iglesias, A. Baranchuk, C. Muratore, M.A. Gonzalez, V. Daru, R. Rabinovich, A.S. Liprandi, Buenos Aires, Argentina

76. REDUCTION OF QT INTERVAL DISPERSION BY SUCCESSFUL CORONARY ANGIOPLASTY
P. Konecna, R. Dvorak, P. Kala, B. Semrad, Brno, Czech Republic

77. ELECTROPHYSIOLOGICAL EFFECTS OF MELATONIN IN ISOLATED GUINEA PIG HEARTS
P. Lercher, S. Fleck, U. Haiden, I. Schwarzl, K. Stoschitzky, W. Klein, G. Stark, Graz, Austria

78. DISPERSION OF VENTRICULAR REPOLARIZATION VERSUS SITE OF MYOCARDIAL INFARCTION AND OCCURRENCE OF VENTRICULAR ARRHYTHMIAS
L. Poposka, L. Dobrkovic, M. Vavlukis, I. Trajkov, N. Kostova, Skopje, Macedonia

P144: Poster Session
INTERNAL DEFIBRILLATION, IMPLANTABLE
ANTIARRHYTHMIC DEVICES, PACING

Board No.

79. DEFIBRILLATION THRESHOLDS ARE NOT SIGNIFICANTLY INCREASED BY RIGHT-SIDED IMPLANTATION OF ICDs
M. Achtelik, B. Voigt, L. Obergassel, P. Pfitzner, H.J. Trappe, Herne, Germany

80. SUBCUTANEOUS VERSUS SUBMUSCULAR IMPLANTATION OF ICDs - DOES IT MAKE ANY DIFFERENCE?
M. Achtelik, B. Voigt, L. Obergassel, P. Pfitzner, H.J. Trappe, Herne, Germany

81. TEMPORARY SCREW-IN PACEMAKER ELECTRODES: SECURITY YOU CAN COUNT ON
C. Burbidge, S. Cone, J. Konrad, J. Reynolds, C. Saari, F. Padder, C. Movsowitz, S.P. Kutalek, Philadelphia PA, USA

82. HOLTER MONITORING IN THE EVALUATION OF THE AUTOCAPTURE SYSTEM DURING THE FOLLOW-UP
T. Centella, E. Oliva, A. Hernandez-Madrid, I. Garcia Andrade, A. Epeldegui, C. Moro, Madrid, Spain

TUESDAY, MAY 18, 1999

P144: Poster Session
INTERNAL DEFIBRILLATION, IMPLANTABLE
ANTIARRHYTHMIC DEVICES, PACING (cont)

Board No.

83. THRESHOLDS VARIATIONS WITH ACTIVE FIXATION LEAD ON ACUTE ATRIAL AND VENTRICULAR PACING WITH STEROID
O.T. Greco, R.V. Ardito, R. Costa, M. Martinelli Filho, M.J.C. Pachon, P.T.J. Medeiros, Sao Paulo, Brazil

84. RECORDING OF MONOPHASIC ACTION POTENTIAL BY USING IMPLANTABLE PACEMAKER AND ENDOCARDIAL LEADS - FIRST CLINICAL DATA AFTER ONE YEAR FOLLOW UP
T. Lawo, S. Wagner, V. Lang, B. Lemka, J. Barmeyer, Bochum, Germany

85. EVALUATION OF SPONTANEOUS SUSTAINED VENTRICULAR TACHYCARDIA TREATED BY ANTITACHYCARDIA PACING IN IMPLANTABLE CARDIOVERTER-DEFIBRILLATORS
M.F. Martinelli, H. Moreira, A. Pedrosa, S. Nishioka, R. Costa, E. Sosa, M. Scanavacca, A. d'Avila, S. Siqueira, J. Ramires, A. Jatene, Sao Paolo, Brazil

86. AUTONOMIC NERVOUS SYSTEM - CONTROLLED CLOSED-LOOP CARDIAC PACING VERSUS ACCELEROMETER SENSOR - COMPARATIVE ANALYSIS
A.S. Menezes Jr., W.L. de Carvalho, F.P. Cazorla, J.C. Dourado, C.F.M. Queiroz, Goiania, Brazil

87. INCREASED PACEMAKER LIFETIME DUE TO VENTRICULAR CAPTURE CONTROL
A. da Silva Menezes Jr., C.F.M. Queiroz, F. da Paz Cazorla, W.L. de Carvalho, J.C. Dourado, M. Schaldach, Goiania, Brazil, Erlangen, Germany

88. A NEW HIGH IMPEDANCE SMALL DIAMETER PACING LEAD FAMILY WITH 1.3MM² FRACTALLY STRUCTURED TIPS: ACUTE AND CHRONIC CLINICAL PERFORMANCE
N. Vijay, Denver CO, USA

 

TUESDAY, MAY 18, 1999

P158: Poster Session
MISCELLANEOUS

Board No.

89. LEFT ATRIAL MYXOMA ITS CLINICAL PROFILE AND ECHOCARDIOGRAPHIC FEATURES PHILIPPINE HEART CENTER EXPERIENCE 1976-1998
A.M.L.A. Delos-Reyes-Javier, G.T. Catalan, R.D. Jara, L.W.S. Rondilla, E. Vicaldo, Manila, Philippines

90. RIGHT-SIDED INFECTIVE ENDOCARDITIS: IMPACT OF ECHOCARDIOGRAPHIC FINDINGS ON A NEW DIAGNOSTIC APPROACH
G. Diaz, C. Rios, A. Diaz, H. Acuna, M. Petrozi, A. Centurion, E. Guevara, Chiclayo, Peru

TUESDAY, MAY 18, 1999

P158: Poster Session
MISCELLANEOUS (cont)

Board No.

91. ISCHEMIC HEART DISEASE - DIFFERENCES BETWEEN THE TWO SEXES
A. Felix, C. Barradas, V. Mendes, M. Monteiro, A. Sousa, L. Joao, J. Sa Nogueira, A. Aleixo, A. Sales Luis, Lisbon, Portugal

92. INCREASED AORTIC COMPLIANCE MAINTAINS LEFT VENTRICULAR PERFORMANCE AT LOWER ENERGETIC COST
P. Kolh, B. Lambermont, P. Gerard, C. Gommes, P. Potty, R. Limet, V. D'Orio, Liege, Belgium

93. CORRELATION BETWEEN THE NORMAL MITRAL ANNULUS AREA AND BODY SURFACE AREA
N. Radovanovic, V. Torbica, D.D. Zecevic, M. Kovac, L. Petrovic, B. Mihajlovic, Z. Potic, Novi Sad, Yugoslavia

94. ROSE-HIP GIVEN AS A STANDARDISED DRY POWDER EXERTS ANTI-INFLAMMATORY PROPERTIES, WITHOUT INFLUENCING PLATELET AGGREGATION AND THE COAGULATION CASCADE
E. Rein, A. Kharazmi, K. Winther, Copenhagen, Denmark

 

TUESDAY, MAY 18, 1999

P160: Poster Session
NEUROHUMORAL ASPECTS OF HEART FAILURE, NATRIURETIC PEPTIDES

Board No.

95. NESIRITIDE IMPROVES HEMODYNAMICS IN PATIENTS WITH ACUTELY DECOMPENSATED HEART FAILURE: HEMODYNAMIC SUBGROUP ANALYSIS
R.C. Bourge, W.T. Abraham, L.E. Wagoner, P. Horton, T.H. LeJemtel, Birmingham AL, USA

96. PROGRESSIVE RENIN ANGIOTENSIN SYSTEM ACTIVATION DURING CHRONIC ALCOHOL CONSUMPTION: A POTENTIAL MECHANISM OF ALCOHOLIC CARDIOMYOPATHY
C-P. Cheng, Winston-Salem NC, USA

97. ALPHA- AND BETA-ADRENERGIC PATHWAYS DIFFERENTIALLY REGULATE CELL TYPE-SPECIFIC APOPTOSIS IN RAT CARDIAC MYOCYTES
K. Hasegawa, E. Iwai-Kanai, M. Araki, T. Kakita, T. Morimoto, S. Sasayama, Kyoto, Japan

98. MATURE FORM OF CIRCULATING ADRENOMEDULLIN - AN EVALUATION IN PATIENTS WITH CONGESTIVE HEART FAILURE AND ITS SECRETION AND CLEARANCE SITES
N. Hirayama, K. Kitamura, T. Imamura, Y. Koiwaya, T. Eto, Miyazaki, Japan

TUESDAY, MAY 18, 1999

P160: Poster Session
NEUROHUMORAL ASPECTS OF HEART FAILURE, NATRIURETIC PEPTIDES (cont)

Board No.

99. MODULATION OF TRANSMEMBRANE SIGNALING BY DOMAIN-SPECIFIC ANTIb₁ -ADRENOCEPTOR ANTIBODIES
R. Jahns, V. Boivin, T. Krapf, N. Roethlein, F. Boege, M.J. Lohse, Wuerzburg, Germany

100. AUTOANTIBODIES SENSITIZING THE CARDIAC b₁ -RECEPTOR ARE NOT PRESENT IN CARDIOMYOPATHIES SECONDARY TO VALVULAR OR HYPERTENSIVE HEART DISEASE
R. Jahns, V. Boivin, C. Siegmund, M. Jensen, M.J. Lohse, G. Inselmann, Wuerzburg, Germany

101. IMPROVING ACUTE PULMONARY EDEMA REDUCES ATRIAL NATRIURETIC PEPTIDES LEVELS IN HOSPITALIZED PATIENTS WITH HEART FAILURE
P. Somasundaram, B.H. Sung, S.A. Mousa, M.F. Wilson, Buffalo NY, USA

102. EFFECTS OF AN ADENOSINE DEAMINASE INHIBITOR (EHNA) AND CAFFEINE ON ENDOTOXIN-INDUCED RELEASE OF CYTOKINES AND HEART PERFORMANCE CHANGES IN VIVO IN RATS
S.P. Tofovic, L. Zacharia, E.K. Jackson, J.A. Carcillo, Pittsburgh PA, USA

  WEDNESDAY, MAY 19, 1999

PL14: Plenary Session
SURGERY FOR LV DYSFUNCTION, MECHANICAL SUPPORT, CARDIAC TRANSPLANTATION
Chairpersons:    B.M. Meiser, Munich, Germany
                             E.A. Rose, New York NY, USA

08:30 PROGRESS IN LONG-TERM MECHANICAL CIRCULATORY SUPPORT (Invited Lecture)
E.A. Rose, New York NY, USA

08:45 NEW DEVELOPMENTS IN THE SURGICAL TREATMENT OF HEART FAILURE (Invited Lecture)
W. Piccione, Chicago IL, USA

09:00 PERICARDIECTOMY FOR CHRONIC CONSTRICTIVE PERICARDITIS - LOW MORTALITY AND SUSTAINED LONG TERM FUNCTIONAL IMPROVEMENT
I. Mehta, G. Tellides, G.S. Kopf, L.S. Cohen, J.A. Elefteriades, New Haven CT, USA

09:15 RECOVERY OF CARDIAC FUNCTION IN END-STAGE DILATED CARDIOMYOPATHY BY PROLONGED LEFT VENTRICULAR ASSIST DEVICE APPLICATION (Invited Lecture)
J. Mueller, Y. Weng, M. Dandel, T. Drews, H. Bieda, M. Loebe, R. Hetzer, Berlin, Germany

09:30 IS XENOTRANSPLANTATION THE FUTURE OF HEART TRANSPLANTATION? (Invited Lecture)
B. Reichart, M. Schmoeckei, J. Wallwork, D.J.G. White, Munich, Germany

09:45 DYNAMIC CARDIOMYOPLASTY FOR PATIENTS WITH ADVANCED DILATIVE OR ISCHEMIC CARDIOMYOPATHY AND SEVERE RHYTHM DISTURBANCES (Invited Lecture)
V.S. Chekanov, S. Deshpande, Milwaukee WI, USA

10:00 NEW TRENDS IN IMMUNOSUPPRESSION AFTER HEART TRANSPLANTATION (Invited Lecture)
B.M. Meiser, M. Pfeiffer, D. Schmidt, P. Ueberfuhr, H. Reichenspumer, D. Paulus, W. von Scheidt, D. Seidel, B. Reichart, Munich, Germany

10:15 INTRAMYOCARDIAL IMPEDANCE MEASUREMENTS FOR DIAGNOSIS OF ACUTE CARDIAC ALLOGRAFT REJECTION
R. Pfitzmann, J. Muller, O. Grauhan, R. Hetzer, Berlin, Germany

10:30 PARTIAL LEFT VENTRICULECTOMY: RESULTS ON 48 CASES OPERATED ON A 4 YEARS INTERVAL (Invited Lecture)
F.A. Lucchese, J.D. Frota Filho, C. Blacher, C. Halperin, W.M. Pereira, E.A. Lucio, P.E. Leaes, Porto Alegre, Brazil

10:45 C o f f e e B r e a k

WEDNESDAY, MAY 19, 1999

PL15: Plenary Session
NATRIURETIC PEPTIDES, ENDOTHELIN: ROLE IN HEART FAILURE
Chairpersons:  U. Elkayam, Los Angeles, CA, USA
                          A. Lerman, Rochester MN, USA

08:30 THE ROLE OF ENDOTHELIN IN CARDIOVASCULAR DISEASES (Invited Lecture)
A. Lerman, Rochester MN, USA

08:45 ENDOTHELIAL FUNCTION AND HEART FAILURE (Invited Lecture)
U. Elkayam, Los Angeles CA, USA

09:00 ENDOTHELIN IN HEART FAILURE (Invited Lecture)
A. Caspi, Rehovot, Israel

09:30 ANTIHYPERTROPHIC, CARDIOVASCULAR AND NEUROHUMORAL EFECTS OF KC 12792, A NOVEL DUAL INHIBITOR OF NEUTRAL ENDOPEPTIDASE AND ENDOTHELIN CONVERTING ENZYME, IN ISOPROTERENOL-INDUCED CARDIAC HYPERTROPHY IN RATS
S.P. Tofovic, B. Rominski, Pittsburgh PA, USA

09:45 "NESIRITIDE (SYNTHETIC HUMAN B-TYPE NATRIURETIC PEPTIDE): A NEW THERAPEUTIC AGENT FOR TREATING PATIENTS WITH HEART FAILURE" (Invited Lecture)
R.E. Hobbs, Cleveland OH, USA

10:00 NESIRITIDE (HUMAN B-TYPE NATRIURETIC PEPTIDE) IMPROVES SYMPTOMS AND HEMODYNAMICS IN NYHA CLASS III AND IV HEART FAILURE
W.T. Abraham, A.D. Johnson, L. Wagoner, M.M. Givertz, D.P. Horton, Cincinnati OH, USA

10:15 MOLECULAR DETERMINANTS OF THE SIGNALING MECHANISMS OF ATRIAL NATRIURETIC PEPTIDE RECEPTOR-A
K.N. Pandey, New Orleans LA, USA

10:30 C o f f e e B r e a k

WEDNESDAY, MAY 19, 1999

S51: ACUTE MYOCARDIAL INFARCTION: THROMBOLYSIS AND REPERFUSION
Chairpersons:  B.I. Jugdutt, Edmonton, Canada
                          D. Zahger, Jerusalem, Israel

08:30 NEW THROMBOLYTIC AGENTS: UPDATE, 1999 (Invited Lecture)
D. Zahger, Jerusalem, Israel

08:45 IN-HOSPITAL AND LONG-TERM MORTALITY AND MORBIDITY ASSOCIATED WITH RIGHT VENTRICULAR INFARCTION IN A DEFINED GEOGRAPHIC POPULATION
R.S. Wright, J.G. Murphy, R.J. Gumina, J.P. Grill, S.L. Kopecky, Rochester MN, USA

09:00 ENHANCED SURVIVAL IN OLDER PATIENTS (>75 YEARS) UNDERGOING PRIMARY PTCA FOR TREATMENT OF ACUTE MYOCARDIAL INFARCTION
W.L. Miller, R.S. Wright, J.P. Grill, S.L. Kopecky, Rochester MN, USA

09:15 EFFECTIVENESS OF A SPECIALIST CARDIAC 'THROMBOLYSIS' NURSE IN IMPROVING DELAYS TO THROMBOLYSIS IN ACUTE MYOCARDIAL INFARCTION
J.D. Somauroo, P. McCarten, B. Appleton, E. Rodrigues, Liverpool, UK

09:30 PREDICTION OF REPERFUSION AFTER STREPTOKINASE IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION BY A NEW TEST FOR FUNCTIONALLY NEUTRALISING STREPTOKINASE ANTIBODIES
S. Gill, S.R. Kristensen, B. Haastrup, T. Haghfelt, Odense, Denmark

09:45 CARDIOPROTECTIVE EFFECTS OF HUMAN PLACENTA ANTIISCHEMIC COMPOUND (PLAFERON-LB) IN A CANINE MODEL
W.D. Johnson, N.N. Kipshidze, N. Javakhishtvili, Z. Tsagareli, V. Bakhutashvili, Milwaukee WI, USA

10:00 EARLY DEATHS WITH THROMBOLYTIC THERAPY FOR ACUTE MYOCARDIAL INFARCTION IN CORTICOSTEROID-DEPENDENT RHEUMATOID ARTHRITIS
P. Kotha, M.J. McGreevy, A. Kotha, M. Look, M.H. Weisman, San Diego CA, USA

10:30 C o f f e e B r e a k

WEDNESDAY, MAY 19, 1999

S63: HYPERTROPHIC CARDIOMYOPATHY
Chairpersons:  G.A. Mensah, Augusta GA, USA
                          M.A. Rossi, Sao Paulo, Brazil

08:30 THE RESULTS OF DUAL CHAMBER PACING FOR MID-CAVITY LEFT VENTRICLE OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY
D. Begley, S. Mohiddin, L. Fananapazir, Bethesda MD, USA

08:45 ASSESSMENT OF QUANTITATIVE HYPERTROPHY SCORES IN HYPERTROPHIC CARDIOMYOPATHY: MAGNETIC RESONANCE IMAGING VERSUS ECHOCARDIOGRAPHY
J.L. Posma, E.E. van der Wall, Groningen, Leiden, The Netherlands

09:00 CORRELATION BETWEEN BRUCE PROTOCOL TREADMILL EXERCISE TEST AND BICYCLE MAXIMAL OXYGEN UPTAKE EXERCISE TEST IN HYPERTROPHIC CARDIOMYOPATHY
S. Mohiddin, J. Arevalo, G. Rowe, S. Biddle, D. Tripodi, L. Fananapazir, Bethesda MD, USA

09:15 SUSTAINED BENEFICIAL EFFECT OF LONG-TERM SEQUENTIAL PACING IN SEVERE HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
J.C. Tascon, A. Albarran, F. Hernandez, M. Alonso, J. Andreu, R. Coma, J. Rodriguez, R. Gascuena, P. Hernandez, M. Lazaro, Madrid, Spain

09:30 EFFECT OF OCTREOTIDE IN PATIENTS WITH HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY
E. Demirtas, C. Sag, H. Kursaklioglu, M. Uzun, S. Kose, Ankara, Turkey

09:45 MORPHOLOGIC DESCRIPTION OF THE COLLAGEN MATRIX IN THE MYOCARDIUM OF PIGS WITH SPONTANEOUSLY OCCURRING HYPERTROPHIC CARDIOMYOPATHY
S.K. Liu, Y.-T. Chiu, M. Liu, J.J. Shyu, R. Chu, New York NY, USA

10:00 ELECTROPHYSIOLOGIC ASSESSMENT OF PATIENTS WITH HYPERTROPHIC CARDIOMYOPATHY PRESENTING WITH ATRIAL FIBRILLATION: RELATION OF INDUCED TO SPONTANEOUS ATRIAL FIBRILLATION
D. Begley, L. Fananapazir, Bethesda MD, USA

10:15 EFFECTS OF PERMANENT DUAL-CHAMBER PACING ON MYOCARDIAL PERFUSION IN SYMPTOMATIC HYPERTROPHIC CARDIOMYOPATHY
J.L. Posma, E.E. van der Wall, Groningen, Leiden, The Netherlands

10:30 C o f f e e B r e a k

WEDNESDAY, MAY 19, 1999

PL16: Plenary Session
NEW APPROACHES TO SURGICAL REVASCULARIZATION
Chairpersons:  J.A. Elefteriades, New Haven CT, USA
                          T.A. Sanborn, New York NY, USA

10:45 NEW DEVELOPMENTS IN CARDIOPULMONARY BYPASS FOR NEONATES AND INFANTS - THE IMPORTANCE OF pH AND HEMATOCRIT (Invited Lecture)
R.A. Jonas, Boston MA, USA

11:00 THE BRAIN AND CARDIAC SURGERY (Invited Lecture)
J.G. Reves, Durham NC, USA

11:15 MECHANISMS OF ANGIOGENESIS AND PROSPECTS FOR ANGIOGENIC THERAPY (Invited Lecture)
J.M. Isner, Weston MA, USA

11:30 PERCUTANEOUS ENDOCARDIAL GENE THERAPY: IN VIVO ADENOVIRAL MEDIATED MARKER GENE TRANSFER AND EXPRESSION (Invited Lecture)
T.A. Sanborn, N. Tarazona, E. Deutsch, L. Lee, N. Hackett, T. El-Sawy, R.G. Crystal, T.K. Rosengart, New York NY, USA

11:45 THE CHANGING PRACTICE OF CORONARY BYPASS SURGERY: IMPACT ON RISKS AND RESULTS (Invited Lecture)
N.M. Katz, Washington DC, USA

12:00 MINIMAL ACCESS CORONARY BYPASS SURGERY (Invited Lecture)
V.A. Subramanian, New York NY, USA

12:15 SURGERY IN ENDSTAGE CORONARY ARTERY DISEASE (Invited Lecture)
H. Hausmann, R. Hetzer, Berlin, Germany

12:30 THE EFFECTS OF GLYCEMIC CONTROL ON CARDIAC SURGERY OUTCOMES
(Invited Lecture)
A.P. Furnary, K.J. Zerr, G. Grunkemeier, Portland OR, USA

WEDNESDAY, MAY 19, 1999

PL17: Plenary Session
DRUG THERAPY IN CARDIAC FAILURE
Chairpersons:  B.H. Greenberg, San Diego CA, USA
                          M.R. Johnson, Chicago IL, USA

10:45 VENTRICULAR REMODELING - IMPLICATIONS FOR PHARMACOLOGIC INTERVENTIONS (Invited Lecture)
B.H. Greenberg, San Diego CA, USA

11:00 PHARMACOLOGIC MODIFICATION OF DIASTOLIC DYSFUNCTION AFTER MYOCARDIAL INFARCTION (Invited Lecture)
B.I. Jugdutt, Edmonton, Alberta, Canada

11:15 TREATMENT OPTIONS FOR THE PATIENT WHO HAS FAILED CONVENTIONAL HEART FAILURE THERAPY (Invited Lecture)
M.R. Johnson, Chicago IL, USA

11:30 DRUG INTERACTIONS WITH DIURETICS IN CHRONIC CONGESTIVE HEART FAILURE (Invited Lecture)
A.J. Reyes, Montevideo, Uruguay

11:45 THE EMERGING PATHOPHYSIOLOGICAL ROLE OF ENDOTHELIN IN CARDIOVASCULAR DISEASE
E.H. Ohlstein, King of Prussia PA, USA

12:00 RENAL DOPAMINERGIC SYSTEM IN HEART FAILURE (Invited Lecture)
M. Cerqueira-Gomes, Porto, Portugal

12:15 SUPERIORITY OF 'TRIPLE' DRUG THERAPY IN HEART FAILURE: INSIGHTS FROM THE PROVED AND RADIANCE TRIALS
K.F. Adams, Jr., J.B. Young, M. Gheorghiade, B.F. Uretsky, H. Patterson, T.A. Schwartz, Chapel Hill NC, USA

WEDNESDAY, MAY 19, 1999

S61: ATHEROSCLEROSIS: BASIC RESEARCH AND CLINICAL ASPECTS
Chairpersons: O. Abdel-Aziz, Cairo, Egypt
                         S. Stern, Jerusalem, Israel

10:45 NEW DEFINITIONS FOR MYOCARDIAL ISCHEMIA WITHOUT CLINICAL MANIFESTATIONS
S. Stern, Jerusalem, Israel

11:00 EFFECT OF ENHANCED EXTERNAL COUNTERPULSATION ON NITRIC OXIDE PRODUCTION IN CORONARY DISEASE
X.-X. Qian, W.-K. Wu, Z.-S. Zheng, C.-Y. Zhan, B.-Y. Yu, W.E. Lawson, J.C.K. Hui, Stony Brook NY, USA

11:15 HIGH PREVALENCE OF CORONARY CALCIFICATIONS DETECTABLE BY ELECTRON BEAM CT IN YOUNG PATIENTS WITH ACUTE MYOCARDIAL INFARCTION AS THEIR FIRST MANIFESTATION OF CORONARY ARTERY DISEASE
S. Achenbach, D. Ropers, G. Muschiol, W. Moshage, W.G. Daniel, Erlangen, Germany

11:30 PURPLE GRAPE JUICE IMPROVES ENDOTHELIAL FUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE
J.H. Stein, J.G. Keevil, S. Aeschlimann, J.D. Folts, Madison WI, USA

11:45 DOES LOW FLUID INTAKE INCREASE THE RISK OF CORONARY HEART DISEASE?
J. Chan, S. Knutsen, Loma Linda CA, USA

12:00 LIFELONG ENDURANCE TRAINING IS ASSOCIATED WITH ENHANCED CARDIOVASCULAR EFFICIENCY AND IMPROVED AUTONOMIC CARDIOVASCULAR MODULATION IN THE ELDERLY
F. Galetta, F. Franzoni, C. Palombo, M. Kozakova, F. Cinotti, D. Taccola, C. Giusti, Pisa, Italy

12:15 THE RELATIONSHIP BETWEEN ENDOTHELIAL DYSFUNCTION AND INSULIN SENSITIVITY IS MODULATED BY LIPID PROFILE
S. Bandinelli, G. dell'Omo, L. Pucci, M. Mariani, R. Navalesi, R. Pedrinelli, G. Penno, Pisa, Italy

12:30 EXPRESSION OF PAI-1 AND TPA IS STIMULATED BY PHYSIOLOGICAL DOSES OF INSULIN IN THE FOREARM VASCULAR DISTRICT OF NORMAL SUBJECTS
F. Carmassi, F. De Negri, L. Ferrini, G. Dell'Omo, R. Pedrinelli, R. Fioriti, A. De Giorgi, Pisa, Italy

12:45 INFLUENCE OF METABOLIC CONTROL IN TYPE 2 DIABETES MELLITUS ON LIPID PEROXIDATION
D.D. Trifunovic-Zamaklar, M. Zamaklar, S. Markovic, N. Rajkovic, T. Milicic, Belgrade, Yugoslavia

13:00 DIETARY L-ARGININE SUPPLEMENTATION INHIBITED PLATELET AGGREGATION IN PATIENTS WITH CORONARY ARTERY DISEASE
E. Noeva, A. Sozykin, M. Menshikov, T. Balahonova, Moscow, Russia

WEDNESDAY, MAY 19, 1999

S68: VALVULAR HEART DISEASE / HEART VALVE SURGERY - ADULT
Chairpersons:  H. Boudoulas, Columbus OH, USA
                          D.M. Meyer, Dallas TX, USA

10:45 CARDIOMYOCYTE CYTOSKELETON CHANGES IN PATIENTS WITH LEFT VENTRICULAR HYPERTROPHY UNDERGOING AORTIC VALVE REPLACEMENT USING COLD CRYSTALLOID OR WARM BLOOD CARDIOPLEGIA
M. Caputo, S. Di Somma, G. Salvatore, G. Cudemo, M. Marotta, C. Rosati, M. Di Benedetto, G. Caputo, D.G. Angelini, Naples, Italy

11:00 NEW TECHNIQUE FOR CORRECTION OF ATRIAL FIBRILLATION - REDUCTION OF ATRIAL SIZE
M.C.S. Abreu, J. Carvalho, L.C. Sampaio, C. Alves, C.A.P. Alves, A.R. Filho, C. Cueva, A. Rabelo Jr., Salvador, Brazil

11:15 SURGICAL CORRECTION OF AORTIC DISEASE USING INTRALUMINAL RING - TEN YEARS EXPERIENCE
R. de Castro Bernardes, L.C. Moreira Lima, L.A. D'Avila Goncalves, F.A.R.R. Filho, Belo Horizonte, Brazil

11:30 EXPERIMENTAL HYPERCHOLESTEROLEMIA INDUCES APOPTOSIS IN THE RABBIT AORTIC VALVE
N. Rajamannan, K. Arnold, A.J. Tajik, R. Schwartz, Rochester MN, USA

11:45 PREDICTION OF COMMISSURAL MORPHOLOGY BY ECHOCARDIOGRAPHY AND ITS ROLE IN DETERMINING OUTCOME FOLLOWING INOUE BALLOON MITRAL VALVOTOMY
A. Kapoor, R.K. Singh, N. Sinha, A.S. Kumar, S. Radhakrishnan, S. Shrivastava, Lucknow, India

12:00 THE FREESTYLE STENTLESS BIOPROSTHIS HAS OPTIMAL HEMODYNAMICS FOR THE SMALL AORTIC ROOT
L.H.B. Baur, X.Y. Jin, A.P. Kappetein, J. Braun, C.H. Peels, Y. Houdas, P. Voogd, E.E. van der Wall, S. Westaby, H.A. Huysmans, Leiden, The Netherlands

12:15 NEW SCORE INDEX FOR PREDICTION OF SIGNIFICANT MITRAL REGURGITATION AFTER BALLOON MITRAL VALVOTOMY
O. Rifaie, A. Saleh, A. El Fiky, N. Farag, T. Zaki, Cairo, Egypt

WEDNESDAY, MAY 19, 1999

P113: Poster Session
ACUTE MYOCARDIAL INFARCTION, THROMBOLYSIS AND REPERFUSION

Board No.

1. THE DYNAMICS OF ECG CHANGES IN ACUTE MYOCARDIAL INFARCTION PATIENTS TREATED WITH STREPTOKINASE (SK)
I. Balla, A. Kondili, G. Ndrepepa, N. Kuka, P. Vargu, Tirana, Albania

2. ACUTE MYOCARDIAL INFARCTION (AMI) IN THE YOUNG, RISK FAXTORS EVOLUTION AND PROGNOSIS IN COMPARISON WITH AMI IN OLDER PATIENTS
C. Carp, A. Jalba, C. Ginghina, D. Rogozea, M. Tarlea, Bucharest, Romania

3. MYOCARDIAL INFARCTION WITH AND WITHOUT REPERFUSION IN SHEEP: CARDIAC, NEUROHUMORAL AND HEMODYNAMIC EFFECTS
C.J. Charles, J.M. Elliott, M.G. Nicholls, M.T. Rademaker, A.M. Richards, Christchurch, New Zealand

4. VALUE OF THE INITIAL ELECTROCARDIOGRAM IN PATIENTS WITH INFERIOR WALL ACUTE MYOCARDIAL INFARCTION FOR PREDICTION OF NEED FOR MULTIVESSEL CORONARY ARTERY REVASCULARIZATION
A. Mager, S. Sclarovsky, I. Herz, Y. Adler, B. Strasberg, Y. Birnbaum, Petah Tikva, Israel

5. EARLY PERICARDITIS AFTER ACUTE MYOCARDIAL INFARCTION, WITH AND WITHOUT THROMBOLYTIC THERAPY
M.M. Mendes Pedro, A. Paz Monteiro, A. Laureano-Santos, J.T.S. Soares-Costa, Lisbon, Portugal

6. PRIMARY REPERFUSION ASSOCIATED WITH IMPROVED IN-HOSPITAL AND LONG-TERM SURVIVAL OF KILLIP CLASS IV ACUTE MYOCARDIAL INFARCTION PATIENTS
W.L. Miller, T.C. Kim, R.S. Wright, J.P. Grill, S.L. Kopecky, Rochester MN, USA

7. THROMBOLYTIC THERAPY IN ELDERLY (>75 YRS) MI PATIENTS IS ASSOCIATED WITH INCREASED MORTALITY IN A COMMUNITY-BASED POPULATION
W.L. Miller, R.S. Wright, J.P. Grill, S.L. Kopecky, Rochester MN, USA

8. IN-HOSPITAL AND LONG-TERM OUTCOMES OF NON-Q WAVE MYOCARDIAL INFARCTIONS WITH AND WITHOUT THROMBOLYTIC THERAPY
J. Nagendran, S.M. Shaben, M.P. Senaratne, Edmonton, Alberta, Canada

9. CAPTOPRIL DOES NOT AFFECT PLASMA ENDOTHELIN-1 DURING THROMBOLYSIS AND REPERFUSION
P. Di Pasquale, S. Paterna, V.G. Parrinello, V. Bucca, S. Cannizzaro, F. Pipitone, G. Maringhini, S. Scalzo, G. Licata, Palermo, Italy

10. ST-SEGMENT DEPRESSION PATTERNS IN ACUTE MYOCARDIAL INFARCTION, AN ANALYSIS OF SIGNIFICANCE
A. Prasetyo, E. Caguioa, Quezon City, Philippines

WEDNESDAY, MAY 19, 1999

P128: Poster Session
PRIMARY PREVENTION OF CORONARY ARTERY DISEASE

Board No.

11. CLINICAL PREDICTORS OF THE LIKELIHOOD OF SIGNIFICANT CAD IN YOUNG MEN AND WOMEN ADMITTED WITH CHEST PAIN: INFLUENCE OF GENDER
K.O. Akosah, B. Gower, J. Cool, A. Schaper, La Crosse WI, USA

12. REVISITING PREMATURE CORONARY ARTERY DISEASE IN YOUNG WOMEN: IS ANYBODY PAYING ATTENTION?
K.O. Akosah, B. Gower, B. Rooney, K. Paul, R. Sundaram, A. Schaper, La Crosse WI, USA

13. IS ACUTE MYOCARDIAL INFARCTION MORE FREQUENT IN YOUNG MEN IN RURAL COMMUNITIES: THE GUNDERSEN LUTHERAN EXPERIENCE?
K.O. Akosah, C. Paul, A. Schaper, La Crosse WI, USA

14. CAROTID ARTERY STENOSIS AND OTHER RISK FACTORS FOR STROKE
E.S. del Fuerte, R.V. Anastacio, D.R. Flores Jr., E.S. Caguioa, M.J.D. Garcia, R.A. Naranjilla, Manila, Philippines

15. THE FUNCTIONAL CHARACTERIZATION OF THE SYMPATHETIC AND PARASYMPATHETIC NERVOUS SYSTEM OF THE HEART DURING VALSALVA MANEUVER
V.R.F.S. Maraes, E. Silva, T.F. Ribeiro, J. Petto, M.S.A. Moura, A.M. Catai, L. Oliveira, L.C. Trevelin, L. Gallo Jr., Sao Paulo, Brazil

16. STUDY OF MEDICAL PERFORMANCE IN THE PREVENTION AND DETECTION OF CARDIOVASCULAR RISK FACTORS IN A URBAN POPULATION OF FLORENCIO VARELA (BS. AS. ARGENTINA)
H. Navas, J. Vujocevich, A. Moiso, S. De Lena, M. Tavella, La Plata, Argentina

 

WEDNESDAY, MAY 19, 1999

P147: Poster Session
ANGIOPLASTY OR SURGERY FOR MULTIVESSEL
CORONARY ARTERY DISEASE

Board No.

17. DIRECT MYOCARDIAL REVASCULARIZATION WITHOUT EXTRACORPOREAL CIRCULATION
J.G. Lobo Filho, J.M.A.C. de Albuquerque, C.B.G. Gomes, M.C. Leitao, E.B. Pinheiro, N. Paes Jr., R.P. de Siqueira, R.M. Landim, R.R. Oliveira, Fortaleza, Brazil

18. PERFUSION FOR CARDIAC SURGERY USING VENOUS ARTERIAL SHUNT AND PURE OXYGEN IN MEMBRANE OXYGENATORS: 40 TO 50% OF THE VENOUS BLOOD RECIRCULATE ONLY
M.C.J. Moraes, J.R.J. Dias, Z.J. Moraes, S.L. Azevedo, N.M. Holanda, D.J. Moraes, Rio de Janeiro, Brazil

WEDNESDAY, MAY 19, 1999

P147: Poster Session
ANGIOPLASTY OR SURGERY FOR MULTIVESSEL
CORONARY ARTERY DISEASE (cont)

Board No.

19. GENDER DIFFERENCES FOR PERCUTANEOUS CORONARY INTERVENTIONS
A. Neri-Souza, G. Godinho, N. Ramos, R. Santos-Jesus, A. Rabelo, Salvador, Brazil

20. DOES AGE INFLUENCE THE OUTCOME OF CORONARY INTERVENTIONS?
A. Neri-Souza, G. Godinho, N. Ramos, R. Santos-Jesus, A. Rabelo, Salvador, Brazil

21. PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY VERSUS MEDICAL THERAPY FOR CORONARY ARTERY DISEASE
G.C. Vilela, P.P. San Diego, Quezon City, Philippines

22. PROGNOSIS AND QUALITY OF LIFE AFTER CABG IN THE ELDERLY
M.O. Shapira, J.D. Alkon, R. Chartrand, K. DeAndrade, S. Roy-Cutter, D. Whalen, J.L. Lazar, R.J. Shemin, Boston MA, USA

 

WEDNESDAY, MAY 19, 1999

P132: Poster Session
DILATED CARDIOMYOPATHY: VARIOUS ETIOLOGIES

Board No.

23. FAMILY STUDY IN IDIOPATHIC DILATED CARDIOMYOPATHY
Z.T. Bilinska, E. Michalak, B. Kusmierczyk-Droszcz, J. Grzybowski, M. Skwarek, W. Rydlewska-Sadowska, W. Ruzyllo, Warsaw, Poland

24. IGF-I AND IGFBP-3 RESPONSES TO THE LOWEST EFFECTIVE rhGH DOSE IN PATIENTS WITH DILATED CARDIOMYOPATHY (DCM)
F. Broglio, G. Aimaretti, E. Arvat, A. Benso, C. Gottero, M.F. Boghen, M. Bobbio, E. Ghigo, Turin, Italy

25. A STABLE MODEL OF CHRONIC BILATERAL HEART FAILURE INDUCED BY ARTERIO-VENOUS ANASTOMOSIS AND DOXORUBICIN ADMINISTRATION
V.S. Chekanov, G.V. Tchekanov, M.A. Rieder, Milwaukee WI, USA

26. CHAGAS HEART DISEASE PATIENTS AND RATE RESPONSIVE PACING (VVIR) REGULATED BY RIGHT VENTRICULAR CONTRACTILITY
O.T. Greco, R.V. Ardito, S.A.C. Garzon, N.C.S. Machado, M. Schaldach, Sao Paulo, Brazil

27. DETECTION OF ADENOVIRAL DNA IN ENDOMYOCARDIAL BIOPSIES OF ADULT PATIENTS WITH MYOCARDITIS OR DILATED CARDIOMYOPATHY
G. Hufnagel, C. Busse, B. Ihsche, S. Pankuweit, B. Maisch, Marburg, Germany

28. NONINVASIVE DETERMINANTS OF MORTALITY IN NON-ISCHEMIC DILATED CARDIOMYOPATHY
G. Kazianis, C. Michaelidis, A. Gournizakis, A. Economou, Athens, Greece

WEDNESDAY, MAY 19, 1999

P132: Poster Session
DILATED CARDIOMYOPATHY: VARIOUS ETIOLOGIES (cont)

Board No.

29. CLINICAL CHARACTERISTICS IN PATIENTS WITH DILATED PHASE OF HYPERTROPHIC CARDIOMYOPATHY
T. Morooka, N. Kotooka, K. Yoshida, K. Kido, K. Yoshida, T. Ogata, S. Tsuji, K. Ohmori, T. Utsunomiya, S. Matsuo, Saga, Japan

30. DETERMINATION OF MITOCHONDRIAL DNA POINT MUTATIONS IN PATIENTS WITH DILATED CARDIOMYOPATHY
V. Ruppert, B. Maisch, Marburg, Germany

31. ANOTHER FORM OF INTRAVENTRICULAR CONDUCTION DELAY: A VECTORCARDIOGRAPHIC STUDY OF THE LEFT-MIDDLE (SEPTAL) FASCICULAR BLOCK
P.J. Moffa, P.C.R. Sanches, C.A. Pastore, N.M.M.O. Tobias, A.P. Moraes, E.V. Lima, G. Belotti, Sao Paulo, Brazil

32. ECHOCARDIOGRAPHIC CORRELATES OF INCREASED LEFT VENTRICULAR CHAMBER SIZE
M. Baber, B.H. Sung, M.F. Wilson, K. Shah, A. Goldfarb, Buffalo NY, USA

 

WEDNESDAY, MAY 19, 1999

P135: Poster Session
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME

Board No.

33. GENDER DIFFERENCES IN SELF-ASSESSED QUALITY OF LIFE IN PATIENTS WITH HEART FAILURE
F. Bonaguidi, C. Palombo, C. Michelassi, E. Barberini, A. L'Abbate, Pisa, Italy

34. PROGNOSTIC VALUE OF HEART RATE VARIABILITY IN TIME AND FREQUENCY DOMAIN ANALYSIS IN CONGESTIVE HEART FAILURE
S. Boveda, M. Galinier, J. Fourcade, P. Lagrange, P. Massabuau, A. Patack, N. Prouteau, M. Delay, J-M. Fauvel, J.-P. Bounhoure, Toulouse, France

35. DOES EXERCISE OXYGEN CONSUMPTION ADD PROGNOSTIC INFORMATION TO REST ECHOCARDIOGRAPHY IN AMBULATORY PATIENTS WITH DILATED CARDIOMYOPATHY
G.R. Ciliberto, G. Piccalo, E. Lobiati, G. Cataldo, M. Frigerio, M. Mangiavacchi, A. Moreo, G. Cataldo, M. Frigerio, M. Mangiavacchi, A. Moreo, G. Masciocco, E. Gronda, Milan, Italy

36. CHANGES IN PEAK OXYGEN CONSUMPTION OVER TIME AS INDEPENDENT PROGNOSTIC MARKER IN PATIENTS WITH CHRONIC HEART FAILURE
V.G. Florea, M.Y. Henein, S.D. Anker, D.P. Francis, J.S. Chambers, D.G. Gibson, A.J.S. Coats, London, UK

WEDNESDAY, MAY 19, 1999

P135: Poster Session
PREDICTORS AND MARKERS OF HEART FAILURE OUTCOME (cont)

Board No.

37. PROGNOSTIC SIGNIFICANCE OF ABNORMAL SIGNAL-AVERAGED ELECTROCARDIOGRAM IN PATIENTS WITH ISCHEMIC CARDIOMYOPATHY
G. Kazianis, A. Economou, C. Michaelidis, P. Kalogeropoulos, S. Feggos, Athens, Greece

38. CLINICAL USE OF LACTATE TO IDENTIFY OCCULT PERFUSION DEFICITS IN HEART FAILURE PATIENTS
D. Milzman, R. Samaddar, W. Strudwick, Washington DC, USA

39. QUALITY OF LIFE OF CONGESTIVE HEART FAILURE PATIENTS AT THE PHILIPPINE GENERAL HOSPITAL
G.C. Vilela, P.P. San Diego, Jr., Quezon City, Philippines

40. WHICH EXERCISE PARAMETER BEST PREDICTS THE MORTALITY IN CHRONIC HEART FAILURE?
W. Shamim, M. Yousufuddin, S. Varney, C. Addison, J.S. Chambers, F.R. Amin, S.D. Anker, A.J.S. Coats, London, UK

41. LONG TERM RESULTS OF RIGHT VENTRICULAR OUTFLOW TRACT PACING EXPRESSED IN ECHOCARDIOGRAPHY
E. Krzyminska-Stasiuk, R. Wilczek, J. Staniewicz, G. Swiatecka, Gdansk, Poland

 

WEDNESDAY, MAY 19, 1999

P137: Poster Session
ACE INHIBITORS AND ANGIOTENSIN-II RECEPTOR BLOCKER

Board No.

42. EPROSARTAN REDUCES CARDIOMYOPATHY, IMPROVES ULTRASOUND AND MRI INDICES OF CARDIAC FUNCTION, IMPROVES RENAL FUNCTION AND ELIMINATES MORTALITY IN STROKE-PRONE RATS
R.W. Coatney, S. Chandra, A.H. Nelson, E.H. Ohlstein, G.Z. Feuerstein, R.N. Willette, D.P. Brooks, F.C. Barone, King of Prussia PA, USA

43. EFFECTS OF AT-1 RECEPTOR ANTAGONISTS ON OXIDATIVE STRESS, IN PATIENTS WITH CHRONIC HEART FAILURE
O. Burta, A. Salajan, A. Lazar, V. Salajan, L. Lazar, L. Burta, M. Farcas, Oradea, Romania

44. DO WE SELECT THE RIGHT PATIENTS IN CLINICAL TRIALS, IN CONGESTIVE HEART FAILURE?
P. Duc, V. Massuelle, J.M. Juliard, M.C. Aumont, Paris, France

WEDNESDAY, MAY 19, 1999

P137: Poster Session
ACE INHIBITORS AND ANGIOTENSIN-II RECEPTOR BLOCKER (cont)

Board No.

45. SAFETY, TOLERABILITY, AND NEUROHORMONAL CHANGES OF THE COMBINATION CAPTOPRIL PLUS LOSARTAN IN THE EARLY POSTINFARCTION PERIOD: A PILOT STUDY
P. Di Pasquale, V. Bucca, S. Scalzo, G. Parrinello, A. Pinto, A. Tuttolomondo, E. Capodieci, G. Follone, A. Cardinale, T. Maniscalchi, S. Paterna, Palermo, Italy

46. EFFECTS OF LONG TERM TREATMENT OF LOSARTAN ON RENAL HAEMODYNAMIC AND FUNCTION IN HYPERTENSIVE SUBJECTS
S. Paterna, R. Costa, R. Seaglione, V. Accardo Palumbo, A. Bova, G. Follone, A. Cardinale, T. Maniscalchi, G. Licata, Palermo, Italy

47. IRBESARTAN COMPARED WITH LISINOPRIL IN HEART FAILURE
N.K. Vijay, I.A. Alhaddad, D.M. Denny, D. Ruff, M. Yasin, L. Yellen, S. Lyver, C. Bryson, C.-S. Lin, R.A. Wolf, Denver CO, USA

 

WEDNESDAY, MAY 19, 1999

P146: Poster Session
PEDIATRIC CARDIOLOGY AND CARDIAC SURGERY, CONGENITAL HEART DISEASE

Board No.

48. THE VALUE OF 24-HOUR AMBULATORY ECG MONITORING IN CHILDREN WITH CARDIAC ARRHYTHMIAS DUE TO OPERATIONS OF CONGENITAL CARDIAC ANOMALIES
K. Baysal, F. Ozturk, R. Agac, B. Akkin, F. Kolbakir, H.I. Yaman, Samsun, Turkey

49. M MODE ECHOCARDIOGRAPHY EVALUATING CARDIOVASCULAR PERFORMANCE, AND VENTRICULAR FUNCTION IN VASOVAGAL SYNCOPE INDUCED BY TILT TEST
A. de Dios, E. Fischman, B. Zuchiatti, E. Flores, I. Abella, I. Torres, L.B. Lianes, P. Ziotsky, B. Zarlenga, E.A. Kreutzer, Buenos Aires, Argentina

50. SIGNIFICANCE OF PERFUSION ABNORMALITIES ON MYOCARDIAL SCINTIGRAPHY FOR PREDICTION OF THE SYSTEMIC RIGHT VENTRICULAR FAILURE IN PATIENTS AFTER ATRIAL SWITCH FOR COMPLETE TRANSPOSITION
B. Lubiszewska, E. Gosiewska, J. Rozanski, P. Hoffman, W. Poplawska, A. Teresinska, W. Ruzyllo, Warsaw, Poland

51. EXTRACARDIAC REPAIR OF COMPLEX UNROOFED CORONARY SINUS
J.A.M. van Son, G.S. Haas, J. Hambsch, F.W. Mohr, Leipzig, Germany

WEDNESDAY, MAY 19, 1999

P149: Poster Session
NEW APPROACHES TO SURGICAL PROCEDURES, MINIMALLY INVASIVE SURGERY, TMLR

Board No.

52. A NEW LOOK IN THE SURGERY OF THE JEHOVA'S WITNESS - SUPPORTING TECHNIQUES
M.C.S. Abreu, J.L. Carvalho, M. Granato, M.F. Fereira, C.A.P. Alves, A.R. Filho, C.N. Cueva, A. Rabelo Jr., Salvador, Brazil

53. "L"-SHAPE MINI-STERNOTOMY VERSUS MEDIAN COMPLETE STERNOTOMY FOR AORTIC VALVE OPERATIONS
J.L. Carvalho, L.C. Sampaio, M.C.S. Abreu, A. de J. Ribeiro, G. Pieracciani, C. Cueva, A. Rabelo Jr., Salvador, Brazil

54. INFLUENCE OF MEDIAN STERNOTOMY ON SURGICAL TREATMENT OF CORONARY ARTERY MULTIVESSEL DISEASE - A PROSPECTIVE CLINICAL TRIAL
V. Gulielmos, M. Brandt, T. Jost, M. Knaut, R. Cichon, M. Dangel, S. Schueler, Dresden, Germany

55. SELECTIVE APPLICATION OF CARDIOPULMONARY BYPASS AND MEDIAN STERNOTOMY FOR LESS MORBIDITY IN CORONARY ARTERY BYPASS SURGERY
U. Kappert, V. Gulielmos, T. Jost, K. Matschke, R. Cichon, M. Knaut, S. Schueler, Dresden, Germany

56. HYBRID REVASCULARIZATION
J.E. Rodriguez, M.J. Lopez Gude, J.J. Rufilanchas, L.C. Maroto, J. Tascon, A. Albarran, Madrid, Spain

57. TRIAL ON ADVANTAGES OF PRONE POSITIONING ON STROKE VOLUME IN HEALTHY VOLUNTEERS
D. Milzman, L. Moskowitz, A. Zlindenny, Washington DC, USA

58. EARLY AND MEDIUM TERM RESULTS OF AORTO-VENOUS BY-PASS GRAFTING ON MYOCARDIAL PERFUSION, VENTRICULAR FUNCTION AND PATIENT SYMPTOMS
P. Neary, A.D. Small, G. McCurrach, W. Martin, S.K. Naik, Glasgow, UK

59. NEW TECHNOLOGY FOR CARDIOPULMONARY BYPASS CANNULATION IN LIMITED-ACCESS CARDIAC SURGERY
J.B. Riebman, R.S. Bertolero, San Jose CA, USA

60. HOSPITAL MORTALITY FOLLOWING OPEN HEART SURGERY BASED ON POSTOPERATIVE INOTROPE REQUIREMENTS
L.E. Samuels, M.P. Thomas, P.C. Lin, J. Lee-Llacer, A.S. Wechsler, Philadelphia PA, USA

61. TRANSMYOCARDIAL LASER-REVASCULARISATION WITH A HOLMIUM:YAG-LASER: CLINICAL EXPERIENCE
R. Seitelberger, T. Wild, S.C. Beutelspacher, S. Memtsoudis, E. Wolner, J. Wolfram, Vienna, Austria

WEDNESDAY, MAY 19, 1999

P149: Poster Session
NEW APPROACHES TO SURGICAL PROCEDURES, MINIMALLY INVASIVE SURGERY, TMLR (cont)

Board No.

62. IS ENDOVASCULAR TREATMENT OF AORTIC ANEURYSMS POSSIBLE AS AN OUTPATIENT PROCEDURE?
H. Sievert, S. Vogt, H. Zeplin, D. Axt-Manz, J. Peters, S. Marzoll, H. Spies, R. Ensslen, R. Schrader, D. Scherer, H. Merle, A. Fach, Frankfurt, Germany

63. EARLY MYOCARDIAL HISTOLOGY AFTER TRANSMYOCARDIAL LASER-REVASCULARISATION
T. Wild, K. Schmidt, J. Wolfram, S.C. Beutelspacher, E. Wolner, R. Seitelberger, Vienna, Austria

 

WEDNESDAY, MAY 19, 1999

P150: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULT

Board No.

64. THROMBOLYTIC THERAPY FOR THROMBOSED MECHANICAL MITRAL VALVE PROTHESIS
V. Koca, T. Bozat, C. Sarikamis, V. Akkaya, Istanbul, Turkey

65. THE UTILITY OF PROBE PATENT FORAMEN OVALE IN REPLACING SEPTAL PUNCTURE DURING MITRAL BALLOON VALVULOPLASTY
T. Bozat, V. Koca, C. Sarikamis, V. Akkaya, Istanbul, Turkey

66. FACTORS WITH INFLUENCE IN THE REGRESSION OF LEFT VENTRICULAR MASS AFTER AORTIC VALVE REPLACEMENT
M. Vega, A. Amaro, F. Gude, J.R. Gonzalez-Juanatey, M. Gil, Santiago de Compostela, Spain

67. CLINICAL AND ECHOCARDIOGRAPHIC MONITORING OF PREGNANTS WITH AORTIC VALVE DISEASES
A. Lesniak, W. Tracz, P. Podolec, M. Pasowicz, Krakow, Poland

68. TRICUSPID ANNULOPLASTY IN MULTIVALVULAR DISEASE - RESULTS IN 1515 PATIENTS
B. Mihajlovic, L. Petrovic, M. Kovac, J. Lavac, S. Nicin, D. Kovacevic, D.D. Zecevic, Z. Jonjev, M. Mijatov, V. Scekic, P. Kovacevic, M. Fabri, N. Radovanovic, Novi Sad, Yugoslavia

WEDNESDAY, MAY 19, 1999

P150: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULT (cont)

Board No.

69. IMPROVEMENT IN CLINICAL OUTCOME AND LEFT VENTRICLE FUNCTION AFTER VALVE REPLACEMENT IN PATIENTS WITH AORTIC STENOSIS AND PREOPERATIVE LOW EJECTION FRACTION
E. Orlowska-Baranowska, D. Zakrzewski, M. Cybulski, T. Hryniewiecki, W. Rydlewska-Sadowska, K. Suwalski, M. Sliwinski, I. Rawczynska-Englert, Warsaw, Poland

70. PERCUTANEOUS TRANSVENOUS MITRAL COMMISSUROTOMY USING THE TRI-LUMEN SINGLE BALLOON CATHETER
C. Weng, Z. Guo, Guangzhou, China

 

WEDNESDAY, MAY 19, 1999

P152: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULT

Board No.

71. NEW TECHNIQUE FOR CORRECTION OF MITRAL INSUFFICIENCY IN RHEUMATIC FEVER
M.C.S. Abreu, J.L. Carvalho, R.S. Jesus, C. Alves, C.A.P. Alves, A.R. Filho, C.N. Cueva, A. Rabelo Jr., Salvador, Brazil

72. DESIRED ANTICOAGULATION LEVELS AMONG PATIENTS WITH MECHANICAL HEART VALVES
G.T. Catalan, A.M.L.A. Delos Reyes-Javier, F.C. Tomacruz, Manila, Philippines

73. THROMBOLYTIC THERAPY IN PROSTHETIC VALVE THROMBOSIS
I.M. Coman, E. Apetrei, C.T. Ginghina, C. Macarie, D. Qeshta, D. Filipescu, N. Florica, C. Carp, Bucharest, Romania

74. INITIAL EXPERIENCE WITH ATS MEDICAL MECHANICAL BILEAFLET PROSTHESIS
N. Radovanovic, B. Mihajlovic, L. Petrovic, M. Kovac, S. Nicin, M. Mijatov, J. Lavac, Z. Jonjev, M. Popov, M. Golubovic, A. Redzek, A. Milosavljevic, Novi Sad, Yugoslavia

75. CARBOMEDICS VERSUS ST. JUDE MEDICAL MECHANICAL AORTIC PROSTHESIS - COMPARATIVE FOLLOW-UP STUDY
B. Mihajlovic, M. Mijatov, L. Petrovic, J. Lavac, S. Nicin, Z. Potic, J. Selestiansky, Z. Jonjev, M. Popov, M. Potic, N. Radovanovic, Novi Sad, Yugoslavia

76. QT DURATION AND QT DISPERSION ANALYSIS IN PATIENTS WITH AORTIC STENOSIS - ARE THEY RELATED TO THE PRESENCE OF DECREASED LEFT VENTRICLE EJECTION FRACTION?
E. Orlowska-Baranowska, R. Baranowski, I. Rawczynska-Englert, W. Rydlewska-Sadowska, Warsaw, Poland

WEDNESDAY, MAY 19, 1999

P152: Poster Session
VALVULAR HEART DISEASE, HEART VALVE SURGERY-ADULT (cont)

Board No.

77. EVOLUTION OF ECHO PARAMETERS AND MORTALITY IN ELDERLY PATIENTS WITH SEVERE AORTIC STENOSIS. A 5 YEARS FOLLOW-UP
H. Pierri, L.V. Decourt, C. Medeiros, A. Catani, J.B. Serro-Azul, O. Gebara, A. Nussbacher, L.B.P. Pivotto, A.C.P. Barretto, M. Wajngarten, J.A.F. Ramires, Sao Paulo, Brazil

78. DIFFERENCES IN LENGTH OF STAY BETWEEN CORONARY BYPASS AND VALVE PROCEDURES
H.F. Tripp, J.A. Obney, D.L. Febinger, Houston TX, USA

P153: Poster Session
SURGERY FOR LV DYSFUNCTION, MECHANICAL SUPPORT, CARDIAC TRANSPLANTATION

Board No.

79. SHOULD OBESITY BE A CONTRAINDICATION TO CARDIAC TRANSPLANT LISTING?
C.W. Sprowles, P. Singh, P. Cerrito, G. Bhat, Louisville KY, USA

80. ENHANCED EXTERNAL COUNTERPULSATION PROTECTS CORONARY ARTERY DISEASE PATIENTS FROM FUTURE CARDIAC EVENTS
S. Karim, M. Kasim, R. Suwita, I. Andaningshih, Jakarta, Indonesia

81. NON INVASIVE CONTROL OF REJECTION AFTER HEART TRANSPLANTATION USING INTRACARDIAC ELECTROGRAM MONITORING
F.A. Lucchese, P. Brofman, P. Leaes, J.D. Frota Filho, W. Pereira, Porto Alegre, Brazil

82. INFLUENCE OF ACUTE CARDIAC ALLOGRAFT REJECTION ON TRANSMURAL DISPERSION OF REPOLARISATION
A.Z. Pietrucha, B. Stobierska-Dzierzek, D. Mroczek-Czernecka, I. Pietrzak, M. Wegrzynowska, A. Paradowski, W. Piwowarska, Cracow, Poland

83. CHANGES IN LEFT VENTRICULAR MORPHOLOGY AND FUNCTION IN END-STAGE DILATED CARDIOMYOPATHY AFTER REDUCTIVE ANNULOPLASTY OF DOUBLE MITRAL AND TRICUSPID ORIFICES - TEE STUDY
N. Radovanovic, L. Petrovic, M. Kovac, B. Mihajlovic, M. Mijatov, S. Nicin, Z. Konstantinovic, S. Popovic, M. Preradovic, M. Popov, D.D. Zecevic, Novi Sad, Yugoslavia

84. THE PATHOLOGICAL STUDY OF CENTRIFUGAL IMPELLER PUMP AS LEFT VENTRICULAR ASSIST DEVICE (LVAD) IN CALF
J.J. Shyu, S.H. Chu, S.S. Wang, N.K. Chou, K.X. Qian, S.K. Liu, Taipei, Taiwan-R.O.C.

WEDNESDAY, MAY 19, 1999

P153: Poster Session
SURGERY FOR LV DYSFUNCTION, MECHANICAL SUPPORT, CARDIAC TRANSPLANTATION (cont)

Board No.

85. HEMODYNAMIC EFFECTS OF ENHANCED EXTERNAL COUNTERPULSATION IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
I. Taguchi, K. Ogawa, A. Oida, H. Kuga, H. Suzuki, I. Nagao, N. Kaneko, H. Sakio, Tochigi, Japan

86. SIGNAL AVERAGED ELECTROCARDIOGRAM IN PATIENTS SUBMITTED TO THE LEFT VENTRICULAR PARTIAL VENTRICULECTOMY (BATISTA OPERATION)
N. Tobias, P.J. Moffa, C.A. Pastore, P. Sanches, E. Bochi, F. Bacal, M.A. Silva, N. Stolf, J.F. Ramires, Sao Paulo, Brazil

 

WEDNESDAY, MAY 19, 1999

P159: Poster Session
DRUG THERAPY FOR ISCHEMIC HEART DISEASE

Board No.

87. OXIDATIVE STRESS IN PATIENTS WITH UNSTABLE ANGINA: THE EFFECTS OF TALINOLOL, A CARDIOSELECTIVE BETA-BLOCKERS
A. Campeanu, R. Olinescu, M. Vasile, V. Teodorescu, O. Zaharia, Bucharest, Romania

88. EFFECTS OF VERAPAMIL ON e-NOS mRNA EXPRESSION FOLLOWING ISCHEMIA-REPERFUSION IN ISOLATED WORKING RAT HEARTS
P. Di Napoli, A. Maggi, A.A. Taccardi, A. Di Crecchio, R. Spina, G. Ranalli, L. Stuppia, G. Palka, A. Barsotti, Chieti, Italy

89. EFFECTS OF ADENOSINE ON eNOS mRNA EXPRESSION IN RAT HEARTS SUBMITTED TO ISCHEMIA - REPERFUSION
P. Di Napoli, A.A. Taccardi, A. Maggi, R. Spina, G. Torge, L. Stuppia, G. Palka, A. Barsotti, Chieti, Italy

90. EFFECTS OF LOSARTAN ON e-NOS AND i-NOS mRNA EXPRESSION AND ON MYOCYTES APOPTOSIS IN ISOLATED WORKING RAT HEART
P. Di Napoli, A. Maggi, A.A. Taccardi, G. Contegiacomo, R. Spina, S. Volpe, L. Stuppia, G. Palka, A. Barsotti, Chieti, Italy

91. ROLE OF INTRAVENOUS METOPROLOL IN ACUTE MYCARDIAL INFARCTION
P. Kumar, B.S. Kushwaha, Jhansi U.P., India

92. NEW IN SUSTAC-FORTE METABOLISM IN CAD PATIENTS
A.P. Sisetskiy, Kiev, Ukraine

WEDNESDAY, MAY 19, 1999

P163: Poster Session
VASCULAR BIOLOGY, BASIC RESEARCH II

Board No.

93. COMPARATIVE PROSPECTIVE B-MODE ULTRASOUND IMAGING STUDIES OF CAROTID AND FEMORAL ARTERY WALLS IN PATIENTS WITH CORONARY, CEREBROVASCULAR OR FEMOROPOPLITEAL ARTERY DISEASE
E. de Groot, R.J.G. Peters, L.M. Blok, M.H. Prins, A.H. Zwinderman, H.R. Bueller, Amsterdam, The Netherlands

94. INHIBITION OF NEOINTIMA HYPERPLASIA OF MOUSE VEIN GRAFTS BY LOCALLY-APPLIED SURAMIN
Y. Hu, Y. Zou, B. Metzler, H. Dietrich, G. Wich, Q. Xu, Innsbruck, Austria

95. ACTIVATION OF STRESS-ACTIVATED PROTEIN KINASES/C-JUN N H _2- TERMINAL PROTEIN KINASES (SAPK/JNK) IN ATHEROSCLEROTIC LESIONS: ROLE OF LDL
B. Metzler, Y. Hu, H. Dietrich, Q. Xu, Innsbruck, Austria

96. IMPAIRED SHEAR-MEDIATED COLLATERAL DEVELOPMENT IN RESISTANCE ARTERIES OF HYPERTENSIVE RATS
V.K. Murthy, S.W. Fath, H.M. Burkhart, M.C. Dalsing, J.L. Unthank, Indianapolis IN, USA

97. SMOOTH MUSCLE CELL PHENOTYPE INFLUENCES APOPTOSIS IN RAT AORTIC NEOINTIMA AFTER ENDOTHELIAL INJURY
A. Orlandi, M. Marcellini, L. Anemona, L.G. Spagnoli, Rome, Italy

98. 8-CHLORO- cAMP INHIBITS SMOOTH MUSCLE CELL PROLIFERATION IN VITRO AND NEOINTIMA FORMATION INDUCED BY BALLOON INJURY IN VIVO
C. Perrino, C. Indolfi, E. Di Lorenzo, A. Rapacciuolo, G. Esposito, O. Arcucci, M. Pascotto, A. Cioppa, G.P. Tortora, F. Cardiello, M. Chiariello, Naples, Italy

99. ANTI-PROTHROMBIN ANTIBODIES ARE FREQUENTLY FOUND IN PATIENTS WITH ARTERIAL THROMBOSIS WITHOUT BIOLOGICAL RISK FACTORS FOR THROMBOPHILIA
J.C. Reverter, F.J. Munoz, D. Tassies, J. Font, G. Escolar, M. Ingelmo, A. Ordinas, Barcelona, Spain